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Abstract 
 
As for many proteins, subunits of the COPI and COPII vesicular coats have diverged during evolution. 
To date, multiple isoforms of almost all proteins involved in the formation of these vesicles can be 
found in higher organisms. While work of others and our own lab has established an important role 
of the four Sec24 isoforms in the process of cargo/machinery recruitment into COPII vesicles, it 
remains largely elusive what purpose the isoforms of the coatomer subunits γ- and ζ-COP as well as 
of the small GTPase Arf (Arf1-6) serve in COPI formation. To investigate a putative role of these 
proteins in the recruitment of specific proteins into COPI vesicles, and deepen our current 
understanding of the roles of COPII coat isoforms, we established a method to purify in vitro 
reconstituted vesicles from SILAC-labeled cells in order to assess and compare their protein content. 
By doing so we were able to narrow down a concise set of proteins that represents the proteome of 
these two classes of early secretory pathway vesicular carriers. In contrast to the COPII system, we 
found that neither isoforms of γ- or ζ-COP, nor any of the four vesicle-generating isoforms of Arf 
seem to have any influence on the content composition of COPI vesicles. However, while the 
isoforms of coatomer seem to be capable of recruiting cargo proteins with virtually identical efficacy, 
Arf1 could be distinguished as the most potent COPI-forming GTPase isoform. 
We further investigated disease-related mutations identified in one particular Sec24 isoform, 
Sec24D. These mutations were recently shown to be the sole cause for the development of a 
syndromic form of osteogenesis imperfecta, which is better known as brittle bone disease. We could 
show that one single point mutation within Sec24D, the conversion of serine in position 1015 to 
phenylalanine, completely abrogates the ability of this protein to bind to the ER-Golgi Qa-SNARE 
protein Syntaxin5 in direct interaction studies. As a consequence, COPII vesicles formed by this 
Sec24D variant were largely depleted in not only Syntaxin5 but also its partner ER-Golgi SNAREs GS27 
and Bet1. 
Moreover we studied fibroblast cells derived from a patient that carries the Sec24DS1015F mutation in 
one allele and a point mutation that causes a premature stop-codon within the second allele of the 
gene. In such cells, the level of all four ER-Golgi SNAREs and also some intra-Golgi SNARE proteins 
was markedly reduced. However, the distribution of Syntaxin5 under steady state conditions 
reflected that of control cells. 
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Zusammenfassung 
 
Im Verlauf der Evolution kam es zur Diversifikation vieler Proteine, darunter auch Untereinheiten der 
COPI und COPII Vesikelhüllen-Proteine. Inzwischen ist klar, dass von fast allen Proteinen, welche bei 
der Entstehung von COPI oder COPII Vesikeln in höheren Organismen eine Rolle spielen, mehrere 
Isoformen existieren. Während eine entscheidende Rolle der vier Isoformen von Sec24 beim Prozess 
der Maschinerie-/Frachtaufnahme in COPII Vesikel durch die Arbeiten Anderer und unseres Labors 
etabliert wurde, bleibt die Frage nach der Funktion der Isoformen der Coatomer Untereinheiten γ- 
und ζ-COP beziehungsweise der kleinen GTPase Arf (Arf1-6) bei der COPI Biogenese bisher 
unbeantwortet. Um eine mögliche Rolle dieser Proteine im Zusammenhang mit spezifischer Protein 
in COPI Vesikel zu untersuchen und unser bestehendes Verständnis dieser Rolle für COPII 
Vesikelhüllen-Proteine zu vertiefen, haben wir eine neue Methode zur Aufreinigung von in vitro 
rekonstituierten Vesikeln aus SILAC-markierten Zellen etabliert um deren Inhalt untersuchen und 
vergleichen zu können. Hierdurch war es uns möglich eine präzise Aufstellung jener Proteine 
vorzunehmen, die in Vesikeln des frühen sekretorischen Wegs zu finden sind. Wir konnten 
feststellen, dass Isoformen von γ- oder ζ-COP, beziehungsweise der vier Vesikel-formenden 
Isoformen von Arf keinen wesentlichen Einfluss auf den Protein-Inhalt von COPI Vesikeln haben, 
anders als im COPII System. Wir konnten jedoch beobachten, dass Arf1 die potenteste Isoform aller 
COPI-formenden GTPasen ist, während die Fähigkeit zur Frachtaufnahmen bei den Coatomer 
Isoformen sehr ähnlich zu sein scheint. 
Desweiteren haben wir krankheitsausprägende Mutationen in einer bestimmten Sec24 Isoform - 
Sec24D - untersucht. Diese kürzlich identifizierten Mutationen führen als einzige Ursache zur 
Ausprägung einer syndromischen Form von osteogenesis imperfecta, besser bekannt als 
Glasknochenkrankheit. Mithilfe direkter Interaktionsstudien konnten wir zeigen, dass eine einzige 
Punktmutation in Sec24D, Konversion von Serin in Position 1015 zu Phenylalanin, die Fähigkeit des 
Proteins an das ER-Golgi Qa-SNARE Protein Syntaxin5 zu binden, vollständig in blockiert. Als 
Konsequenz daraus, enthalten COPII Vesikel, die mit dieser Sec24D Variante hergestellt werden 
sowohl kaum Syntaxin5 als auch nur geringe Mengen der übrigen ER-Golgi SNAREs GS27 und Bet1. 
Wir untersuchten zudem Fibroblasten eines Patienten, der zum einen die bereits erwähnte 
Sec24DS1015F Mutation trägt und dessen zweites Sec24D Allel zudem eine Mutation enthält die in 
einem verfrühten Stop-Codon resultiert. Die Menge aller vier ER-Golgi und einiger intra-Golgi SNARE 
Proteine war in diesen Zellen erheblich reduziert. Demgegenüber konnten wir keine abweichende 
intrazelluläre Verteilung von Syntaxin5 im Vergleich zu Kontrollzellen beobachten.   
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1 Introduction 
 
1.1 Organelles of the Secretory Pathway and their Discovery 
 
The secretory pathway is an elaborate logistic center that is found in all eukaryotes. The major part 
of a cells’ membrane material forms this system. It can be roughly divided into three major functional 
units: The endoplasmic reticulum, the Golgi apparatus, and the endosomal system including the 
plasma membrane. In the following I briefly discuss the discovery of these organelles and try to point 
out their main functions. 
 
1.1.1  The Endoplasmic Reticulum  
 
In an early electron microscopic study from 1945, Keith Porter and his colleagues discovered 
structures which they described as “lace-like reticulum” (Porter et al., 1945). The term reticulum 
became widely accepted and was further specified by the prefix endoplasmic which simply 
underlines its location within the cytoplasm of a cell (Porter and Kallman, 1952). Over the cause of 
the following years it became clear that the endoplasmic reticulum (ER) is the largest of organelles 
which together make up the endomembrane system of a eukaryotic cell. George Palade noticed in 
the mid 1960s that the ER can be basically divided into two major functional units already based on 
its appearance under the electron microscope. He observed that some areas of the ER membrane 
appear to be smooth (smooth ER; sER), other regions seemingly were surrounded by a rough (rough 
ER; rER), dense outer surface (Palade, 1955, 1956; Palade and Siekevitz, 1956). 
Shortly thereafter, first indications pointed towards a role of the rER in protein secretion. It became 
clear that the dense surface of the rER was formed by “ribosomes”, a term coined by Richard B. 
Roberts that supposedly serve the synthesis of proteins destined to enter the pathway of secretion 
(Siekevitz and Palade, 1960). In the following decade more and more evidence was gathered in 
electron microscopic studies and radioactive labeling experiments that supported this idea (Blobel 
and Sabatini, 1970; Redman and Sabatini, 1966; Sabatini and Blobel, 1970; Sabatini et al., 1966). 
Together these findings then ultimately led to the proposal of the signal hypothesis by Günther 
Blobel and David Sabatini in 1971 which predicts the presence of specific targeting signals for protein 
entry into the secretory pathway. Only four years later, Blobel together with Bernhard Dobberstein 
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was able to prove the signal hypothesis experimentally in two classic publications (Blobel and 
Dobberstein, 1975a, b). 
It is common knowledge nowadays that the rough ER is the birthplace of secreted proteins. Most of 
them carry a so-called signal sequence/peptide, a short stretch of amino acids at the N-terminus of 
the protein (Blobel and Dobberstein, 1975b). This sequence is recognized like a barcode once it 
emerges from the exit tunnel of the translating ribosome by targeting factors, amongst other 
proteins (Krieg et al., 1986; Kurzchalia et al., 1986). The most prominent and first discovered 
ER-targeting factor was the signal recognition particle (SRP) (Walter and Blobel, 1980). When 
engaged with a ribosome, the SRP-ribosome complex is targeted to the ER membrane (Walter and 
Blobel, 1981a, b). The nascent chain subsequently elongates while being transcribed through a pore 
that is formed by the so-called Sec61 translocon in order to reach the lumen or the ER (Crowley et al., 
1994; Crowley et al., 1993; Görlich et al., 1992).  
In contrast to the rough ER which on EM images often appears as ribosome-studded flat cisternae, 
the smooth ER is more dilated and vesicular in structure. The difference in shape is linked to its 
function. The sER is not specified in producing transmembrane and secreted protein, but plays a 
pivotal role in lipid biosynthesis, synthesis of steroids, detoxification and the regulation of calcium 
homeostasis (reviewed in Baumann and Walz, 2001; Fagone and Jackowski, 2009; Schwarz and 
Blower, 2016; Shibata et al., 2006). Moreover, the smooth ER is often viewed as part of a larger 
fraction of the ER, called the transitional ER (tER) (Palade, 1975). The term transition in this context 
does not point out the transition from ribosome-associated to ribosome-free regions but rather at its 
function: It is the region of the ER from where vesicular transport/transition is initiated. The tER is 
located close to the cis-side of the Golgi (Schweizer et al., 1988). Because of its appearance it is also 
called vesicular tubular clusters (VTCs) (Bannykh et al., 1996), a name that can be used synonymous 
with tER. More commonly used nowadays is the term ER-Golgi intermediate compartment (ERGIC) 
(Klumperman et al., 1998; Schweizer et al., 1990) which points out the chimeric character of this sub-
compartment. The export of proteins from the ER is discussed in detail in the following. 
 
1.1.2 The Golgi Apparatus 
 
In contrast to the ER, the Golgi apparatus was discovered long before the invention of electron 
microscopy. At the end of the 19th century, Italian physician and histologist Camillo Golgi invented a 
silver-staining method for his studies of neuronal cells. Eventually he recognized reappearing 
intracellular structures that now carry his name (Golgi, 1989a, b; translations of the original articles 
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from 1898). Reportedly, the existence of the Golgi apparatus was hotly debated because it could not 
be observed in living cells but was only visible with the silver-staining technique introduced by Golgi. 
It took until the advent of electron microscopy when the existence of a membranous organelle that 
occupied the same regions stained by the Golgi-staining could be ultimately confirmed (Dalton and 
Felix, 1954; Sjostrand and Hanzon, 1954). Dalton and Felix described the morphology of the Golgi 
complex as it is generally found in higher organisms. They observed vacuole-like structures, flat 
profiles, lamellae, and vesicles (Dalton and Felix, 1954, 1956). 
Scientist started to understand the function of this organelle during the 1960s. Again, Palade, this 
time together with co-workers Lucien Caro and James Jamieson, found first evidence for a role of the 
Golgi apparatus in protein secretion by using a combined approach of autoradiography, electron 
microscopy, and cellular fractionation (Caro and Palade, 1964; Jamieson and Palade, 1967; Palade, 
1975). Simultaneously, employing similar methods, the lab of Charles Lebond could show that the 
Golgi apparatus is incorporating labeled sugar molecules (Neutra and Leblond, 1966; Whur et al., 
1969). This work was further substantiated by parallel studies from other labs which could show that 
the activity of glycosyltransferases is greatly increased in Golgi-enriched membrane fractions, 
pointing towards a role of the Golgi in glycosylation (Fleischer et al., 1969; Morre et al., 1969). After 
having found two major tasks of the Golgi it became clear that the Golgi complex cannot be viewed 
as one compartment where each region carries out the same functions (Novikoff et al., 1971). 
Instead, distinct regions of the Golgi are fulfilling very specific tasks (Kornfeld and Kornfeld, 1985). 
Nowadays, the cisternae of a Golgi stack are generally divided into a cis-, medial-, and trans-Golgi 
entity. Each sub-compartment contains a specific set of enzymes that successively drive the 
maturation of glycosylation that begins in the ER (reviewed in Dunphy and Rothman, 1985; Kornfeld 
and Kornfeld, 1985). Moreover, looser network-like structures were found both at the cis- and the 
trans-side of the Golgi. The ERGIC, mentioned in the previous section, is also known as cis-Golgi 
network (CGN). Here, secretory COPII vesicles from the ER arrive and also retrograde COPI vesicles do 
form (Appenzeller-Herzog and Hauri, 2006). Furthermore, it has also been shown to play a pivotal in 
sorting of lysosomal proteins, the initial tagging of which takes place as early as at the CGN-level 
(Coutinho et al., 2012; Schweizer et al., 1991). 
The trans-Golgi network (TGN) on the opposite side of the complex is a very specialized sorting hub. 
There is no other sub-compartment of the secretory pathway from where more different trafficking 
routs are taken (Griffiths and Simons, 1986; Gu et al., 2001). The TGN is furthermore the stage at 
which vesicular transport is no longer driven by the COPI/COPII system. Here other classes of 
vesicles, of which many are associated with the scaffold clathrin, take over vesicular transport 
(Robinson, 2004). 
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1.1.3 Late Secretory Organelles: The Endosomal System 
 
For some secreted proteins, the last packing into a carrier occurs at the TGN from where they are 
then directly transported towards the plasma membrane (PM). In yeast this is facilitated by packing 
of such proteins into carriers that are formed by the exomer complex (Wang et al., 2006). In 
mammals, the same trafficking route seems to exist, although it remains unclear how exactly these 
carriers form (Bard and Malhotra, 2006; Klemm et al., 2009; Wakana et al., 2012). The TGN-PM 
trafficking is in general poorly understood when compared to for example the back-and-forth 
exchange of material between the ER and the Golgi. One possible reason for this might be the 
presence of another elaborate section of the secretory pathway acting after the Golgi: The 
endosomal system. Its discovery is preceded by the discovery of the lysosomes by de Duve and his 
co-workers (Appelmans et al., 1955; De Duve and Wattiaux, 1966; Essner and Novikoff, 1961). First 
evidence for the existence of a compartment he called “phagosome” came from Werner Straus 
(Straus, 1964). He observed that internalized horseradish peroxidase was first in a membranous 
compartment separate from the lysosome with which it would eventually merge over time. Twenty 
years later, Ira Mellman and co-workers separated those organelles which they named “endosomes” 
from denser lysosomes (Galloway et al., 1983). 
After first discovering the organelle it became rapidly clear that - similar to Golgi complex - the 
endosome cannot be viewed as a uniform compartment. Endocytic vesicles fuse in order to form an 
early endosome which are also referred to as sorting endosomes (Gruenberg et al., 1989). Here, 
molecules to be ultimately degraded via the lysosomal pathway are separated from e.g. receptors 
which are recycled for another round of recognition and internalization (Maxfield and McGraw, 2004; 
Mayor et al., 1993). Moreover, trafficking between early endosomes and the TGN has been observed 
(Bonifacino and Rojas, 2006). The early endosomes will at some point mature to become a late 
endosome, a process that is regulated in part by Rab GTPases (Huotari and Helenius, 2011). Late 
endosomes then fuse with one another and with lysosomes in order to form a terminal organelle for 
the degradation of proteins (Luzio et al., 2010; Luzio et al., 2007). 
 
Introduction 
7 
 
 
Figure 1.1 Organelles of the Secretory Pathway 
Drawn are the organelles of the secretory pathway. Red arrows mark the transport of material. The classes of vesicular 
coat, which acts at the respective organelles, are indicated above the drawing. For additional information refer to 
(Bonifacino and Glick, 2004; Robinson, 2004) 
 
1.2 COPII Vesicles: ER to Golgi Transport 
 
The endoplasmic reticulum as the largest of secretory organelles harbors its own vesicular transport 
system. The current knowledge about the general mechanism of COPII vesicle biogenesis, 
non-essential accessory protein which support this process, as well as cargo-uptake, is discussed in 
the following. 
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1.2.1 COPII Vesicles: Biogenesis 
 
The endoplasmic reticulum (ER) is the first organelle which proteins have to access in order to enter 
the secretory pathway. From here proteins are transported within an organelle-specific type of 
vesicles to the Golgi apparatus. The proteins that form the coat of the so-called COPII vesicles were 
first identified in genetic screen carried out in the lab of Randy Schekman (Novick et al., 1981; Novick 
et al., 1980). COPII vesicles bud at specialized domains of the ER termed ER-exit sites (ERES) (Orci et 
al., 1991; Rossanese et al., 1999). These are stable, long-lived structures which can be formed de 
novo (Bevis et al., 2002; Stephens, 2003).  
COPII vesicle formation at these sites starts by the activation of secretion-associated Ras-related 
GTPase 1 (Sar1). This is facilitated by its membrane-bound guanidine nucleotide exchange factor 
(GEF) Sec12, which exchanges GDP for GTP rendering the protein from a soluble to a membrane 
associated-state (Barlowe et al., 1993; Barlowe and Schekman, 1995; d'Enfert et al., 1991; Nakano et 
al., 1988). The activation of Sar1 in mammals seems to occur mainly at ERES as both, Sec12 and Sar1, 
are enriched in this region of the ER (Kuge et al., 1994; Weissman et al., 2001).  
Once bound to GTP, the conformation of Sar1 changes dramatically. It exposes an amphipathic 
α-helix located at its N-terminus which unlike that of other small GTPases involved in trafficking is 
not post-translationally modified by a myristoyl group or prenyl moiety (Bi et al., 2002; Huang et al., 
2001). The helix is not only pivotal for the membrane binding ability but is furthermore key to the 
membrane surface activity of Sar1 (Bielli et al., 2005). Membrane-anchored Sar1 binds to single 
dimers of Sec23/Sec24 with the interaction surface being formed be Sar1 and Sec23 (Bi et al., 2002). 
The trimeric complex is further believed to interact with acidic lipids of the ER-membrane via a 
conserved positively charged surface in order to achieve a more stable association (Bi et al., 2002; 
Matsuoka et al., 1998). 
Between the two subunits of the inner coat complex, Sec23/Sec24, there is a strict division of labor. 
While Sec23 functions as the build-in GTPase activating proteins (GAP) for Sar1 (Yoshihisa et al., 
1993), Sec24 is binding to short cytoplasmic tails of membrane proteins, a process that is important 
for the formation of so-called “pre-budding complexes” (Aridor et al., 1998; Kuehn et al., 1998; 
Kuehn et al., 1996). These pre-budding complexes alone are not capable of deforming the ER 
membrane into a bud or vesicle (Lee et al., 2005). This is only achieved by the addition of a second, 
outer layer of coat which is composed of heterotetramers containing two subunits of each, Sec13 
and Sec31. The fact that Sec13/31 functions as the scaffold for COPII formation can already be 
deduced from its feature of forming empty cages by itself (Stagg et al., 2006). In vivo, the outer coat 
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is recruited via an interaction of the Sec31 subunit with an interface that is formed by Sec23 and Sar1 
(Bi et al., 2007). This interaction does not only lead to the formation of a COPII bud but also triggers 
GTP hydrolysis in Sar1 (Antonny et al., 2001). Another factor that seems to play an important role in 
modulating Sar1 activity and organization of ERES is Sec16 (Sprangers and Rabouille, 2015). 
Scission of the vesicles relies on the ability of Sar1 so deform membranes into tubules or even small 
vesicles at very high concentrations (Hariri et al., 2014; Lee et al., 2005). While the scission of COPII 
vesicles is not dependent on the ability of Sar1 to hydrolyze GTP (Adolf et al., 2013; Barlowe et al., 
1994) uncoating cannot happen when GTP hydrolysis is blocked (Aridor et al., 1995; Barlowe et al., 
1994; Oka and Nakano, 1994). In addition to the core machinery of COPII vesicle biogenesis, several 
other factors are crucial to ensure an optimal efficacy in cargo of formation, cargo packing and 
targeting in vivo which are thoroughly discussed elsewhere (Venditti et al., 2014; Zanetti et al., 2011).  
 
Figure 1.2 COPII Vesicle Biogenesis 
At the ER membrane, Sar1 is brought into an active, membrane-bound state by nucleotide exchange to GTP facilitated by 
Sec12. It in turn recruits the inner COPII coat, various heterodimeric Sec23/Sec24 complexes which together with 
transmembrane proteins form a pre-budding complex. The outer scaffolds, heterotetrameric Sec13/Sec31 complexes, join 
the pre-budding complex and polymerize to form a bud that will eventually undergo scission. Hydrolysis of GTP bound to 
Sar1 is stimulated by its built-in GAP, Sec23, will release the coat and allow fusion of the vesicle with its target membrane. 
For details and literature please refer to the main text. Images were taken and modified from Adolf et al. (2016) and Popoff 
et al. (2011a). 
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1.2.2 COPII vesicles: Cargo sorting 
 
After the finding that COPII vesicles are responsible for the ER-exit of secreted proteins, it was 
discovered that certain components of the COPII coat modulate the content of these carriers (Aridor 
et al., 1998; Kuehn et al., 1998; Kuehn et al., 1996). This led to the discovery of the first COPII sorting 
motif present in the C-terminal cytoplasmic tail of the vesicular stomatitis virus glycoprotein (VSV-G) 
(Nishimura and Balch, 1997) which is required to concentrate the protein at sites of COPII formation 
(Nishimura et al., 1999). The VSV-G sorting motif – DxE - is extremely short and its main feature is 
two acidic residues. Motifs following the same consensus (i.e. DxD/ExE/ExD) have been identified 
subsequently in non-viral endogenous protein Sys1p/Gap1p in yeast (Malkus et al., 2002; Votsmeier 
and Gallwitz, 2001) and Kir1.1/Kir2.1 in mammals (Ma et al., 2001). Later it was shown that the 
regions flanking diacidic motifs are important for their proper function (Ma et al., 2001; Sevier et al., 
2000). 
Using pulldown assays, reconstitutions and crystallography, the labs of Jonathan Goldberg and Randy 
Schekman were able to identify the binding site for these sequences present in the COPII 
components Sec24p in yeast (Miller et al., 2003; Mossessova et al., 2003). They found that not only 
the classical DxE of Sys1p but also an LxxLE and an LxxME motif present in Bet1p and Sed5p were 
bound by Sec24p at this interface, which was further referred to as “B-site” (Mossessova et al., 
2003). In the same study, a second Sec24p binding site - the “A-site” – was identified. Via this site, 
Sec24p interacts with the SNARE Sed5p, through a peptide sequence YNNSNPF present in Sed5p that 
becomes exposed when the ER-Golgi SNARE complex assembles (Mossessova et al., 2003).  
Most recently, it was proposed that another type of binding motif (ΦC motifs) which is characterized 
by bulky, hydrophobic residues at the very C-terminus of transmembrane proteins also binds to the 
B-site (Ma et al., 2017). Amongst the proteins that carry such a signal are ERGIC53 (Kappeler et al., 
1997), the yeast homologues Emp46p and Emp47p (Sato and Nakano, 2002), as well as 
Erv41p/Erv46p (Otte and Barlowe, 2002), and members of the yeast p24 family (Dominguez et al., 
1998). Similar to observations made for p24 in the COPI system, the oligomeric state of proteins 
carrying COPII sorting signals, can influence their efficient uptake (Springer et al., 2014). 
A third distinct binding site, the “C-site”, binds to a conformational epitope formed by the SNARE 
Sec22b when it is in the so-called closed conformation (Mancias and Goldberg, 2007). The binding 
motif can only be recognized by two of the four mammalian Sec24 isoforms (Sec24A/B) (Mancias and 
Goldberg, 2007). This observation is in line with the fact that not all Sec24 proteins have the same 
potential to bind and recruit cargo proteins in budding yeast several years earlier. The ER-Golgi 
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SNARE proteins Bet1p, Bos1p, and Sec22p are recruited into COPII vesicles by Sec24p and bind to the 
coat subunit directly while no such interactions could be observed for its homologue Lst1p (Miller et 
al., 2002). After the initial findings that the subclasses of Sec24 in yeast and mammals can influence 
the content of COPII vesicles, more and more isoform specific clients were identified. They are 
discussed in the following section. 
 
1.2.3 COPII vesicles: Coat Protein Isoforms 
 
As mentioned in the previous section, several isoforms of Sec24 with distinct functions exist in simple 
eukaryotes such as yeast. This repertoire of isoforms increases vastly when moving to higher 
organisms. In mammals, various isoforms of four of the five cytosolic proteins essential for COPII 
vesicle biogenesis have been identified. Sec24, the main cargo sorting subunit has four isoforms 
(Sec24A-D), Sar1, Sec13, and Sec31 have two isoforms (A/B), each. The Sec24 isoforms, which can be 
divided into the two subclasses Sec24A/B and Sec24C/D, came to the center of attention roughly ten 
years ago, when Mancias and Goldberg investigated the binding of ER-Golgi SNARE proteins so the 
COPII coat. They concluded that the two SNAREs Syntaxin5 (Sed5p in yeast) and GS27 (Bos1p in 
yeast) bind exclusively to Sec24C/D via an IxM peptide motif (Mancias and Goldberg, 2008). Sec22b 
and Bet1, the further SNAREs of the complex, were identified as interactors of Sec24A/B via the 
aforementioned conformational epitope in Sec22b and an YxxCE motif present in Bet1, respectively 
(Mancias and Goldberg, 2007, 2008). Most recently our lab could show that Bet1 does not bind to 
Sec24A but to Sec24C/D (Adolf et al., 2016). Moreover, we did not observe any direct binding of 
either Bet1 or GS27 to Sec24C which together with other experimental data led us to the conclusion 
that their recruitment into COPII vesicles is facilitated through binding to Syntaxin5 (Adolf et al., 
2016). 
Isoforms specific cargo sorting by Sec24 has even since become a major interest in the COPII field. 
Several proteins which are destined to reach the plasma membrane were identified as specific 
interactors of Sec24A (e.g. PCSK9, γ-Secretase), Sec24B (Vangl2), Sec24C (SERT1, AE1, Claudin-1), or 
Sec24D (GAT1, NET1, DAT) (Chen et al., 2013; Farhan et al., 2007; Kim et al., 2007; Merte et al., 2010; 
Otsu et al., 2013; Sucic et al., 2011; Yin et al., 2017). This led to the identification of novel, isoform 
specific targeting motifs such as the ΦxΦxΦ motif (Φ=bulky, hydrophobic amino acid) or a very short 
R[I/L] motif (Otsu et al., 2013; Sucic et al., 2013). As briefly pointed out before, not all proteins, e.g. 
the ER-Golgi SNAREs discriminate between individual isoforms. Most proteins rely on one of the two 
Sec24 classes in order to be correctly transported. For example, ER export of members of the p24 
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family and CD59 was shown to rely on Sec24C/D (Bonnon et al., 2010). The observation that p24 
proteins are transported by Sec24C/D was recently challenged by a crystallographic study from the 
Goldberg lab in which they found the cytoplasmic tail of p24 bound to the B-site in Sec24A (Ma et al., 
2017). Unpublished data from out lab does not support this finding as we could consistently observe 
elevated levels of p24 packing in in vitro reconstitution experiments only for Sec24C/D.  
Since Sec24 is the designated cargo-binding subunit of the COPII coat, much effort concentrated on 
investigating the role of its isoforms. However, as pointed out at the beginning of this section, also 
other COPII subunits exist as two distinct isoforms. Until today, however, little is known about their 
function. Mutations in the genes encoding either Sec23A or Sec23B have been linked to the 
development of different syndromes. While mutations in Sec23A lead to Cranio-lenticulo-sutural 
dysplasia (CLSD), Sec23B deficiency could be liked to Congenital Dyserythropoietic Anemia Type II 
(Bianchi et al., 2009; Boyadjiev et al., 2006). Despite the fact that the development of either 
syndrome is probably mainly due to the varying expression levels of the two Sec23 isoforms in 
different tissues, their discovery pointed at possibly diverging roles of the Sar1 isoforms (Fromme et 
al., 2008; Fromme et al., 2007). Sec23A with an F to L conversion in position 382 which caused CLSD 
was potent in packing ERGIC53 into COPII vesicles together with Sar1A. However, packing of the 
same cargo was completely abrogated in combination with Sar1B (Fromme et al., 2007). Although 
this observation could well be an artifact, the secretion of other large cargo molecules has been 
linked specifically to Sar1B (Fryer et al., 2014; Jones et al., 2003). In summary, isoforms of Sec23 and 
Sar1 are poorly understood and virtually no distinct functions have been assigned to the isoforms of 
Sec31. 
 
1.3 COPI: Transport System of the Golgi Apparatus 
 
Scientists in the Rothman lab in collaboration with Lelio Orci identified a new type of vesicles budding 
from the Golgi apparatus during the eighties of the last century (Malhotra et al., 1989). The new 
carriers were named COat Protein complex I (COPI) vesicles. It has early been shown that these 
carriers play a pivotal role in retrieving escaped ER-residents (Cosson and Letourneur, 1994; 
Letourneur et al., 1994). A role of COPI vesicles in intra-Golgi transport has ever since their discovery 
been heavy debated (reviewed by Glick and Luini, 2011; Glick and Nakano, 2009). 
In the following section I briefly review the work that has been done to elucidate the fundamental 
mechanisms that underlie the formation of these carriers.  
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1.3.1 COPI Vesicles: Biogenesis 
 
It is a common motif of vesicles biogenesis that it starts with the activation of a small GTPase. In case 
of COPI these GTPases belong to the ADP-ribosylation factor (Arf) family. Nucleotide exchange in Arf 
can be performed by multiple GEFs (reviewed in Casanova, 2007; Gillingham and Munro, 2007). 
Associated with COPI trafficking is the Golgi-associated brefeldin A-resistant GEF 1 (GBF1) (Claude et 
al., 1999; Kawamoto et al., 2002; Zhao et al., 2002). 
Despite the fact that several Arf family members have the ability to form COPI vesicles (Liang and 
Kornfeld, 1997; Popoff et al., 2011b; Volpicelli-Daley et al., 2005), Arf1 was the first COPI-forming 
GTPase to be identified and is believed to be the most involved Arf isoform (Serafini et al., 1991). 
Recruitment of Arf1 to the Golgi membrane is supported by transmembrane proteins of the early 
secretory pathway. The first protein implicated in this context was p23, which was shown to interact 
directly with Arf1 (Gommel et al., 2001; Majoul et al., 2001). In vitro binding experiments showed 
that this interaction is dependent on the oligomeric state of p23, and the nucleotide-state of Arf1. In 
order to be recruited, Arf1 needs to be in a GDP-bound state and p23 has to form oligomers 
(Gommel et al., 2001). The second protein implicated in Arf1 recruitment by means of binding and 
co-localization experiments was the ER-Golgi SNARE protein GS27 (Honda et al., 2005).  
Once recruited to the Golgi membrane and after GBF1 has stimulated nucleotide exchange, Arf1 
undergoes a significant structural rearrangement. The N-terminal amphipathic α-helix modified with 
a myristoyl group at its very end becomes exposed and concomitantly inserts into the lipid bilayer 
(Antonny et al., 1997; Franco et al., 1995, 1996). Thus anchored Arf1 recruits the outer COPI coat 
coatomer en bloc (Donaldson et al., 1992; Hara-Kuge et al., 1994). Coatomer (CM) is a 550 kDa 
heptameric complex that consists of the seven subunits α-, β’-, β-, γ-, δ-, ε-, and ζ-COP (Waters et al., 
1991). Four of the seven subunits have been implicated in binding directly to Arf: β-, γ-, δ-, β’-COP 
(Sun et al., 2007; Zhao et al., 1997; Zhao et al., 1999). Structural studies of the COPI coat assembled 
on the membrane could confirm the direct interaction of three of these subunits, while the 
interaction of Arf1 with β’-COP was not directly observed (Dodonova et al., 2017; Dodonova et al., 
2015). 
While Arf1 and coatomer constituted the minimal cytosolic machinery to form COPI vesicles 
(Bremser et al., 1999; Sohn et al., 1996; Spang et al., 1998), cytoplasmic tails exposed by 
transmembrane proteins of the Golgi have been identified as having a distinguished role in this 
process (discussed in more detail below). Especially proteins of the p24/TMED family, p23 and p24, 
which as dimers bind to the γ-COP subunit, were shown to affect the overall structure of the complex 
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(Langer et al., 2008; Reinhard et al., 1999). These rearrangements that can be observed in solution 
are believed to be the equivalent of coat polymerization on a membrane. 
Like for COPII vesicles, scission of COPI vesicles can occur even when GTP hydrolysis in Arf1 is blocked 
(Adolf et al., 2013; Malhotra et al., 1989). Concerning the driver of COPI vesicle scission there are 
different views. The brefeldin A ADP-ribosylated substrate (BARS) protein and the lipid phosphatic 
acid (PA) have been implicated in COPI vesicle fission (Yang et al., 2008; Yang et al., 2005). However, 
as both, BARS and PA were not determined as critical components in a minimal system (Bremser et 
al., 1999; Spang et al., 1998); their action is most likely restricted to a supportive role. Noteworthy, 
GTP-loaded Arf1, like Sar1-GTP, displays a strong membrane surface activity and can form tubules 
from synthetic liposomes by itself (Beck et al., 2008; Krauss et al., 2008). Together with the 
observation that a dimerization-deficient mutant of Arf1 fails to produce free vesicles, a pivotal role 
of the small GTPase in vesicle scission has been forwarded (Beck et al., 2011b).  
Uncoating of COPI vesicles depends on the hydrolysis of GTP in Arf that is stimulated by members of 
the ArfGAP family (Reinhard et al., 2003; Tanigawa et al., 1993). Unpublished data from our lab 
suggests that ArfGAPs in addition to promoting GTP hydrolysis furthermore drive the disassembly of 
the COPI coat (Ganeva et al., unpublished data).  
An extensive review on COPI biogenesis can be found elsewhere (Popoff et al., 2011a). 
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Figure 1.3 COPI Vesicles Biogenesis 
Arf1 is recruited to the Golgi membrane through interaction with p23/p24 and activated by its GEF GBF1. ArfGAP1 
potentially stimulates GTP hydrolysis at this stage to concentrate cargo. Coatomer is recruited by Arf1-GTP and binds to 
cytoplasmic tails of various transmembrane proteins. As the local concentration of coat protein rises, they will start to 
polymerize and form a bud. Vesicle scission is promoted by the small GTPase Arf in its dimeric form. Uncoating of COPI 
vesicles requires the hydrolysis of GTP stimulated by ArfGAPs. The model was taken from Popoff et al. (2011a). For more 
detailed information on COPI biogenesis and the accompanying literature please refer to the main text. 
 
1.3.2 COPI Vesicles: Cargo Sorting 
 
In order to make vesicle formation a productive process, it is not only required to correctly assemble 
the coat but to furthermore concentrate the right proteins at the site of vesicle budding. In the COPI 
system, selection of the right cargo molecules is driven by direct interactions of five of the seven 
subunits with short peptide motifs. The initially identified COPI binding motifs are characterized by 
the presence of two lysine residues at the very C-terminus of the short cytoplasmic tails of 
transmembrane proteins (Nilsson et al., 1989; Pääbo et al., 1987). These lysine residues can be either 
directly following one another (KKxx motif) or be separated by one amino acid (KxKxx motif) (Cosson 
and Letourneur, 1994; Jackson et al., 1990; Schröder-Köhne et al., 1998). Dilysine motifs are 
recognized be the two large coatomer subunits α-COP and β`-subunit. Both subunits show a 
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preference for either the KKxx motif (α-COP) or the KxKxx motif (β`-COP) (Eugster et al., 2004; 
Schröder-Köhne et al., 1998; Schröder et al., 1995) which they recognized with a high specificity via 
their most N-terminal WD-repeat domains (Jackson et al., 2012). The two best characterized proteins 
with dilysine motifs are Wbp1 in yeast and ERGIC53 in mammals (Gaynor et al., 1994; Schindler et al., 
1993). 
Another retrieval motif is characterized by the presence of basic arginine residues (Schutze et al., 
1994). The positioning of the residues within the protein is not as strict as for the lysine-based motifs 
(Michelsen et al., 2005). In contrast to KK-based motifs, binding of arginine-based motifs is mediated 
by the coatomer subuits β-COP and δ-COP via a binding site that is believed to be homologues to the 
region in AP complexes that recognize YxxΦ motifs (Michelsen et al., 2007). Functionally, RR motifs 
serve the same purpose as lysine-based motifs, namely the retrieval of proteins back to the ER. This 
however often serves the greater purpose to allow for the correct assembly of multimeric complexes 
at the level of the ER before they are ultimately exported as one functional unit (Brock et al., 2005; 
O'Kelly et al., 2002; Zerangue et al., 1999). 
As mentioned in the beginning, five subunits of coatomer are directly involved in binding to 
transmembrane proteins. The fifth, so far not mentioned subunit is γ-COP. It has been shown to bind 
to members of the p24 family (Fiedler et al., 1996; Sohn et al., 1996). The motifs found in these 
proteins are bipartite. They contain in addition to a basic signature, two pivotal phenylalanine 
residues (Harter and Wieland, 1998). Moreover, the FFxxBBxn motif (B=basic amino acid; n≥2) binds 
to γ-COP only after dimerization hinting at a possible mechanism for the circulation of p24 proteins in 
the early secretory pathway (Béthune et al., 2006; Harter and Wieland, 1998). 
Although heavily studied, the roles that p24 proteins fulfill in the context of COPI trafficking is still not 
fully understood. While a crucial role during the formation of the vesicles itself has been established 
earlier (Bremser et al., 1999; Sohn et al., 1996), more recent studies suggest that some p24 proteins 
are actively involved in the retrieval of (HDEL)/KDEL-bearing ER-residents (Pastor-Cantizano et al., 
2017a; Pastor-Cantizano et al., 2017b). 
In order to be retrieved to the ER via COPI, luminal proteins need to be concentrated at sites of 
vesicle formation despite the inability to directly interact with the COPI coat. Thus, they need to be 
recognized by receptors which can couple them to the coat proteins. The KDEL-receptor was the first 
such retrieval factor to be identified in the COPI trafficking system (Munro and Pelham, 1987). It 
posses seven transmembrane domains connected by short loops and its C-terminal tail is facing 
towards the cytosol. The recognition of the receptor by coatomer happens via a short peptide stretch 
in the cytosolic tail which contains in addition to two lysine residues a serine that can be 
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phosphorylated by PKA (Cabrera et al., 2003). This phosphorylation has been shown to be critical for 
an interaction with coatomer and ArfGAP1 (Cabrera et al., 2003). Where exactly the KDEL-receptor 
binds to the COPI coat has not been shown, yet. A recent publication suggested a role for δ-COP in 
KDEL-receptor sorting (Arakel et al., 2016). Via the luminal portion, the receptor binds to more than 
50 proteins which bear a KDEL signal at their very C-Terminus which is recognized by the receptor in 
the early Golgi cisternae (Lewis and Pelham, 1992; Lewis et al., 1990; Majoul et al., 1998). The 
retrieval of KDEL-tagged proteins, despite happening indirectly, seems to be even more efficient than 
the retrieval of KKxx-bearing transmembrane proteins (Stornaiuolo et al., 2003). Release of the cargo 
from its receptors is likely mediated by the pH-difference between the ER and the Golgi (Wilson et 
al., 1993) as the Golgi complex has a slightly more acidic pH (~6.4) when compared to the ER (~7.2) 
(Wu et al., 2000).  
Other receptors with a different mode of client recognition are for example RER1 or Vps74/GOLPH3. 
RER1 is important for retrieval of the Sar1-GEF Sec12 (Boehm et al., 1994; Nishikawa and Nakano, 
1993) which it binds via its transmembrane domain and in doing so couples it to the COPI coat via a 
cytosolic motif (Sato et al., 2001). Vps74/GOLPH3 is a more recently discovered adaptor for 
glycosyltransferases that need to be properly retained in the Golgi. Unlike KDEL-receptor or RER1, 
recognition of its clients happens via the cytosolic portion of the protein (Eckert et al., 2014; Schmitz 
et al., 2008; Tu et al., 2008). Furthermore, the soluble proteins of the ArfGAP family, especially 
ArfGAP1, have been implicated in cargo sorting (Liu et al., 2005; Rein et al., 2002; Shiba and 
Randazzo, 2014; Spang et al., 2010). The most recently identified COPI sorting motif is characterized 
by the C-terminal sequence KxD/E. It was found in members of the nonaspanin protein family and 
serves the retention of these Golgi-residents (Woo et al., 2015). 
It is of note that none of the proteins that has been identified to bear a COPI sorting signal is 
transported to a destination other than the ER or the Golgi. This implies that uptake of secreted 
cargo is rather passive as has been proposed earlier (Karrenbauer et al., 1990; Wieland et al., 1987). 
 
1.3.3 COPI vesicles: Coat Protein Isoforms 
 
Coatomer consists of seven subunits (Stenbeck et al., 1993; Waters et al., 1991). Out of these seven 
subunits, γ-COP and ζ-COP two were found in genetic screen to exist as different isoforms which 
were termed γ1/2- and ζ1/2-COP (Blagitko et al., 1999; Futatsumori et al., 2000). They were 
furthermore shown to localize to the Golgi when expressed as tagged versions (Futatsumori et al., 
2000). Our lab shortly after studied the endogenous proteins (Wegmann et al., 2004). It was revealed 
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that in various mouse tissues, the expression levels of γ-COP and ζ-COP isoforms was very similar. No 
sample showed a marked expression of either isoform (Wegmann et al., 2004). Furthermore, 
Wegmann et al. probed the composition of coatomer complexes and found that >95 % of 
endogenous CM has either of the three combinations γ1ζ1, γ2ζ1, and γ1ζ2. Coatomer containing γ2ζ2 
was not found in significant amounts. Subsequently, a γ1ζ1:γ2ζ1:γ1ζ2 ratio of 2:1:2 was proposed 
(Wegmann et al., 2004). This ratio was roughly confirmed by a follow-up study which came up with a 
ratio of approximately 2.5:1:1.5 (Moelleken et al., 2007). Latter study was the first to point towards a 
putative functional difference between the isoforms of coatomer since a very clear divergence of 
intracellular distribution could be observed. While CM containing γ1-COP (any therefore also ζ2-COP) 
was predominantly located at the cis-Golgi (>70%), γ2-COP was found mainly associated with the 
trans-Golgi (>60%). In vitro reconstitution experiments later showed, that all coatomer isoforms, 
even γ2ζ2, are capable of forming COPI vesicles with similar efficacy (Sahlmuller et al., 2011). Until 
today only one further study by Hamlin et al. provides functional data regarding the isoforms of CM. 
In this study it was shown that the inactive cytosolic kinase Scyl1 interacts specifically with γ2-COP 
and furthermore with class II Arfs (Hamlin et al., 2014).  
The second family of cytosolic proteins important for COPI vesicle biogenesis are members of the Arf 
family. Six different isoforms of Arf have been identified in mammals, and simply termed Arf1-6 
(Bobak et al., 1989; Kahn et al., 1991; Lee et al., 1992; Price et al., 1988; Tsuchiya et al., 1991). All Arf 
isoforms except for Arf2 can be found in humans. Based on their sequence identity they can be 
grouped into three classes. Arf1, Arf2, and Arf3 constitute class I and are ~96% identical. Arf4 and 
Arf5 form class II (Kahn et al., 2006). They are ~90% identical to one another and show still a high 
similarity to class I Arfs (~80% identity). The only Arf in class III is Arf6. It shows still a decent amino 
acid sequence similarity to all other Arfs (~64-70% identity) (Kahn et al., 2006). 
The fact that Arf6 forms a separate class is in line with its unique intracellular localization (Cavenagh 
et al., 1996; D'Souza-Schorey and Stahl, 1995). The lab of Richard Kahn demonstrated that Arf6 is 
tightly associated with the plasma membrane and that this association is not controlled by its 
nucleotide state. In contrast they could observe that all other human Arfs are cytosolic and become 
bound to the endomembrane system only upon activation with GTPγS (Cavenagh et al., 1996). Its 
unique localization is likely the reason why Arf6 is, besides Arf1, the most studied Arf family member. 
It has been implicated amongst other things in events of endocytosis, endosomal sorting, actin 
remodeling, and cholesterol homeostasis (D'Souza-Schorey and Chavrier, 2006; Donaldson, 2003; 
Schweitzer et al., 2011). The second, intensely-studied Arf isoform, Arf1, has been identified as the 
main partner of coatomer for the formation of COPI vesicles (Serafini et al., 1991). It is furthermore 
involved in the biogenesis of clathrin-coated vesicles (see section 1.4.1). However, also Arf1 has been 
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shown to function beyond membrane trafficking. Early studies have identified Arf1 (and other Arf 
family members) as a regulator of lipid metabolism by activating e.g. phospholipase D or stimulating 
PIP2 biosynthesis (Brown et al., 1993; Cockcroft et al., 1994; Godi et al., 1999). Arf3, Arf4, and Arf5 
have been subject of much less investigation. A knockdown study by the Kahn lab showed that each 
Arf isoform is dispensable. Only when knocked down pairwise were they able to observe effects on 
protein trafficking and localization as well as organelle integrity (Volpicelli-Daley et al., 2005). The 
partial redundancy is in line with the fact that Arf3-5, like Arf1, support COPI vesicle biogenesis in 
vitro (Popoff et al., 2011b). Overall our knowledge, especially concerning the functions of class II Arfs 
is very scarce. Only recently, experimental evidence is gathered which points at distinct molecular 
roles of these Arfs. Arf4, for example, has been shown to play a specific role in trafficking of 
Rhodopsin C at late stages of the secretory pathway (Deretic et al., 2005). Additionally, recent studies 
showed that Arf4/5 in the early secretory pathway behave differently from Arf1. Both Arfs stayed 
associated with the ERGIC even in their GDP state (Chun et al., 2008; Duijsings et al., 2009). Overall, 
the mounting biochemical and cell biological data suggests that the Arf family of proteins is not 
nearly understood. Very comprehensive reviews covering the topic can be found elsewhere 
(Casanova, 2007; D'Souza-Schorey and Chavrier, 2006; Kahn et al., 2005). 
 
1.4 Clathrin-coated Vesicles (CCVs): Post-Golgi traffic 
 
The first class of vesicles identified were clathrin-coated vesicles (CCVs), during the advent of EM 
(Kanaseki and Kadota, 1969; Roth and Porter, 1964). Over the course of the last forty years it became 
clear that CCVs are by far the most diverse group of vesicles, which share common principles and the 
outer scaffold clathrin. A great review on the topic can be found elsewhere (Robinson, 2015), here I 
try to briefly outline the important aspects of CCV trafficking including other post-Golgi vesicle types 
which do not necessarily use clathrin as a scaffold. 
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Figure 1.4 Post-Golgi Vesicular Transport 
Vesicular transport between post-Golgi stack compartments is largely facilitated by CCVs in concert with adaptor protein 
complexes AP-1 (TGN-endosomes), AP-2 (endocytosis), and possibly AP-3 (endosomes-lysosomes). AP-4 and AP-5 are 
clathrin-independent adaptors acting at the TGN and late endosomes/lysosomes, respectively. The AP complexes often 
work in concert with alternative adaptors such as γ-adaptin ear-containing Arf-binding proteins (GGAs) and epsins at 
various sites. The most recently discovered endocytic adaptor complex TSET is not found in animals (Hirst et al., 2014). The 
image was taken from Robinson (2015) and modified. 
 
1.4.1 CCVs: Biogenesis 
 
Shortly after CCVs had been acknowledged as recurring structures in cells of higher organisms, 
Barbara Pearse purified the key protein for their formation by accident and called it “clathrin” 
(Pearse, 1976). At the same time, Goldstein and Brown working on uptake of LDL showed that in this 
process, (clathrin)-coated pits (CCPs) play a fundamental role (Anderson et al., 1977). With this the 
first functional data for CCVs was being provided.  
Insight into the molecular structure of CCVs came from studies which showed that clathrin is not a 
single protein but a complex composed of three light and three heavy chains (Ungewickell and 
Branton, 1981) and that the formation of clathrin cages is assisted by “assembly peptides (APs)” 
(Keen et al., 1979; Zaremba and Keen, 1983). Nowadays, AP is usually translated as adaptor protein 
(complex), for they not only assemble clathrin but also bind cargo and machinery. AP-1 and AP-2 
were the first APs discovered almost simultaneously. They serve trafficking in the TGN/endosomal 
Introduction 
21 
 
system (AP-1) and endocytosis at the plasma membrane (AP-2) (Pearse and Robinson, 1984; Unanue 
et al., 1981). APs are tetrameric complexes that consist of two large subunits, a medium sized and a 
small subunit (Owen et al., 2004). Until to date, three additional tetrameric adaptor protein 
complexes were identified and termed AP-3, AP-4, and AP-5 (Dell'Angelica et al., 1999a; Dell'Angelica 
et al., 1997; Hirst et al., 2011). In addition there are many other proteins which function as adaptors 
for clathrin and cargo but are not part of the AP family. Monomeric adaptors belonging into this 
group are for example AP180/CALM (Morris et al., 1993; Murphy et al., 1991), γ-adaptin 
ear-containing Arf-binding proteins 1-3 (GGA1-3) (Boman et al., 2000; Dell'Angelica et al., 2000; 
Puertollano et al., 2001b) and epsin1-3 (Chen et al., 1998; Drake et al., 2000). 
The fact that AP-3/4/5 were identified relatively long after the initial discovery of AP-1 and AP-2 can 
be partially explained by the circumstance that they act completely or partially clathrin-independent. 
Adaptor protein complex 3 despite having a discrete binding site to clathrin (Dell'Angelica et al., 
1997) shows only partial co-localization with the scaffold (Kural et al., 2012; Peden et al., 2004). AP-4 
and AP-5 function as adaptors independent of clathrin (Dell'Angelica et al., 1999a; Hirst et al., 2011; 
Hirst et al., 1999) and seem to use other layers of outer scaffold like SPG11 and SPG15 in case of AP-5 
(Hirst et al., 2013). 
Membrane recruitment of most of the APs (AP-1/3/4) and all GGAs have in common that it is 
triggered by a small GTPase of the Arf family (Boehm et al., 2001; Boman et al., 2000; Ooi et al., 
1998; Puertollano et al., 2001b; Stamnes and Rothman, 1993; Traub et al., 1993). Alternatively, 
binding to the lipid Phosphatidylinositol-4,5-bisphosphate (PIP2), like in the case of AP-2, can 
substitute for priming of the vesicle formation site by a small GTPase (Gaidarov et al., 1996; Ohno et 
al., 1995). Noteworthy, Arf6 has been shown to play an indirect role in AP-2 recruitment by binding 
to the PIP2-producing kinase (Krauss et al., 2003). 
Recruitment to the respective membrane by either Arf or PIP2 leads to a structural change within 
AP-1/2 which is referred to as transition from the “locked” to the “unlocked/open” conformation. 
The open conformation reveals binding sites for both clathrin and cargo (Collins et al., 2002; 
Heldwein et al., 2004; Jackson et al., 2010; Ren et al., 2013). Clathrin then is recruited from the 
cytosol and forms a lattice on its adaptors. A recent study suggests that clathrin – at least on the 
plasma membrane – first builds a flat lattice which then, possibly with the aid of other factors, forms 
into a CCP (Avinoam et al., 2015). 
Similar to their recruitment, also the scission of endocytic CCVs seems to be distinct from that of 
other late secretory vesicles. A pivotal role in this process is played by the large GTPase dynamin 
which is the key factor for scission (reviewed by Ferguson and De Camilli, 2012). The exact 
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mechanism of vesicle scission for all other CCVs is not clear, however, dynamin seems not to be 
involved (Kural et al., 2012). Possibly, the small GTPase of the Arf family which functions in adaptor 
recruitment plays a similar role in scission as has been forwarded in the COPI system. 
The final step of vesicle biogenesis, shedding of the coat, is a chaperone-assisted process in the CCV 
system. The clathrin lattice is actively disassembled by an Hsp70/Hsp40 pair, Hsc70 and auxilin 
(Ungewickell et al., 1995). Uncoating of the inner layer involves again ArfGAPs in case of the 
Arf-dependent adaptors (reviewed in Randazzo and Hirsch, 2004) and likely other factors in the case 
of AP-2 CCVs (Semerdjieva et al., 2008) 
 
1.4.2 CCVs: Cargo Sorting 
 
Sorting of proteins by adaptors in the late secretory pathway is mainly driven by two types of signals. 
The first motif is characterized by the presence of tyrosine. A mutation that led to conversion of the 
C-terminal tyrosine in the low density lipoprotein receptor (LDLr) was spotted as the cause of familial 
hypercholesterolemia (Davis et al., 1986). In the same study it was observed that the LDLr was no 
longer concentrated at sites of CCV formation at the plasma membrane when the NPxY motif was 
changed to NPxC. The same motif was subsequently identified in ten additional proteins (Chen et al., 
1990). It was shown that this particular trafficking signal is used only to mediate internalization at the 
plasma membrane, while more common, related YxxΦ motifs (Φ=bulky, hydrophobic amino acid) are 
used in virtually all steps of the late secretory pathway (Aguilar et al., 2001; Ohno et al., 1998). The 
YxxΦ motif was first identified as the signal for internalization of the mannose-6-phosphate/insulin-
like growth factor 2 receptor (Canfield et al., 1991; Jadot et al., 1992). The role of the YxxΦ motif in 
mediating protein trafficking between other organelles of the post-Golgi compartments was 
established shortly thereafter (Hunziker et al., 1991; Matter and Mellman, 1994). The promiscuity of 
this signal is reflected by the fact that it is bound by multiple AP complexes via their µ-subunit 
(Aguilar et al., 2001; Boll et al., 2002; Ohno et al., 1998). This binding occurs via a site that is distinct 
from the binding site used by NPxY-bearing receptors in order to get internalized (Ohno et al., 1998). 
Besides the NPxY/YxxΦ motifs, a third common targeting signal that contains critical (iso-)leucine 
residues has been identified first in CD3-γ chain (Letourneur and Klausner, 1992). Because the 
(usually two) leucines, which are important for the function of the signal are positioned close to 
glutamate or aspartate residues the motif is often called “acidic dileucine motifs”. The DKQTLL 
sequence found in CD3-γ chain was the first of the D/ExxxL/[LI] family. This signature drives 
transportation of a large number of proteins between virtually all organelles of the late secretory 
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pathway (Bonifacino and Traub, 2003; Chen et al., 1997; Johnson and Kornfeld, 1992). It interacts 
simultaneously with two subunits of various AP-complexes. One of the two subunits is always the 
σ-subunit; the second subunit is one of the two large subunits of the respective AP-complexes 
(Chaudhuri et al., 2007; Doray et al., 2007; Mattera et al., 2011).  
The second sub-family of acidic dileucine motifs follows the consensus DxxLL. They are recognized by 
GGAs via their VHS domain and hence only involved in trafficking between the TGN and endosomes 
(Misra et al., 2002; Nielsen et al., 2001; Puertollano et al., 2001a; Shiba et al., 2002). Interestingly, 
while all the sorting motifs so far described in the COPI/COPII system are located within the 
cytoplasmic regions of transmembrane proteins, acidic dileucine motifs were also identified in 
soluble proteins e.g. HIV-Nef which down regulates CD4 (Greenberg et al., 1998). Furthermore, the 
attachment of the soluble ubiquitin to a transmembrane protein can function as a transport signal 
(reviewed in Piper and Luzio, 2007). 
Despite the fact that the number of proteins carrying one of the classical post-Golgi sorting motifs is 
very large when compared to the COPI/COPII system (Bonifacino and Traub, 2003), they still do not 
account for all the trafficking events. A very impressive study in this concern was carried out by the 
Robinson lab in which they screen for endocytic motifs and found that their hits would usually not 
follow any consensus sequence (Kozik et al., 2010). This points out at a possibly much larger number 
of signals which have thus far not been assigned. 
 
1.4.3 CCVs: Coat Protein Isoforms 
 
Since the number of coat proteins that do function in post-Golgi transport is greater than the number 
of coat subunits found in the COPI or COPII system it is not surprising that CCV coat proteins account 
for the largest number of isoforms in vesicular transport. Apart from the isoforms of Arf, which were 
already discussed in paragraph 1.3.3, several subunits of the AP complexes have different isoforms. 
While the four proteins which form the latest discovered clathrin-independent heptameric AP-4 and 
AP-5 complexes have no isoforms, AP-2 possess one subunit with two isoforms: AP-2α1/2. The AP-1 
complex has two subunits, AP-1µ1/2/σ1-3, which exist as isoforms, AP-3 even harbors three isotypic 
subunits, AP-3µ1/2/σ1/2/β1/2. Hence, in the AP system alone 6 proteins exist that have different 
isoforms. The number of isotypic proteins expands, however vastly, when other adaptors are taken 
into account e.g. Epsin1-3, GGA1-3 (Dell'Angelica et al., 2000).  
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Evidence for a specific function of some isoforms came from the observation that in cells lacking the 
polarized cell specific AP-1µ2 subunit, baso-lateral sorting was disturbed. It could be re-established 
once the protein was restored (Folsch et al., 1999; Ohno et al., 1999). The AP1-µ2-containing AP 
complex was further called AP-1B because it became clear that its function in polarized cells is very 
distinct from the AP-1A complex containing isoform 1 of AP1-µ (Folsch et al., 2003; Guo et al., 2013). 
For example does AP-1B but not AP1-A interact with Arf6 (Shteyn et al., 2011). 
At around the same time, different isoforms of the AP-3 complex were discovered (Dell'Angelica et 
al., 1997; Pevsner et al., 1994; Simpson et al., 1996). Like for AP-1, there is one variant which is cell 
type specific, and one that is ubiquitously expressed. The AP-3B (with AP-3µ2/β2) is exclusively 
expressed in neurons, AP-3A (with AP-3µ1/β1) in all tissues (Hirst and Robinson, 1998; Le Borgne and 
Hoflack, 1998; Robinson and Bonifacino, 2001). The neuronal specific variant has been implicated in 
the formation of synaptic vesicles from endosomes (Blumstein et al., 2001; Faundez et al., 1998) 
while AP-3A seems to be involved in transport from the TGN/endosomes to lysosomes (Nakatsu and 
Ohno, 2003). 
Evidence is emerging which indicates that like in the COPII system, isoforms of the various coat 
subunits participate in specific sorting events. For example AP-1σ1 is thought to be involved in the 
trafficking of sortilin (Baltes et al., 2014) and GGA1 in transport of adiponectin (Xie et al., 2006). In 
general it can be said that these sorting events appear to be more cell-type specific in contrast to 
isoform-specific packing performed by Sec24 proteins which applies to ubiquitously expressed SNARE 
proteins (Adolf et al., 2016; Mancias and Goldberg, 2008). More concise information about this topic 
can be found elsewhere (Bonifacino and Traub, 2003; Nakatsu and Ohno, 2003; Paczkowski et al., 
2015; Robinson, 2015). 
 
1.5 Mass Spectrometry (MS) 
 
Mass spectrometry is a powerful tool in chemistry, pharmacology, as well as biochemistry of proteins 
and lipids. In analogy to the term “genomics” which describes the study of whole genomes, the term 
proteomics was coined for investigations that aim at the understanding of proteins at a global scale. 
In the following, basic principles and techniques used in modern proteomics are outlined. For 
further, more intensive review on this topic, the following articles are well suited (Aebersold and 
Mann, 2016; Bantscheff et al., 2012; Glish and Vachet, 2003). 
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1.5.1 Basic principles of MS and Proteomics 
 
Modern mass spectrometry allows for the simultaneous analysis of highly complex biological samples 
containing thousands of proteins. This discipline, called proteomics, was made possible by two 
important advancements. The first critical progress was the invention of ionization methods 
applicable to large, instable analytes such as proteins. Those were electrospray ionization (ESI) 
developed by John Fenn and, simultaneously, matrix-assisted laser desorption/ionization (MALDI) 
introduced by Koichi Tanaka (Fenn et al., 1989; Karas and Hillenkamp, 1988). Until then, the analysis 
of substances by mass spectrometry was limited to small, heat-resistant molecules due to the high 
energy used for ionization (e.g. electron ionization, EI). The second major breakthrough for 
proteomics was the progress made in the field of DNA sequencing. Approximately two decades ago, 
it became possible to sequence whole genomes (Goffeau et al., 1996). This was prerequisite for 
modern proteomics as it was now possible to develop databases containing all potentially expressed 
proteins with which mass spectra could be compared (Mann and Wilm, 1994; Perkins et al., 1999). 
In a typical modern MS experiment, proteins are separated according to their molecular mass by 
one- or two-dimensional SDS-PAGE with the second dimension being a focusing of proteins 
corresponding to their isoelectric point (Laemmli, 1970; O'Farrell, 1975). The gel can then be stained 
with Coomassie or silver to visualize the proteins. Bands or spots of interest are excised, in-gel 
digested with a sequence-specific protease, typically trypsin, and subjected to liquid chromatography 
(LC) (Shevchenko et al., 2006; Shevchenko et al., 1996; Wilm et al., 1996). Following LC, the peptides 
enter the mass spectrometer where a first MS scan is performed. Subsequently, (potentially 
pre-selected) precursor ions are fragmented by collision and subjected to a second round of MS 
scanning (tandem MS). The resulting product ions are detected and their spectra interpreted. In this 
regard, interpretation means they are usually compared to in silico generated databases containing 
the possible peptide fragments of all proteins which can occur during such an experiment. In doing so 
it is possible to determine the protein composition of a sample with high accuracy (the experimental 
setup is explained in more detail in Han et al., 2008 and Karpievitch et al., 2010). 
One of the major challenges of protein MS has been to directly compare two or more biological 
samples with one another. To overcome this problem, mainly two strategies have emerged: 
protein/peptide labeling of samples and metabolic labeling of studied organisms. The first protein 
labeling reagents introduced were so-called isotope-coded affinity tags (ICATs) (Gygi et al., 1999). 
Here, cysteine residues are labeled with an affinity tag (e.g. biotin) which is coupled to the cysteine-
reactive group via an isotope-labeled linker. The initially used deuterium for labeling was replaced by 
C13- and N15-based labels due to the observation that deuterium can cause differences in retention 
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time during LC (Yi et al., 2005; Zhang et al., 2001). The most popular sample labeling procedure 
nowadays is isobaric labeling, notably tandem mass tags (TMTs) and isobaric tags for absolute and 
relative quantification (iTRAQs) (Ross et al., 2004; Thompson et al., 2003; Wiese et al., 2007). These 
tags, of which a large variety exits, are coupled to the proteins/peptides like ICATs. When intact, they 
all have identical masses. Only upon fragmentation during tandem MS, reporter ions are produced 
which allow for the comparison of their precursor and ultimately the biological samples. Since the 
number of such tags it high, a large number of samples can be analyzed in parallel. 
The labeling strategies outlined above are challenged by an intensive modification of the samples 
prior to MS analysis. These experiments require a high level of accuracy and efficacy during the 
labeling procedure in order to be quantitative. The second type of labeling methods, metabolic 
labeling, overcome this potential bias very elegantly by introducing the labels directly into the 
proteins and allowing them to be incorporated by the studied biological model. The most prominent 
method, stable isotope labeling by amino acids in cell culture (SILAC), was described 15 years ago 
(Ong et al., 2002). Although crude labeling methods such as cultivation with heavy nitrogen (N15) is 
still in use (reviewed by Gouw et al., 2010), most labeling procedures use amino acids with heavy 
atoms, most frequently lysine and arginine (Ong and Mann, 2007). SILAC experiments are as the 
name implies usually done with cultured cells but also whole organisms have been isotope-labeled 
(Gouw et al., 2010). In contrast to post-sample preparation labels such as TMTs, there is a quite 
limited number SILAC labels available, restricting the number of samples that can be analyzed in 
parallel. Furthermore, the method is restricted to experiments where a sufficient labeling of proteins 
can be achieved by the studied organism/cell. However, if these requirements are met, SILAC is the 
most direct way to compare protein samples by simply calculating the ratio/enrichment of labeled 
versus non-labeled peptides from their MS intensities. 
Noteworthy, there are ways to quantify proteins without introducing a label (Wong and Cagney, 
2010). Such methods, but also all labeling methods, do not provide absolute quantification of 
samples but rather access the relative abundance of proteins in comparison to another sample. 
Hence absolute quantification is still one of the major challenges for MS in the upcoming years. 
 
1.5.2 Proteomics as a Tool to Study Organelles and Vesicles 
 
Modern mass spectrometry has advanced to a stage that allows the analysis of whole proteomes of 
classical model organisms such as yeast (de Godoy et al., 2008) or even the proteomes of more 
complex samples e.g. total human cell lines (Beck et al., 2011a; Nagaraj et al., 2011). Hence the 
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analysis of a cellular substructure is easily achievable which opens the possibility to study in detail 
which proteins belong to a certain organelle and how the protein composition of it changes in 
response to a certain treatment (Gannon et al., 2011; Yates et al., 2005) .  
Isolation of the cellular entity of interest can be achieved in different ways. The most simple way is 
differential centrifugation including density gradient centrifugation that has been used to isolate and 
study the proteomes of lysosomes (Bagshaw et al., 2005), mitochondria (Sickmann et al., 2003), or 
multiple organelles in one study (Dunkley et al., 2004; Foster et al., 2006; Gilchrist et al., 2006; Itzhak 
et al., 2016). Such isolation strategies have been extended by means of affinity purification. Zhang et 
al. for example labeled cells with biotin and subsequently performed streptavidin affinity purification 
in order to obtain a fraction highly enriched in plasma membrane (Zhang et al., 2003). Similarly, the 
Hauri lab has used an antibody against the KDEL receptor in order to isolate the ER-Golgi 
intermediate compartment from BFA-treated cells (Breuza et al., 2004). In all studies mentioned 
above, new proteins could be assigned to the respective organelles. But not only have organelles 
been subjected to MS analysis after enrichment, also vesicles which facilitate the transport between 
many of these compartments have been studied. To study them, two principal strategies were 
applied: Isolation of endogenous vesicles and in vitro reconstitution.  
The first strategy, isolation of endogenous vesicles, was applied to synaptic vesicles and CCVs (Borner 
et al., 2006; Takamori et al., 2006). In latter experiments, a CCV-enriched fraction was quantitatively 
compared to a mock fraction from cells where the heavy chain of the pivotal scaffold clathrin was 
knocked down (Borner et al., 2006). This clever setup has been improved by adaption of fast protein 
rerouting to mitochondria (“knocksideways”) (Robinson et al., 2010). It was used to mislocalize 
certain clathrin adaptor proteins. Subsequently, a CCV fraction from these knocksideways cells was 
prepared and compared to a non-treated control. Whatever proteins are no longer found in the CCV 
fraction from knocksideways cells are potential interactors of the depleted adaptor (Hirst et al., 
2012). 
The second approach, in vitro reconstitution, has been used to study COPI and COPII vesicles. COPI 
vesicles were reconstituted from a Golgi-enriched membrane fraction using cytosol and nucleotides 
(Gilchrist et al., 2006). The more recently published proteomic study of COPII vesicles was performed 
with yeast microsomes and purified COPII coat components (Margulis et al., 2016). In both cases, 
quantification was done without any labeling of the samples prior or after vesicle preparation. 
In general, proteomic investigation of organelles and vesicles has helped to understand the protein 
content of these structures and also the flow of material between different cellular compartments. 
With evolving bioinformatics tools, it is possible to do cellular proteomics using very crude 
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differential centrifugation as has been demonstrated by the Borner lab (Itzhak et al., 2016). All these 
developments will round out the intracellular protein landscape. A very comprehensive review on 
proteomic studies of organelles was written by Yates et al. (2005), the most recent advancement for 
rapid profiling of cellular organelles can be found in the publication of Itzhak et al. (2016). 
 
1.6 Emerging Role of Coat Proteins in Disease  
 
The first medical afflictions which partially result from protein miss-trafficking were beginning to be 
understood on a cell biological level during the sixties of the last century (Hashimoto et al., 1965; 
Hers, 1963). These so-called lysosomal storage disorders (LSDs) represent a broad group of diseases 
with more than 40 different known syndromes (Vellodi, 2005). One of these syndromes results for 
example from mutations that cause inactivity of the phosphotransferase that primes lysosomal 
enzymes for correct targeting by the mannose-6-phosphate (Kornfeld, 1986; Reitman and Kornfeld, 
1981; Reitman et al., 1981; Varki et al., 1981). Shorty after this finding, the famous single point 
mutation that affects the transportation of the LDLr was identified (Davis et al., 1986). Trafficking of 
the LDL receptor was studied in the first place because its perturbation causes familial 
hypercholesterolemia (Davis et al., 1986).  
The advent of deep sequencing at the turn of the millennium has made it easier to identify such 
mutations even for rare diseases with only very few patients. Amongst the first mutations identified 
in this fashion, were a deletion and a non-conservative amino acid conversion affecting the AP-3β1 
subunit of adaptor protein complex 3 (Dell'Angelica et al., 1999b). Those mutations lead to 
development of the Hermansky-Pudlak syndrome which is characterized by defective lysosomal 
targeting of proteins ultimately causing albinism and bleeding disorders (Dell'Angelica et al., 1999b; 
Gahl and Huizing, 1993; Huizing et al., 2002). Ever since then, several mutations in subunits of various 
AP complex subunits have been implicated in the development of disease. Mutations in AP-1σ2 were 
linked to X-linked mental retardation (Cacciagli et al., 2014; Tarpey et al., 2006). Similarly, mutations 
in the second isoform, AP-1σ1 cause the severe MEDNIK (mental retardation, enteropathy, deafness, 
peripheral neuropathy, ichthyosis, and keratodermia) syndrome (Montpetit et al., 2008). Moreover, 
the two AP complexes AP-4 and AP-5 are tightly linked to hereditary spastic paraplegia (HSP/SPG), a 
syndrome marked by spasticity of the lower limbs and sometimes mental retardation (reviewed in 
Fink, 2013, 2014). This connection is so intimate that some of the AP complex subunits were first 
identified as factors of SPG-development before becoming designated coat components, i.e. 
SPG11/SPG15 (Hirst et al., 2013; Slabicki et al., 2010). 
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In recent years, it became clear that not only coat proteins of the late secretory pathway play a role 
in development of disease, also proteins of the COPI and COPII systems are associated with medical 
conditions. For example mutations in the small GTPase Sar1B were shown to cause lipid absorption 
disorders (Jones et al., 2003). Furthermore, mutations within the inner coat subunits Sec23A were 
associated with Cranio-lenticulo-sutural dysplasia (CLSD) (Boyadjiev et al., 2006; Fromme et al., 
2007). The other Sec23 isoform, Sec23B, was shown to play a role in Dyserythropoietic Anemia Type 
II (Bianchi et al., 2009) and the Cowden syndrome which is characterized by a high risk of epithelial 
cancer (Yehia et al., 2015). Most recently, mutations within the isoform Sec24D were identified as 
the cause of syndromic form of osteogenesis imperfecta (OI) (Garbes et al., 2015). In the COPI 
system, mutations of the α-COP subunit could be linked to hereditary autoimmune-mediated lung 
disease and arthritis (Watkin et al., 2015), while mutations of δ-COP correlated with a craniofacial 
disorder (Izumi et al., 2016). 
Taken together the number of proteins which serve vesicular transport and play a role in the 
development of various diseases is strongly increasing especially in most recent years. 
 
1.7 Objective 
 
As pointed out in the previous sections, coat proteins and their isoforms can have a major influence 
on cargo-uptake, and on the directionality of vesicular transport (see 1.2-1.4). These findings are 
underlined by the fact that mutations within different isoforms of the same coat component can 
result in completely different medical afflictions (see 1.6). While for many subunits of the COPII and 
the CCV system data, which assigns them to a certain function, exists, such data is virtually absent for 
isoforms in the COPI system. Likewise, while the molecular mechanism which leads to the occurrence 
of a certain syndrome is understood for many of the mutations highlighted in section 1.6, such an 
explanation is missing for the most recently discovered mutations in Sec24D leading to syndromic 
osteogenesis imperfecta (Garbes et al., 2015). Therefore, in this thesis I worked on the following 
questions: 
- Do isoforms of γ- and ζ-COP influence the steady-state proteome of COPI vesicles? 
- Do isoforms of the small GTPase Arf influence the protein content of COPI vesicles? 
- What are the shared/diverging proteins in COPI vesicles with different origin? 
- What is the molecular mechanism that leads to a syndromic form of osteogenesis imperfecta 
in patients with Sec24D mutations? 
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2 Results 
 
2.1 Establishing a Workflow for COPI Proteomics 
 
As pointed out in section 1.7, one of the major goals of this study was to investigate the protein 
content of COPI vesicles prepared with different isoforms of coat proteins. Hence we decided to take 
advantage of an in vitro COPI reconstitution system in which recombinant coat proteins are used to 
produce vesicles from semi-intact cells (SIC) (Adolf et al., 2013), schematically drawn in figure 2.1. 
Briefly, the plasma membrane of cells is permeabilized with digitonin and the cytosol removed 
through washing with a physiological assay buffer. Recombinant coatomer, Arf, and nucleotides are 
added to the semi-intact cells following an incubation step to allow vesicle formation. Vesicles can be 
separated from the vast amount of SIC via medium-speed centrifugation (MSP) (Fig. 2.1; Material and 
Methods). 
 
Figure 2.1 COPI Reconstitution from Semi-intact Cells 
Cells are permeabilized with digitonin, washed with buffer, and incubated with COPI coat proteins and nucleotides for 30 
minutes. Donor membranes can be subsequently separated from the vesicles via medium-speed centrifugation at 14.000 ×g 
for 10 minutes. For experimental details see Material and Methods. 
 
The vesicle-containing supernatant recovered after MSP contains, besides COPI vesicles, the huge 
excess of recombinant coat protein used for reconstitution. When performing Western blot analyses 
it is usually sufficient to subject the supernatant to high-speed centrifugation (HSP) at 100.000 ×g in 
order to harvest the vesicles (Fig. 2.2). As can be clearly seen, vesicle marker proteins ERGIC53, 
ERGIC1, and p24 are enriched in the harvested fraction, when all COPI components and nucleotides 
were present compared to a control reaction without coatomer. In contrast, the non-vesicle marker 
GM130 is not particularly enriched in the COPI vesicle fraction (Fig 2.2). 
Results 
31 
 
 
Figure 2.2 Western Blot Analysis of Harvested COPI Vesicles 
Representative Western blot analysis of COPI vesicles reconstituted from SIC HeLa using recombinant CM, Arf1, GTP, and 
ATP regenerating system (ATPr) with 5 µg of SIC loaded as input. Vesicles were isolated via differential centrifugation (MSP 
and HSP). Indicated on the left are the antibodies used for detection. 
 
Despite the fact that HSPs from vesicle reconstitutions can be analyzed via Western blot, a mass 
spectrometric analysis of such a sample is not possible. When we tried to directly assess the protein 
content of such samples, very low quality data was obtained. We attributed this shortcoming to 
excess coat, which is harvested alongside the vesicles. The majority of peptides, coming from these 
coat proteins, seemed to hamper the detection of proteins from the vesicle membrane and inside. 
Thus we decided to purify the reconstituted vesicles by means of density gradient floatation. For this 
we used the density matrix iodixanol, which had been previously used to purify COPII vesicles (M.Sc. 
thesis Manuel Rhiel, Adolf et al., unpublished data). Vesicle samples obtained from medium-speed 
centrifugation were adjusted to a concentration of 40 % iodixanol. The samples were overlaid with a 
big 30 % and small 20 % layer and the whole gradient centrifuged over night at 250.000 ×g (for 
details see Material and Methods). Following ultracentrifugation, the gradient, which is schematically 
depicted in figure 2.3A, was fractionated into ten fractions from top (1) to bottom (10). Each fraction 
was diluted in assay buffer and subjected to high-speed centrifugation at 100.000 ×g for 2 h in order 
to harvest vesicles and to some extend free protein. Subsequently, the fractions were analyzed by 
Western blot and probed for the COPI vesicle marker proteins ERGIC53 and p24 as well as the COPI 
coat component γ-COP. When either coatomer or nucleotide had been omitted during the budding 
reaction, faint signals for ERGIC53 and p24 could be detected predominantly in fraction 2, but also 
fraction 3 (Fig. 2.3B two upper panels). The signal intensities for both proteins increased strongly, 
when GTP was added to the reaction. Also here, the strongest signals were detected in fraction 2 
(Fig. 2.3B second lowest panel). Using a non-hydrolysable GTP analog, GMP-PNP, instead of GTP also 
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resulted in the detection of strong signals for both COPI marker proteins. However, especially the 
detection for p24 did not longer give the strongest signal in fraction 2 but rather in fraction 3. 
Moreover, unlike under all conditions mentioned before, using GMP-PNP lead to the detection of 
γ-COP in fraction 3 of the gradient (Fig. 2.3B lower panel). Coat detection and the shift of marker 
proteins from fraction 2 to fraction 3 as observed for the GMP-PNP sample is in line with a higher 
buoyant density of coated vesicles, compared to uncoated vesicles. It is worth noting that most of 
the endogenous coatomer was removed from the SIC during the washing step. Hence, the 
recombinant protein complex, here detected via γ-COP, is in vast excess of the remaining fraction of 
endogenous proteins (Fig. 2.3B inputs). 
 
Figure 2.3 COPI Vesicle Purification via Floatation in an Iodixanol Density Gradient 
(A) Scheme of the density gradient used for COPI floatation. Samples were adjusted to 40 % and overlaid with 30 % and 20 
% density matrix. The black arrow indicated the movement of the vesicles; the red arrow indicates the fractionation 
procedure from top to bottom. (B) Western blot analysis of the fractions indicated above the blots. Components 
added/omitted during reconstitutions are depicted on the left. As inputs, 5 % of the SIC and 1% of CM used for the 
reconstitutions were loaded. Membranes were probed for the presence of the protein indicated on the right. Black box 
highlights the fractions that contain COPI marker proteins (2 and 3). 
 
In order to further verify that fractions 2 and 3 contain COPI vesicles, they were investigated by 
electron microscopy. A combined fraction 2/3 was harvested from gradients loaded with 
reconstitutions performed with GTP, GMP-PNP, or without coatomer and subjected to 
resin-embedding. From control samples (without CM), no pellet could be obtained. This is not 
unexpected as the Western blot analysis of this sample displayed only weak signals for COPI marker 
proteins (Fig. 2.3B second highest panel). For GTP and GMP-PNP reconstitutions, resin-embedded 
samples could be prepared. Inspection of ultrathin sections from these samples revealed 
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predominantly vesicle-like structures (Fig. 2.4). The vesicles were not perfectly homogenous in size, 
ranging from 60-100 nm. Moreover, while the vesicles recovered from the GTP sample appeared 
almost exclusively uncoated, an electron-dense coat could be observed on many of the vesicle 
profiles isolated from gradient loaded with the GMP-PNP reconstitution (compare Fig. 2.4 A and B). 
 
Figure 2.4 Resin-embedding EM of Purified COPI Vesicles 
Representative EM images of embedded samples recovered from a combined fraction 2/3 after iodixanol density gradient 
purification. Reconstitutions were performed either with GTP (A) or non-hydrolysable analog GMP-PNP (B). Scale bars with 
their respective length are depicted in the main images and insets. 
 
With an assay and purification procedure at hand to obtain a clean fraction of COPI vesicles we 
needed to choose a method for proteomics. Since semi-intact cells were used as source of Golgi 
membranes, we decided to use isotope labeling (SILAC) which would allow us to perform 
quantitative mass spectrometry. The workflow that was employed in order to investigate the protein 
content of COPI vesicles is outlined in figure 2.5: 
i) Cells were in parallel cultivated in heavy medium, containing isotope-labeled arginine and lysine, 
and light medium with unlabelled amino acids. ii) Once an incorporation of the heavy amino acids 
>95 % was achieved, cells were expanded and used as donor material for COPI reconstitution. In 
parallel to the budding reaction, a mock reaction without CM was performed, which contains 
background levels of COPI marker proteins (Fig. 2.3B), and furthermore all contaminants that are 
co-purified with the reconstituted vesicles. iii) Samples from the budding reaction and the mock 
reaction were mixed and processed for LC-MS. iv) The samples from both reactions were analyzed in 
the same MS run. By comparing the intensities of heavy and light peptides (SILAC ratio) it is possible 
to quantify the enrichment of proteins in either one of the two samples (Fig. 2.5). 
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Figure 2.5 Workflow of a SILAC-based COPI Proteomic Experiment 
i) Cells were labeled with heavy amino acids. ii) Heavy and light cells were used as membrane source for budding and mock 
reactions (without CM). The reconstituted (mock) vesicles were purified through density gradient floatation. iii) Vesicle and 
mock samples were mixed and processed for LC-MS. iv) Samples were analyzed in the same MS run. Labels allow the 
assignment of each peptide to one of the two samples. From their intensities, quantitative SILAC ratios can be calculated. 
 
2.2 The HeLa Cell COPI Vesicle Core Proteome 
 
In the workflow shown in figure 2.5, the COPI reconstitution was performed from heavy cells, while 
the mock reaction was carried out with unlabeled cells. In order to make sure that the labeling 
procedure had no influence on the later sample, the same experiment was performed with switched 
isotope labels – vesicles light, mock heavy. This general intrinsic control was kept for further SILAC 
experiments as they were usually performed as label switch replicates. 
The SILAC ratios obtained from two independent experiments are displayed in the scatter plot in 
figure 2.6. Here, each protein detected in both runs is displayed as a dot with its coordinates being its 
respective SILAC ratios. Obvious contaminants identified by high light/heavy and low heavy/light 
ratios e.g. keratin species or coat proteins were excluded from the plot. Noteworthy, in the final 
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experiments, presented here, only coatomer was omitted in the mock reactions. Initially also Arf1 
was omitted with the results that subunits of the adaptor protein complex 1 (AP-1) were enriched 
almost fourfold in the vesicle fraction. Through the addition of Arf1, no AP complex subunit displays 
SILAC ratios >1.6. From the plot in figure 2.6 it can be clearly seen that the majority of proteins have 
SILAC ratios of close to one meaning they are neither enriched in the COPI sample nor the mock 
control. Proteins which are enriched in the COPI vesicle sample spread out towards the upper right 
corner of the plot, aligning to a virtual diagonal. Values from both independent runs display a high 
degree of correlation, with an R2 value of 0.7. This value rises to 0.83 when a single protein with 
heavily diverging SILAC ratios, Zinc finger protein-like 1 (ZFPL1), which displays SILAC ratios of 29.5 
and 4.3, is excluded from the analysis (Fig. 2.6). The cis-Golgi protein ZPFL1, as well as other proteins 
and protein families that display particularly high SILAC ratios are highlighted in the plot. In 
particular, 6 members of the p24/TMED family, the two calcium binding proteins nucleobindin 1 and 
2 (NUCB1/2), the zinc transporters SLC30A6/7, as well as the ER-Golgi cycling protein ERGIC3, display 
robust enrichment in the COPI vesicle sample (Fig. 2.6). 
 
Figure 2.6 The HeLa Cell COPI Proteome 
Scatter plot of SILAC ratios obtained from two independent experiments performed according to figure 2.5 with switched 
labels. CMγ1ζ1 and Arf1 were used. Contaminants were removed from the datasets. Some proteins and protein families are 
highlighted in color. R
2
 value of the complete dataset is 0.7; it rises to 0.83 when ZFPL1 is neglected. 
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In total three COPI vesicles versus mock experiments were performed with HeLa cells. 102 proteins 
were identified in at least 2 experiments, displaying mean SILAC ratios of >2. An additional 20 
proteins were identified with SILAC ratios >2 in only one experiment with the SILAC label being 
carried by the COPI vesicle fraction. Hence, taken together 122 proteins are high fidelity COPI core 
proteome candidates. A complete list of these proteins is displayed in table 1. 
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Protein.names Gene.names 
ratio 1 
(H/L)  
ratio 2 
(L/H)  
ratio 3 
(H/L)  
Mean 
SILAC 
ratio 
SEM 
Zinc finger protein-like 1 ZFPL1 29,51 4,30 13,37 15,73 7,37 
Transmembrane emp24 domain-containing protein 7 TMED7;TMED7-TICAM2 16,79 10,41 11,29 12,83 2,00 
Solute carrier family 35 member E1 SLC35E1 13,62   10,88 12,25 1,37 
Endoplasmic reticulum-Golgi intermediate compartment protein 3 ERGIC3 15,26 11,43 9,31 12,00 1,74 
Zinc transporter 5 SLC30A5 10,65   12,74 11,69 1,04 
Transmembrane emp24 domain-containing protein 10 TMED10 12,96 10,12 9,31 10,80 1,11 
Transmembrane emp24 domain-containing protein 4 TMED4 13,61 8,95 9,64 10,73 1,45 
Zinc transporter 7 SLC30A7 12,28 11,15 8,67 10,70 1,07 
Nucleobindin-1 NUCB1 12,59 8,35 10,50 10,48 1,23 
Transmembrane emp24 domain-containing protein 2 RNP24;TMED2 11,88 9,17 9,89 10,31 0,81 
Zinc transporter 6 SLC30A6 12,17 7,77   9,97 2,20 
Transmembrane emp24 domain-containing protein 9 TMED9 10,99 8,43 9,64 9,68 0,74 
Nucleobindin-2;Nesfatin-1 HEL-S-109;NUCB2;Nucb2 14,18 7,08 7,69 9,65 2,27 
Transmembrane emp24 domain-containing protein 1 TMED1 11,13 6,16 8,48 8,59 1,44 
Endoplasmic reticulum-Golgi intermediate compartment protein 2 ERGIC2 7,24 8,64 8,16 8,01 0,41 
VIP36-like protein LMAN2L 7,24 7,05 8,10 7,46 0,32 
Protein RER1 RER1 9,28 7,47 5,56 7,44 1,07 
Protein cornichon homolog 4 CNIH4 7,34 6,72   7,03 0,31 
Surfeit locus protein 4 SURF4 7,01 6,90 5,96 6,62 0,33 
Protein ERGIC-53 LMAN1 6,96 6,63 6,23 6,61 0,21 
Protein YIPF;Protein YIPF5 YIPF5 7,07 6,80 5,90 6,59 0,36 
Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 B3GAT3 9,24 3,71   6,47 2,77 
Vesicular integral-membrane protein VIP36 LMAN2 7,52 5,84 5,63 6,33 0,60 
Golgi SNAP receptor complex member 2 GOSR2 8,31   4,30 6,31 2,01 
Transmembrane 9 superfamily member 3 TM9SF3;SMBP 8,67 5,36 4,60 6,21 1,25 
Rab-like protein 3 RABL3 6,05     6,05   
Beta-1,3-galactosyltransferase 6 B3GALT6 5,88     5,88   
Immediate early response 3-interacting protein 1 IER3IP1 7,28 6,04 4,25 5,85 0,88 
Protein YIPF4 YIPF4 8,45 3,10   5,78 2,67 
Vesicle transport protein GOT1B GOLT1B 5,87 5,38 5,72 5,66 0,14 
Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase;alpha-1,2-Mannosidase MAN1B1 7,47 4,36 4,60 5,48 1,00 
Protein YIF1A YIF1A 6,08 5,41 4,88 5,46 0,35 
Vesicle-trafficking protein SEC22b SEC22B 6,76 4,34 5,06 5,39 0,72 
Endoplasmic reticulum resident protein 44 ERP44 6,17 4,91 4,44 5,17 0,52 
Protein kish-A TMEM167A 5,35   4,93 5,14 0,21 
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Protein.names Gene.names 
ratio 1 
(H/L)  
ratio 2 
(L/H)  
ratio 3 
(H/L)  
Mean 
SILAC 
ratio 
SEM 
Golgi reassembly-stacking protein 2 GORASP2 4,99     4,99   
Protein YIF1B YIF1B 5,24 4,98 4,37 4,86 0,26 
Alpha-(1,6)-fucosyltransferase FUT8 8,19 1,51   4,85 3,34 
ER lumen protein-retaining receptor 1;ER lumen protein-retaining receptor KDELR1 5,53   4,00 4,76 0,76 
Endoplasmic reticulum-Golgi intermediate compartment protein 1 ERGIC1 6,45 3,74 4,01 4,73 0,86 
Syntaxin-5 STX5;STX5A 4,88 3,68 5,61 4,72 0,56 
Ras-related protein Rab-18 RAB18 5,06 4,45 4,29 4,60 0,24 
Clusterin;Clusterin beta chain;Clusterin alpha chain;Clusterin CLU 4,36 5,66 3,68 4,57 0,58 
Protein CASP;Homeobox protein cut-like 1 
CUX1;Nbla10317;CUX1-
RETc;CUX1-RETa 6,43 2,45   4,44 1,99 
Protein YIPF3;Protein YIPF3, 36 kDa form III;Protein YIPF YIPF3 5,28 4,40 3,29 4,32 0,58 
Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB MAN1A2 6,04 4,37 2,23 4,21 1,10 
Polypeptide N-acetylgalactosaminyltransferase 1 GALNT1 5,10 3,96 3,55 4,21 0,46 
Protein canopy homolog 2 CNPY2 4,15     4,15   
Lipoprotein lipase LPL 5,25 2,91   4,08 1,17 
Cell growth regulator with EF hand domain protein 1 CGREF1 4,81 2,73   3,77 1,04 
Protein disulfide-isomerase P4HB 4,00 3,51   3,76 0,25 
Palmitoyltransferase ZDHHC13;Palmitoyltransferase ZDHHC13 5,10 2,36   3,73 1,37 
Polypeptide N-acetylgalactosaminyltransferase 3;Polypeptide N-acetylgalactosaminyltransferase GALNT3 4,75 2,78 3,63 3,72 0,57 
Peptidyl-prolyl cis-trans isomerase;Peptidyl-prolyl cis-trans isomerase B HEL-S-39;PPIB 4,84 3,54 2,59 3,65 0,65 
Emerin EMD 2,96 4,82 3,03 3,60 0,61 
Reticulocalbin-1 HEL-S-84;RCN1 4,63 2,56   3,60 1,03 
Transmembrane protein 115 TMEM115 4,90 2,24   3,57 1,33 
Transmembrane emp24 domain-containing protein 5 TMED5 2,79 4,09 3,72 3,53 0,39 
Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase MGAT2 4,55 2,79 3,05 3,46 0,55 
Alpha-mannosidase 2;Alpha-mannosidase MAN2A1 4,91 2,65 2,65 3,41 0,75 
ER lumen protein-retaining receptor;ER lumen protein-retaining receptor 2 KDELR2     3,39 3,39   
Rho-related BTB domain-containing protein 3 RHOBTB3 3,32     3,32   
Glycosyltransferase 8 domain-containing protein 2 GLT8D2 3,26     3,26   
Sec1 family domain-containing protein 1 SCFD1 3,75 2,74   3,25 0,50 
ADP-ribosylation factor 4 ARF4 3,18     3,18   
BET1 homolog BET1;DKFZp781C0425 3,67 2,63   3,15 0,52 
Alpha-2-macroglobulin receptor-associated protein LRPAP1 3,14     3,14   
UbiA prenyltransferase domain-containing protein 1 UBIAD1 4,85 2,10 2,45 3,13 0,86 
Vesicle-trafficking protein SEC22a SEC22A 3,13     3,13   
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Protein.names Gene.names 
ratio 1 
(H/L)  
ratio 2 
(L/H)  
ratio 3 
(H/L)  
Mean 
SILAC 
ratio 
SEM 
Serpin H1 SERPINH1 3,73 3,20 2,34 3,09 0,41 
Galectin-3-binding protein LGALS3BP 4,15 2,01   3,08 1,07 
Thioredoxin domain-containing protein 5 
hCG_1811539;TXNDC5;STRF
8;DKFZp666I134 2,75 3,36   3,05 0,30 
Ras-related protein Rab-2A RAB2;RAB2A 3,65 3,18 2,27 3,03 0,40 
cDNA FLJ76981, highly similar to Homo sapiens golgi autoantigen, golgin subfamily a, 5 (GOLGA5), mRNA GOLGA5 3,06 2,87   2,97 0,09 
Transmembrane emp24 domain-containing protein 3 TMED3 2,42 3,49   2,96 0,54 
Calumenin CALU 3,67 2,29 2,73 2,89 0,41 
Probable glutathione peroxidase 8 GPX8 3,04 2,75 2,80 2,86 0,09 
Calreticulin HEL-S-99n;CALR 2,97 2,58   2,77 0,19 
Polypeptide N-acetylgalactosaminyltransferase 10;Polypeptide N-acetylgalactosaminyltransferase GALNT10 3,41 1,94 2,88 2,74 0,43 
Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase MGAT1 3,99 2,19 1,95 2,71 0,64 
Insulin-like growth factor-binding protein 7 IGFBP7 2,99 2,42   2,71 0,29 
Adipocyte plasma membrane-associated protein APMAP 2,51 2,86   2,69 0,17 
Ras-related protein Rab-6B RAB6A;RAB6B 3,62 2,53 1,88 2,68 0,51 
Exostosin-like 2;Processed exostosin-like 2 EXTL2 2,67     2,67   
Protein disulfide-isomerase A6 PDIA6 3,08 2,23   2,66 0,42 
Neutral alpha-glucosidase AB HEL-S-164nA;GANAB 2,43 2,85   2,64 0,21 
Transmembrane 9 superfamily member 1 TM9SF1 3,87 2,49 1,52 2,63 0,68 
Nucleoporin NDC1 NDC1 2,60     2,60   
78 kDa glucose-regulated protein HEL-S-89n;HSPA5 2,94 3,26 1,48 2,56 0,55 
Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 POMGNT1 3,68 1,40   2,54 1,14 
Sulfhydryl oxidase 2 QSOX2 3,26 2,18 2,12 2,52 0,37 
Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B MGAT4B 2,91 2,10   2,50 0,40 
Golgi SNAP receptor complex member 1 GOSR1 3,28 1,95 2,28 2,50 0,40 
Carbohydrate sulfotransferase 14 CHST14 3,54 2,14 1,82 2,50 0,53 
Chondroitin sulfate synthase 2 CHPF 2,45     2,45   
SPARC-related modular calcium-binding protein 1 SMOC1 3,56 1,33   2,45 1,12 
Beta-1,4-glucuronyltransferase 1 B3GNT6;B4GAT1 3,65 1,23   2,44 1,21 
NADH-cytochrome b5 reductase CYB5R3 2,78 2,06   2,42 0,36 
Transmembrane protein 43 TMEM43;FLJ00144     2,39 2,39   
Golgin subfamily B member 1 GOLGB1 3,36 2,12 1,67 2,38 0,51 
Protein FAM3A FAM3A 2,32     2,32   
Protein CASC4 CASC4 3,22 1,62 2,13 2,32 0,47 
Calcium-transporting ATPase;Calcium-transporting ATPase type 2C member 1 ATP2C1 2,76 1,83 2,34 2,31 0,27 
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Protein.names Gene.names 
ratio 1 
(H/L)  
ratio 2 
(L/H)  
ratio 3 
(H/L)  
Mean 
SILAC 
ratio 
SEM 
Ras-related protein Rab-1B;Putative Ras-related protein Rab-1C RAB1B;RAB1C 2,84 2,31 1,76 2,31 0,31 
45 kDa calcium-binding protein SDF4 2,83 1,96 2,09 2,29 0,27 
DnaJ homolog subfamily B member 11 DNAJB11 2,27     2,27   
Very-long-chain enoyl-CoA reductase TECR 2,26     2,26   
Protein SYS1 homolog SYS1 2,25     2,25   
Catechol O-methyltransferase COMT 2,19     2,19   
Transmembrane protein 33 SHINC3;TMEM33 2,52 1,83 2,17 2,17 0,20 
Prenylated Rab acceptor protein 1 RABAC1 2,95 1,79 1,67 2,14 0,41 
Golgi integral membrane protein 4 GOLIM4 2,36 1,89 2,10 2,12 0,14 
Ras-related protein Rab-1A RAB1A 2,55 1,90 1,84 2,10 0,23 
Solute carrier family 35 member E2B;Solute carrier family 35 member E2 
hCG_2036609;SLC35E2B;SLC
35E2 3,22 0,88   2,05 1,17 
GDP-fucose transporter 1 SLC35C1 2,86 1,20   2,03 0,83 
Myosin-10 MYH10 3,22 0,84   2,03 1,19 
Transmembrane 9 superfamily member 4 TM9SF4 2,84 1,41 1,83 2,03 0,42 
Dermatan-sulfate epimerase DSE 2,28 1,76   2,02 0,26 
Glycoprotein endo-alpha-1,2-mannosidase-like protein MANEAL 4,07 1,97   2,01 1,05 
Transforming growth factor-beta-induced protein ig-h3 TGFBI 2,01     2,01   
40S ribosomal protein S2 RPS2;OK/KNS-cl.6;rps2 2,27 1,75   2,01 0,26 
Cleft lip and palate transmembrane protein 1-like protein CLPTM1L 1,63 2,38   2,00 0,38 
Table 1: Candidate Proteins for the HeLa Cell COPI Core Proteome 
List of candidates for the COPI core proteome from HeLa cells as determined by three independent experiments performed according to Fig. 2.5. CMγ1ζ1, Arf1, and GTP were used for 
reconstitutions. Given are gene and protein names of the identified proteins, the SILAC ratios (H/L or L/H) from each experiment, the mean SILAC ratio, and standard error of the mean (SEM). 
Displayed are protein with mean SILAC ratios of >2 or with a SILAC ratio >2 in one of the two experiments in which the vesicle sample was labeled with heavy isotopes (written in italic in the Mean 
SILAC ratio column). 
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Apart from the aforementioned proteins highlighted in figure 2.6, other ER-Golgi cycling proteins 
(e.g. ERGIC53/LMAN1, RER1, KDEL receptor), trafficking and fusion machinery such as SNAREs (e.g. 
Sec22b, Stx5, and GOSR1) and Rab proteins (e.g. Rab2A, Rab6A, and Rab18) alongside a large number 
of Golgi-localized enzymes (e.g. MAN1A2, ZDHHC13, GALNT1) were identified. Furthermore, ER-
residents, i.e. CALR, P4HB, HSPA5/BiP were found enriched in the COPI fraction. Of the 122 
candidates, few proteins e.g. LPL, CGREF1, TGFBI, and LGALS3BP are secreted from the cells. 
The core proteome of COPI vesicles as defined above consist with exception of the Rab proteins, 
luminal NUCB1/2, and the few secreted cargoes exclusively of transmembrane proteins. Since we 
planned to study CM isoforms, and the only described isoform-specific integrator Scyl1 is a cytosolic 
protein (Hamlin et al., 2014), we decided to test whether our assay was capable of capturing 
cytosolic factor that bind to the assembled COPI coat on a vesicle. To this end, the workflow outlined 
in Fig. 2.5 was modified in three ways. i) Both samples were prepared as actual budding reactions 
with CM, Arf1, and nucleotides. ii) One reconstitution was performed with GTP while the other one 
was performed its non-hydrolysable analog GTPγS to stabilize the COPI coat on the vesicles. 
iii) Isotope-labeled cytosol was added to the budding reaction in order to allow cytosolic factors to 
bind to COP vesicles during or after their formation. 
The cytosol, which was prepared via nitrogen cavitation, was completely depleted in abundant 
transmembrane proteins of the ER/Golgi Calnexin, ERGIC53, and p24 which are enriched in SIC and 
present in the whole cell lysate (Fig. 2.7A). As expected, soluble cytosolic proteins ε-COP and Arf1 are 
completely transferred from the lysate to the cytosol fraction but largely depleted in the SIC. The 
soluble Hsp70 of the ER, BiP, is also detected in large amounts in the cytosol indicating that 
organelles did not stay intact during the cytosol preparation (Fig. 7A). 
When the cytosol was added to COPI reconstitutions performed with GTP or GTPγS, many proteins 
displayed a significant enrichment in the sample prepared with the non-hydrolysable analog (Fig. 7B). 
Unlike expected, the vast majority of these proteins is not part of the cytosol. Among the highest 
scoring proteins, highlighted in Fig. 2.7B, are the large GTPases atlastin-2/3 (ATL2/3), the ER enzymes 
acetolactate synthase-like protein (ILVBL), and lanosterol synthase (LSS), as well as transmembrane 
protein 33 (TMEM33), and adipocyte plasma membrane-associated protein (APMAP) (Fig. 2.7B). 
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Figure 2.7 Influence of a Non-hydrolysable GTP Analog on COPI Budding in Presence of Cytosol 
(A) Western blot analysis of SIC (5 µg), whole cell lysate and a cytosol fraction (both 10 µg). Samples were probed for the 
presence of the proteins indicated on the right. (B) Scatter plot of SILAC ratios obtained from two independent experiments 
performed according to workflow in figure 2.5. Both samples were prepared with CMγ1ζ1, Arf1, and cytosol in the presence 
of either GTP or GTPγS. Experiments were performed with switched labels. Contaminants were removed from the datasets. 
Some proteins are highlighted in color. R
2
 value of the dataset is 0.78. 
 
Noteworthy, Scyl1 was not detected in the dataset. Only one cytosolic protein known to interact with 
Arf1 was enriched in the GTPγS vesicle sample, Arfaptin-1. A list showing the 72 proteins enriched 
more than twofold in either both (mean enrichment) or in the heavy GTPγS sample are displayed in 
table 2. 
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Protein.names Gene.names ratio 1 (H/L) ratio 2 (L/H) 
Mean SILAC 
ratio 
SEM 
Translocon-associated protein subunit alpha SSR1 6,91   6,91   
Acetolactate synthase-like protein ILVBL 6,29 6,76 6,53 0,23 
Translocon-associated protein subunit delta SSR4 5,95   5,95   
Adipocyte plasma membrane-associated protein APMAP 6,49 5,37 5,93 0,56 
Torsin-1A-interacting protein 2 TOR1AIP2 5,62   5,62   
Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 HACD3 5,48   5,48   
Atlastin-2 ATL2 5,03 4,86 4,95 0,09 
Terpene cyclase/mutase family member;Lanosterol synthase LSS 4,92 4,72 4,82 0,10 
Transmembrane protein 33 SHINC3;TMEM33 5,21 4,39 4,80 0,41 
Torsin-1A TOR1A 4,63   4,63   
Cytochrome b5 type B DKFZp686M0619;CYB5B 4,48   4,48   
Atlastin-3 ATL3 4,35 3,61 3,98 0,37 
ADP-ribosylation factor-like protein 6-interacting protein 1 ARL6IP1;hCG_1994130 4,21 3,73 3,97 0,24 
Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating NSDHL 4,15 3,65 3,90 0,25 
Cleft lip and palate transmembrane protein 1-like protein CLPTM1L 3,86   3,86   
Protein FAM134C FAM134C 3,78 3,87 3,82 0,05 
Vesicle-associated membrane protein-associated protein A VAPA 4,08 3,22 3,65 0,43 
Membrane-associated progesterone receptor component 1 PGRMC1 3,92 3,36 3,64 0,28 
Transmembrane and coiled-coil domain-containing protein 1 TMCO1 3,62   3,62   
Vesicle-associated membrane protein-associated protein B/C VAPB 3,81 3,41 3,61 0,20 
7-dehydrocholesterol reductase DHCR7 3,57   3,57   
Receptor expression-enhancing protein;Receptor expression-enhancing protein 5 REEP5 4,00 2,97 3,48 0,52 
Extended synaptotagmin-2 ESYT2 3,67 3,25 3,46 0,21 
PRA1 family protein 3 ARL6IP5 3,87 2,95 3,41 0,46 
Membrane-associated progesterone receptor component 2 PGRMC2 4,48 2,23 3,36 1,12 
Arfaptin-1 ARFIP1 2,44 4,26 3,35 0,91 
Transmembrane protein 43 TMEM43;FLJ00144 3,79 2,91 3,35 0,44 
B-cell receptor-associated protein 31 BCAP31 3,93 2,66 3,29 0,63 
Fatty acid desaturase 2 FADS2 3,29   3,29   
Heme oxygenase 1 HMOX1 3,25   3,25   
Catechol O-methyltransferase COMT 3,58 2,86 3,22 0,36 
Extended synaptotagmin-1 FAM62A;ESYT1 3,40 3,03 3,22 0,18 
Reticulon;Reticulon-3 RTN3 3,80 2,50 3,15 0,65 
Calnexin CANX 3,65 2,61 3,13 0,52 
Reticulon;Reticulon-1 RTN1 3,54 2,70 3,12 0,42 
Reticulon RTN4;NOGOC;Nbla00271 3,55 2,68 3,11 0,44 
Fatty acid desaturase 1 FADS1 3,11   3,11   
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Protein.names Gene.names ratio 1 (H/L) ratio 2 (L/H) 
Mean SILAC 
ratio 
SEM 
Retinol dehydrogenase 11 RDH11 3,35 2,87 3,11 0,24 
NADH-cytochrome b5 reductase;NADH-cytochrome b5 reductase 3;NADH-cytochrome b5 
reductase 3 membrane-bound form;NADH-cytochrome b5 reductase 3 soluble form CYB5R3 3,30 2,90 3,10 0,20 
Epoxide hydrolase 1 EPHX1 3,35 2,79 3,07 0,28 
V-type proton ATPase subunit S1 ATP6AP1;FLJ00383 3,39 2,70 3,05 0,35 
Long-chain-fatty-acid--CoA ligase 3 ACSL3 3,32 2,74 3,03 0,29 
Lysophosphatidylcholine acyltransferase 1 LPCAT1;AYTL2 3,23 2,82 3,02 0,21 
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit DDOST 3,02 2,98 3,00 0,02 
Signal peptidase complex subunit 2 SPCS2 2,99   2,99   
Reticulon RTN3 2,95 2,97 2,96 0,01 
NADPH--cytochrome P450 reductase POR;DKFZp686G04235 2,95 2,90 2,93 0,02 
Thioredoxin-related transmembrane protein 1 TMX1;TXNDC 3,28 2,52 2,90 0,38 
Fatty aldehyde dehydrogenase DKFZp686E23276;ALDH3A2 2,89   2,89   
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 ATP2A2 2,79 2,83 2,81 0,02 
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 RPN1 2,86 2,66 2,76 0,10 
Aspartyl/asparaginyl beta-hydroxylase ASPH 2,71   2,71   
Lanosterol 14-alpha demethylase CYP51A1 2,68 2,64 2,66 0,02 
AP-1 complex subunit beta-1 AP1B1 2,71 2,54 2,62 0,08 
Leucine-rich repeat and calponin homology domain-containing protein 4 LRCH4 1,88 3,31 2,60 0,71 
Protein disulfide-isomerase;Protein disulfide-isomerase A3 HEL-S-269;PDIA3 2,27 2,91 2,59 0,32 
Protein disulfide-isomerase A6 PDIA6 2,85 2,08 2,47 0,38 
ADP-ribosylation factor 4 ARF4 2,41 2,49 2,45 0,04 
AP-1 complex subunit mu-1 AP1M1 2,20 2,64 2,42 0,22 
Immediate early response 3-interacting protein 1 IER3IP1 3,36 1,45 2,41 0,96 
Sarcolemmal membrane-associated protein SLMAP 2,39   2,39   
Glucosidase 2 subunit beta PRKCSH 2,27   2,27   
78 kDa glucose-regulated protein HEL-S-89n;HSPA5 2,29 2,22 2,25 0,04 
Probable glutathione peroxidase 8 GPX8 2,70 1,66 2,18 0,52 
Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 PLOD2 2,60 1,75 2,18 0,43 
Emerin EMD 2,71 1,64 2,17 0,53 
AP-1 complex subunit gamma-1 AP1G1 2,16   2,16   
Calreticulin HEL-S-99n;CALR 2,14   2,14   
Endoplasmin TRA1;HEL-S-125m;HSP90B1 2,29 1,90 2,09 0,19 
Glutathione peroxidase GPX8 2,09 2,09 2,09 0,00 
Transmembrane emp24 domain-containing protein 5 TMED5 2,50 1,57 2,03 0,46 
Aladin AAAS 1,97 2,07 2,02 0,05 
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Table 2: Proteins Enriched by GTPγS in the COPI Vesicle Fraction in the Presence of Cytosol 
List of proteins enriched in the COPI vesicle fraction yielded with GTPγS compared to GTP, both in the presence of cytosol. Experiments were in general performed according to Fig. 2.5. Vesicles 
were made from HeLa cells with CMγ1ζ1 and Arf1 in the presence of labeled/unlabeled cytosol with either GTP or GTPγS. Given are gene and protein names of the identified proteins, the SILAC 
ratios (H/L or L/H) from each experiment, the mean SILAC ratio, and standard error of the mean (SEM). Displayed are protein with mean SILAC ratios >2 or with a SILAC ratio >2 observed within 
the experiment in which the GTPγS vesicle sample was heavy labeled (written in italic in the Mean SILAC ratio column). 
 
Since the majority of proteins enriched in GTPγS vesicles were transmembrane proteins, which with high fidelity did not originate from the cytosol (Fig. 2.7A), 
the possibility was explored that the non-hydrolysable GTP analog had lead to the release of membranes from SIC. To this end, the experiment outlined above 
was performed this time omitting coatomer in both, the GTP and the GTPγS reconstitution. As can be seen in table 3, a large number of the proteins enriched in 
the original experiments (with CM) were also enriched in these samples, e.g. atlastins, reticulons, and many other mostly ER resident transmembrane proteins 
(Tab. 3). 
 
Protein.names Gene.names ratio 1 (H/L) ratio 2 (H/L) 
Mean SILAC 
ratio 
SEM 
Catalase CAT 6,77   6,77   
Atlastin-2 ATL2 4,00 4,82 4,41 0,41 
NADPH--cytochrome P450 reductase POR;DKFZp686G04235 3,53   3,53   
Extended synaptotagmin-2 ESYT2 3,75 3,25 3,50 0,25 
Atlastin-3 ATL3 3,37 3,47 3,42 0,05 
Vesicle-associated membrane protein-associated protein B/C VAPB   3,24 3,24   
PRA1 family protein 2 PRAF2   3,24 3,24   
Receptor expression-enhancing protein;Receptor expression-enhancing protein 5 REEP5 3,13 3,25 3,19 0,06 
Reticulon;Reticulon-3 RTN3 3,12 3,20 3,16 0,04 
ADP-ribosylation factor-like protein 6-interacting protein 1 hCG_1994130;ARL6IP1 3,12 3,15 3,13 0,02 
Extended synaptotagmin-1 FAM62A;ESYT1 3,00 3,25 3,12 0,13 
Calnexin CANX 3,07 3,16 3,12 0,04 
Reticulon;Reticulon-1 RTN1 3,09   3,09   
Reticulon-4 RTN4 3,06 3,07 3,06 0,01 
B-cell receptor-associated protein 31 BCAP31 2,84 3,16 3,00 0,16 
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Protein.names Gene.names ratio 1 (H/L) ratio 2 (H/L) 
Mean SILAC 
ratio 
SEM 
Vesicle-associated membrane protein-associated protein A VAPA 2,79 3,19 2,99 0,20 
Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating NSDHL   2,93 2,93   
PRA1 family protein 3 ARL6IP5 2,83 3,02 2,92 0,10 
Membrane-associated progesterone receptor component 1 PGRMC1 2,90 2,81 2,86 0,04 
Protein FAM134C FAM134C 2,49 3,15 2,82 0,33 
Epoxide hydrolase 1 EPHX1 2,77 2,70 2,73 0,03 
Leucine-rich repeat and calponin homology domain-containing protein 4 LRCH4 2,48 2,88 2,68 0,20 
Retinol dehydrogenase 11 RDH11 3,15 2,11 2,63 0,52 
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 RPN1 2,49 2,75 2,62 0,13 
Membrane-associated progesterone receptor component 2 PGRMC2 2,54 2,64 2,59 0,05 
Long-chain-fatty-acid--CoA ligase 3 ACSL3 2,37   2,37   
Terpene cyclase/mutase family member;Lanosterol synthase LSS 2,36   2,36   
Protein disulfide-isomerase;Protein disulfide-isomerase A3 HEL-S-269;PDIA3 2,28 2,30 2,29 0,01 
Transmembrane protein 33 TMEM33;SHINC3 2,26   2,26   
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2;Calcium-transporting 
ATPase;Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 
ATP2A2;DKFZp779O2152;DK
FZp779G2251;ATP2A1 2,25   2,25   
NADH-cytochrome b5 reductase;NADH-cytochrome b5 reductase 3;NADH-cytochrome b5 
reductase 3 membrane-bound form;NADH-cytochrome b5 reductase 3 soluble form CYB5R3   2,23 2,23   
AP-1 complex subunit mu-1 AP1M1 2,13 2,30 2,22 0,09 
78 kDa glucose-regulated protein HEL-S-89n;HSPA5 2,12 2,17 2,15 0,02 
Translocon-associated protein subunit delta SSR4   2,11 2,11   
AP-1 complex subunit gamma-1 AP1G1 1,97 2,21 2,09 0,12 
Minor histocompatibility antigen H13 HM13   2,07 2,07   
Vesicle transport protein GOT1B GOLT1B 2,07 2,06 2,07 0,01 
Serpin H1 SERPINH1 1,84 2,19 2,02 0,17 
Table 3: Proteins Enriched by GTPγS in the COPI Vesicle Fraction in the Absence of Recombinant Coatomer 
List of proteins enriched in the COPI vesicle fraction when SIC were incubated with GTPγS, Arf1, and cytosol compared to GTP, Arf1, and cytosol. Coatomer was omitted in contrast to the 
experiments shown in table 2. Experiments were in general performed according to Fig. 2.5. Unlike in the other experiments, labels were not switched. Given are gene and protein names of the 
identified proteins, the SILAC ratios (H/L) from each experiment, the mean SILAC ratio, and standard error of the mean (SEM). Displayed are proteins with mean SILAC ratios >2 or with a SILAC 
ratio >2 observed during one of the experiments (written in italic in the Mean SILAC ratio column). 
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2.3 The Influence of Coatomer Isoforms on the COPI Core Proteome and 
Vesicle Size 
 
As pointed out in 1.3.3., the function of coatomer isoforms remains largely elusive. One function that 
coat protein isoforms - especially in the COPII system - have been shown to serve is differential 
sorting of pivotal proteins into vesicles (Adolf et al., 2016; Mancias and Goldberg, 2007, 2008). Using 
a baculovirus expression vector system, it has been possible to produce different coatomer isoforms 
recombinantly (Sahlmuller et al., 2011). The protein complexes, which were purified via an 
One-STreP-Tag C-terminal of α-COP, are shown on a Coomassie-stained SDS gel in figure 2.8A. When 
these isoforms are used to reconstitute COPI vesicles in vitro with subsequent Western blot analysis 
of the isotypic COPI vesicles for the presence of COPI core components ERGIC53 and p24, no 
differential sorting can be observed (Fig. 2.8B and C). The mean incorporation of both proteins in 
relation to the used SIC is highly similar ranging in case of ERGIC53 from 3.4 % (CMζ1µ2) to 
3.6 %(CMζ2µ1) and 10.9 % (CMζ1µ1) to 12.2 % (CMζ2µ1) for p24, respectively (Fig. 2.8C). Incorporation 
of non-vesicle marker Calnexin was ≪1% (Fig. 2.7B). 
 
Figure 2.8 Recombinant CM Isoforms: Incorporation of ERGIC53 and p24 into Isotypic COPI Vesicles 
(A) Coomassie-stained SDS gel loaded with recombinant coatomer isoforms. (B) Representative Western blot analysis of 
COPI vesicles reconstituted from SIC HeLa cells using recombinant CM isoforms, Arf1, GTP, and ATP regenerating system 
(ATPr) with 5 µg of SIC loaded as input. Samples were probed for the presence of the proteins indicated on the left. Vesicles 
were isolated via differential centrifugation. (C) Quantification of (B); n=8; error bars=SEM. 
Results 
48 
 
With our novel COPI proteomics assay, outlined in section 2.1, it was possible to investigate the 
influence of coatomer isoforms on the COPI vesicle protein content not only for two proteins as 
shown in figure 2.8, but systematically for several hundred proteins at once. To this end, following 
the workflow shown in Fig. 2.5, isotypic vesicles were prepared in parallel, purified, and compared by 
SILAC-based quantitative LC-MS. In order to be able to distinguish between the influence of 
individual COPI subunit isoforms, isotypic vesicles were reconstituted with CMζ1µ1 and then 
compared with vesicles made from either CMγ1ζ2 or CMγ2ζ1 coatomer. 
Shown in the scatter plots of figure 2.9 is the comparison of isotypic COPI vesicles, differing with 
respect to the γ-COP subunit. Again, each dot represents a single protein and its respective SILAC 
ratios obtained from two experiments performed with switched isotope labels. Unlike in figure 2.6, 
there is no population of proteins which align to a virtual diagonal, but almost all dots crowd around 
a SILAC ratio of one. While there is virtually no protein that displays a meaningful enrichment in 
vesicles reconstituted with CMγ1ζ1 compared to CMγ2ζ1, very few proteins display slightly increased 
ratios in CMγ2ζ1 vesicles (compare Fig. 2.9A and B). These few proteins, which are marked by color in 
both plots include myosin-9 and myosin-10 (MYH9/10), subunits alpha and beta of the mitochondrial 
ATP synthase (ATP5B/ATP5A1), mitochondrial Hsp60 (HSPD1), as well as Peroxiredoxin-4 PRDX4 
(Fig. 2.9). The highest mean enrichment, 2.4, is scored by ATP5A1. All other proteins display 
enrichments <2. 
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Figure 2.9 Proteomic Comparison of γ-COP-isotypic COPI Vesicles  
(A) Scatter plot of SILAC ratios obtained from two independent experiments performed according to workflow in figure 2.5 
with two types of isotypic COPI vesicles, CMγ1ζ1 versus CMγ2ζ1. Experiments were performed with switched labels. 
Contaminants were removed from the datasets. Some proteins are highlighted in color. (B) Scatter plot of the inverted 
SILAC ratios shown in (A) to compare CMγ2ζ1 versus CMγ1ζ1. The same proteins are highlighted in color. 
 
In table 4, the 25 proteins with the highest enrichment in vesicles made with CMγ1ζ1 compared to 
CMγ2ζ1 are listed. Conversely, table 5 lists the 25 proteins with the highest SILAC ratios during the 
comparison of CMγ2ζ1 versus CMγ1ζ1 vesicles. 
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Protein.names Gene.names 
ratio 1: CMγ1ζ1 
(L) vs. CMγ2ζ1 
(H) 
ratio 2: CMγ1ζ1 
(H) vs. CMγ2ζ1 
(L) 
Mean 
SILAC 
ratio 
SEM 
Thioredoxin domain-containing protein 5 hCG_1811539;TXNDC5;STRF8;DKFZp666I134   1,47 1,47   
Beta-1,3-galactosyltransferase 6 B3GALT6 1,41 1,35 1,38 0,03 
Syntenin-1 SDCBP   1,35 1,35   
Ras-related protein Rab-12 RAB12 1,54 1,14 1,34 0,20 
Glutaminyl-peptide cyclotransferase-like protein QPCTL 1,54 1,13 1,34 0,20 
N-acetylglucosamine-6-sulfatase DKFZp686E12166;GNS 1,79 0,87 1,33 0,46 
Glucosidase 2 subunit beta PRKCSH   1,32 1,32   
CD276 antigen CD276   1,31 1,31   
Molybdate-anion transporter MFSD5   1,31 1,31   
Zinc transporter 7 SLC30A7 1,51 1,08 1,29 0,21 
60S ribosomal protein L27 RPL27 1,27 1,28 1,28 0,00 
Carbohydrate sulfotransferase 14 CHST14 1,26 1,29 1,27 0,01 
60S ribosomal protein L13 RPL13 1,34 1,20 1,27 0,07 
Fukutin-related protein FKRP 1,23 1,29 1,26 0,03 
RING finger and transmembrane domain-containing protein 1 RNFT1 1,52 1,00 1,26 0,26 
Aldo-keto reductase family 1 member C1;Aldo-keto reductase family 1 member C2 AKR1C1;AKR1C3;AKR1C2   1,25 1,25   
Receptor-type tyrosine-protein phosphatase F;Protein-tyrosine-phosphatase PTPRF;LAR;DKFZp686B1310   1,25 1,25   
ER lumen protein-retaining receptor;ER lumen protein-retaining receptor 3 KDELR3 1,22 1,27 1,24 0,03 
Integrin beta;Integrin beta-5 ITGB5 1,27 1,22 1,24 0,02 
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 GNB2   1,22 1,22   
Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 B3GAT3 1,18 1,25 1,22 0,04 
Chondroitin sulfate synthase 1 CHSY1   1,21 1,21   
Nucleoporin NDC1 NDC1 1,32 1,08 1,20 0,12 
Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase MGAT2 1,23 1,17 1,20 0,03 
Gamma-glutamyl hydrolase GGH 1,75 0,64 1,20 0,55 
Table 4: Proteomic Comparison of COPI Vesicles: CMγ1ζ1 versus CMγ2ζ1 
List of the 25 proteins most enriched in the COPI vesicle made with CMγ1ζ1 in comparison to CMγ2ζ1. Vesicles were always reconstituted with Arf1 and GTP. Experiments were in general 
performed according to Fig. 2.5. Given are gene and protein names of the identified proteins, the SILAC ratios (H/L and L/H) from each replicate, the mean SILAC ratio, and standard error of the 
mean (SEM). Displayed are the 25 proteins with the highest mean SILAC ratios and the proteins with the highest SILAC ratios during the experiment in which the CMγ1ζ1 vesicle sample was labeled 
with heavy isotopes (written in italic in the Mean SILAC ratio column). 
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Protein.names Gene.names 
ratio 1: 
CMγ2ζ1 (H) vs. 
CMγ1ζ1 (L) 
ratio 2: 
CMγ2ζ1 (L) vs. 
CMγ1ζ1 (H) 
Mean 
SILAC 
ratio 
SEM 
ATP synthase subunit alpha;ATP synthase subunit alpha, mitochondrial HEL-S-123m;ATP5A1 3,62 1,09 2,36 1,27 
60 kDa heat shock protein, mitochondrial HSPD1 1,85 1,83 1,84 0,01 
ATP synthase subunit beta;ATP synthase subunit beta, mitochondrial HEL-S-271;ATP5B 2,05 1,56 1,81 0,25 
Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B MGAT4B 2,77 0,73 1,75 1,02 
Peroxiredoxin-4 HEL-S-97n;PRDX4 2,32 1,10 1,71 0,61 
Myosin regulatory light chain 12A;Myosin regulatory light chain 12B;Myosin regulatory light 
polypeptide 9 MYL12A;MYL12B;MYL9 1,69   1,69   
Myosin-9 MYH9 2,05 1,27 1,66 0,39 
Myosin-10 MYH10 1,76 1,18 1,47 0,29 
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 ATP2A2 1,18 1,54 1,36 0,18 
Endoplasmin TRA1;HEL-S-125m;HSP90B1 1,37 1,34 1,35 0,01 
Na(+)/H(+) exchange regulatory cofactor NHE-RF2 SLC9A3R2 1,34   1,34   
DnaJ homolog subfamily C member 13 DNAJC13 1,28 1,36 1,32 0,04 
Calreticulin HEL-S-99n;CALR 1,28 1,32 1,30 0,02 
Roundabout homolog 1 ROBO1 1,17 1,41 1,29 0,12 
Zinc transporter 1 SLC30A1 1,29   1,29   
Membrane-associated progesterone receptor component 2 PGRMC2 1,41 1,13 1,27 0,14 
Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A MGAT5 0,95 1,58 1,26 0,32 
Glycosyltransferase 8 domain-containing protein 2 GLT8D2 1,63 0,90 1,26 0,36 
Calnexin CANX 1,23 1,29 1,26 0,03 
Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha;Putative PIP5K1A and PSMD4-like protein PIP5K1A;PIPSL 1,41 1,11 1,26 0,15 
NADPH--cytochrome P450 reductase POR;DKFZp686G04235 1,17 1,31 1,24 0,07 
Myosin light polypeptide 6 MYL6 1,51 0,95 1,23 0,28 
Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 PLOD2 1,28 1,18 1,23 0,05 
Interferon-induced transmembrane protein 3;Interferon-induced transmembrane protein 
1;Interferon-induced transmembrane protein 2 IFITM3;IFITM2;IFITM1 1,09 1,37 1,23 0,14 
Putative sodium-coupled neutral amino acid transporter 10 SLC38A10 1,34 1,11 1,23 0,12 
Table 5: Proteomic Comparison of COPI Vesicles: CMγ2ζ1 versus CMγ1ζ1 
List of the 25 proteins most enriched in the COPI vesicle made with CMγ2ζ1 in comparison to CMγ1ζ1. Vesicles were always reconstituted with Arf1 and GTP. Experiments were in general 
performed according to Fig. 2.5. Given are gene and protein names of the identified proteins, the SILAC ratios (H/L and L/H) from each replicate, the mean SILAC ratio, and standard error of the 
mean (SEM). Displayed are the 25 proteins with the highest mean SILAC ratios and the proteins with the highest SILAC ratios during the experiment in which the CMγ2ζ1 vesicle sample was labeled 
with heavy isotopes (written in italic in the Mean SILAC ratio column). 
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As mentioned above, also COPI vesicles formed in vitro with different isoforms of ζ-COP were 
compared systematically by means of SILAC proteomics. The results are shown in figure 2.10. Similar 
to the comparison of γ-COP-isotypic vesicles, almost all proteins display rather low SILAC ratios. A 
few of the higher scoring proteins are highlighted in color (Fig. 2.10). In case of ζ2-COP, there is only 
one protein which shows a significant mean enrichment, the monocarboxylate transporter 1 
(SLC16A1). However, as can be seen in Fig. 2.10B, its SILAC scores are rather divergent, i.e. 6.1 and 
1.4. In vesicles made with ζ1-COP, no protein showed an enrichment >2. The proteins with the 
highest SILAC ratios, ranging from 1.5-1.7 are the glycosyltransferase POMGNT1, 
palymitoyltransferase ZDHHC13, the nonaspanin TM9SF1, and trophoblast glycoprotein TPBG 
(Fig. 2.10). 
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Figure 2.10 Proteomic Comparison of ζ-COP-isotypic COPI Vesicles 
(A) Scatter plot of SILAC ratios obtained from two independent experiments performed according to workflow in figure 2.5 
with two types of isotypic COPI vesicles, CMγ1ζ1 versus CMγ1ζ2. Experiments were performed with switched labels. 
Contaminants were removed from the datasets. Some proteins are highlighted in color. (B) Scatter plot of the inverted 
SILAC ratios shown in (A) to compare CMγ1ζ2 versus CMγ1ζ1. The same proteins are highlighted in color. 
 
Table 6 and table 7 list the 25 proteins with the highest SILAC ratios in direct comparisons of CMγ1ζ1 
versus CMγ1ζ2 vesicles (Tab. 6) or CMγ1ζ2 versus CMγ1ζ1 vesicles (Tab. 7). 
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Protein.names Gene.names 
ratio 1: CMγ1ζ1 
(L) vs. CMγ1ζ2 (H) 
ratio 2: CMγ1ζ1 
(H) vs. CMγ1ζ2 (L) 
Mean 
SILAC 
ratio 
SEM 
Transmembrane 9 superfamily member 1 TM9SF1 1,94 1,49 1,72 0,22 
Immediate early response 3-interacting protein 1 IER3IP1   1,66 1,66   
Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 POMGNT1 1,94 1,27 1,61 0,34 
Palmitoyltransferase ZDHHC13;Palmitoyltransferase ZDHHC13 1,88 1,28 1,58 0,30 
Trophoblast glycoprotein TPBG 1,64 1,44 1,54 0,10 
Cytochrome b561 domain-containing protein 2 CYB561D2   1,54 1,54   
Transmembrane 9 superfamily member 3 TM9SF3;SMBP 1,69 1,32 1,51 0,18 
Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase;alpha-1,2-Mannosidase MAN1B1 1,59 1,42 1,50 0,08 
Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB MAN1A2 1,73 1,25 1,49 0,24 
Adipocyte plasma membrane-associated protein APMAP 1,51 1,45 1,48 0,03 
Chondroitin sulfate synthase 2 CHPF 1,49 1,43 1,46 0,03 
Protein GPR107 GPR107 1,48 1,44 1,46 0,02 
Phosphatidylcholine:ceramide cholinephosphotransferase 1 TMEM23;SGMS1   1,45 1,45   
Solute carrier family 35 member E1 SLC35E1 1,35 1,54 1,44 0,10 
40S ribosomal protein S8 RPS8 1,68 1,20 1,44 0,24 
Protein CASP;Homeobox protein cut-like 1 
CUX1;Nbla10317;CU
X1-RETc;CUX1-RETa 1,54 1,35 1,44 0,10 
Glycosyltransferase 8 domain-containing protein 2 GLT8D2 1,59 1,29 1,44 0,15 
Polypeptide N-acetylgalactosaminyltransferase;Polypeptide N-acetylgalactosaminyltransferase 
1;Polypeptide N-acetylgalactosaminyltransferase 1 soluble form GALNT1 1,60 1,27 1,43 0,16 
Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase MGAT2 1,54 1,32 1,43 0,11 
Protein YIPF3;Protein YIPF3, 36 kDa form III;Protein YIPF YIPF3 1,40 1,46 1,43 0,03 
UDP-glucuronic acid decarboxylase 1 UXS1 1,61 1,24 1,42 0,18 
Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase MGAT1 1,69 1,14 1,41 0,27 
Transmembrane protein 165 TMEM165 1,42 1,40 1,41 0,01 
Transmembrane 9 superfamily member 4 TM9SF4 1,64 1,17 1,41 0,23 
60S ribosomal protein L21 RPL21 1,60 1,22 1,41 0,19 
Table 6: Proteomic Comparison of COPI Vesicles: CMγ1ζ1 versus CMγ1ζ2 
List of the 25 proteins most enriched in the COPI vesicle made with CMγ1ζ1 in comparison to CMγ1ζ2. Vesicles were always reconstituted with Arf1 and GTP. Experiments were in general 
performed according to Fig. 2.5. Given are gene and protein names of the identified proteins, the SILAC ratios (H/L and L/H) from each replicate, the mean SILAC ratio, and standard error of the 
mean (SEM). Displayed are the 25 proteins with the highest mean SILAC ratios and the proteins with the highest SILAC ratios during the experiment in which the CMγ2ζ1 vesicle sample was labeled 
with heavy isotopes (written in italic in the Mean SILAC ratio column). 
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Protein.names Gene.names 
ratio 1: CMγ1ζ2 
(H) vs. CMγ1ζ1 (L) 
ratio 2: CMγ1ζ2 
(L) vs. CMγ1ζ1 (H) 
Mean 
SILAC 
ratio 
SEM 
Monocarboxylate transporter 1 SLC16A1 6,13 1,37 3,75 2,38 
Rab-like protein 3 RABL3 1,71   1,71   
Roundabout homolog 1 ROBO1 1,57 1,61 1,59 0,02 
Talin-1 TLN1 0,72 2,47 1,59 0,88 
Moesin HEL70;MSN 0,75 2,40 1,58 0,82 
Synaptophysin-like protein 1 SYPL1 1,54   1,54   
Ezrin;Tyrosine-protein kinase receptor EZR;HEL-S-105;EZR-ROS1 0,75 2,30 1,53 0,77 
Reticulon RTN3 1,52   1,52   
Ras GTPase-activating-like protein IQGAP1 IQGAP1;hCG_1991735 1,52   1,52   
Golgi-associated plant pathogenesis-related protein 1 GLIPR2;C9orf19 1,49   1,49   
Prolow-density lipoprotein receptor-related protein 1;Low-density lipoprotein receptor-related 
protein 1 85 kDa subunit;Low-density lipoprotein receptor-related protein 1 515 kDa 
subunit;Low-density lipoprotein receptor-related protein 1 intracellular domain LRP1 1,48   1,48   
40S ribosomal protein SA RPSA;LOC388524 1,23 1,72 1,48 0,24 
Plexin-B2 PLXNB2 1,27 1,68 1,47 0,20 
Tubulin beta chain TUBB;XTP3TPATP1 0,64 2,29 1,46 0,83 
Long-chain-fatty-acid--CoA ligase 3 ACSL3 0,91 2,01 1,46 0,55 
B-cell receptor-associated protein 31 BCAP31 1,15 1,75 1,45 0,30 
Phosphatidylinositol 4-kinase type 2-alpha PI4K2A 1,38 1,50 1,44 0,06 
Fermitin family homolog 2 PLEKHC1;FERMT2 1,00 1,88 1,44 0,44 
Brain acid soluble protein 1 BASP1 0,97 1,90 1,43 0,46 
Copper-transporting ATPase 1 ATP7A 1,42   1,42   
Coatomer subunit epsilon COPE 1,41   1,41   
Polyadenylate-binding protein;Polyadenylate-binding protein 1 PABPC1 1,20 1,61 1,41 0,20 
Pyruvate kinase;Pyruvate kinase PKM HEL-S-30;PKM;PKM2 0,96 1,85 1,40 0,44 
Heterogeneous nuclear ribonucleoprotein M HNRNPM;ORF;HNRPM 1,37 1,43 1,40 0,03 
60S ribosomal protein L18 RPL18 1,40   1,40   
 
Table 7: Proteomic Comparison of COPI Vesicles: CMγ1ζ2 versus CMγ1ζ2 
List of the 25 proteins most enriched in the COPI vesicle made with CMγ1ζ2 in comparison to CMγ1ζ1. Vesicles were always reconstituted with Arf1 and GTP. Experiments were in general 
performed according to Fig. 2.5. Given are gene and protein names of the identified proteins, the SILAC ratios (H/L and L/H) from each replicate, the mean SILAC ratio, and standard error of the 
mean (SEM). Displayed are the 25 proteins with the highest mean SILAC ratios and the proteins with the highest SILAC ratios during the experiment in which the CMγ2ζ1 vesicle sample was labeled 
with heavy isotopes (written in italic in the Mean SILAC ratio column). 
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Since the COPI coat, unlike the COPII or CCV coat, does not have an outer scaffold layer but is 
recruited en bloc, the size of a vesicle likely is dictated by coatomer. Therefore, we decided to 
investigate a putative role of CM isoforms in controlling the size of COPI vesicles. To this end, a set of 
pre-existing negative stain EM images of isotypic COPI vesicles prepared from rat liver Golgi was 
systematically analyzed. The image quality for all samples was comparable, as can be seen from the 
examples shown in figure 2.11A-D. In addition to isotypic vesicles (Fig. 2.11B-D), vesicles prepared 
with rat coatomer (Fig. 2.11A), which represents a physiological mixture of the isoforms, was 
included in the analysis. 
To determine the size of vesicles, we used a semi-automated segmentation approach, which is 
described in detail in the Methods section. Figure 2.11E shows an example of the vesicle areas that 
are recognized by the software marked in light green color. The extracted areas, without an overlay 
of the original EM image are highlighted in Fig. 2.11F. From these areas, the mean diameters of 
isotypic and rat CM vesicles were calculated (Fig. 2.11G). The mean diameter of all four vesicle types 
was almost identical, ranging from 73.4 nm to 74.4 nm. Also the standard deviations (SD) were in the 
same range between 7.7 and 8.9 nm (Fig. 2.11G). 
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Figure 2.11 Size Comparison of Isotypic COPI Vesicles 
(A-D) Representative negative stain EM images of COPI vesicles reconstituted from rat liver Golgi with either a single CM 
isoform or an endogenous mixture (rat CM). (E) Example of software-based vesicle area recognition. The areas recognized 
are colored light green. (F) Picture highlighting the areas recognized in (E) without overlay of the original EM image. (G) 
Summary of the vesicle size determination. Mean diameters, standard deviations (SD), and sample sizes are given. 
 
2.4 Influence of Arf Isoforms on COPI Vesicle Biogenesis 
 
As pointed out in the Introduction (1.3.3.), coatomer is not the only COPI biogenesis factor which 
exists as various isotypes. There are in total six isoforms of Arf, five of which are present in humans. 
In a previous study, performed in our lab, these five isoforms have been studied with regard to their 
ability to participate in COPI vesicle biogenesis (Popoff et al., 2011b). All human Arfs, except Arf6 
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were shown to be able to form COPI vesicles from rat liver Golgi. In order to investigate a possible 
role of the small GTPases in cargo sorting, all isoforms were cloned into a new plasmid so to be able 
to express them according to our latest, highly efficient expression protocol used for Arf1 (see 
Materials and Methods). Figure 2.12A shows a Coomassie-stained SDS gel with all five human Arf 
isoforms. As can be seen, all proteins could be purified with a low level of contaminating proteins. 
Moreover, for all Arfs only one distinct band can be observed which argues for a high degree of 
myristoylation of the proteins (Fig. 2.12A). This is further confirmed by the fact that in initial 
reconstitution experiments with SIC all isoforms except for Arf6 were able to produce COPI vesicles 
as deduced from the strongly increased GTP-dependent release of marker proteins ERGIC53 and p24 
(Fig. 2.12B). Noteworthy, Arf3 seemed to be less capable of producing vesicles compared to all other 
Arf isoforms (Fig. 2.12B). 
 
Figure 2.12 Recombinant Arf Isoforms: Ability to Form COPI Vesicles 
(A) Coomassie-stained SDS gel loaded with recombinant Arf isoforms. (B) Representative Western blot analysis of a COPI 
vesicles reconstituted from SIC HeLa using recombinant CM, Arf1 isoforms, GTP, and ATP regenerating system (ATPr) with 5 
µg of SIC loaded as input. Samples were probed for the presence of the proteins on the left. Vesicles were isolated via 
differential centrifugation. 
 
In order to obtain a deeper insight into the protein content of COPI vesicles formed with the different 
isoforms of Arf, the vesicle proteomics workflow outlined in section 2.1 was employed. Vesicles were 
produced from heavy and light semi-intact HeLa cells and compared to a light or heavy mock reaction 
lacking only coatomer. As can be told from the scatter plots of these experiments, presented in 
figure 2.13A-C, highly correlative datasets could be obtained in all six experiments (Fig. 2.13A-C). This 
is reflected by high R2 values of 0.87, 0.89, and 0.81 for experiments with Arf3, Arf4, and Arf5, 
respectively. Also here, some of the highest scoring proteins are highlighted with color. Several 
members of the p24/TMED family, nucleobindin 1, and ER cycling proteins ERGIC53 and ERGIC2/3 
are among the proteins with the highest SILAC ratios. Moreover, the proteins YIF1A and ERP44, both 
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of which are also ~sixfold enriched in the COPI proteome obtained with Arf1, exhibit high SILAC 
scores (Fig. 2.13A-C). 
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Figure 2.13 The Proteome of COPI Vesicles Made with Different Isoforms of Arf 
(A-C) Scatter plot of SILAC ratios obtained from two independent experiments performed according to figure 2.5, with 
various isoforms of Arf, as indicated above the plots. Experiments were performed with switched labels. Contaminants 
were removed from the datasets. Some proteins/protein families are highlighted in color. R
2
 values of the datasets are 0.87 
(A), 0.89 (B), and 0.81 (C). 
 
A comparison of the scatter plot in Fig. 2.6 and the plots shown in figure 2.13 reveals that less 
peptides and therefore proteins could be identified during the LC-MS runs of COPI samples obtained 
with Arf4 and Arf5, least with Arf3. Hence, less proteins fulfill the criterion of being twofold enriched 
in either sample, or the sample in which the vesicle fraction carried the isotope label. These criteria 
are met by only 25 proteins of the Arf3 datasets, 50 proteins in the datasets obtained with Arf4, and 
55 proteins in the datasets produced with Arf5. The vast majority of these proteins are found among 
the 122 best COPI proteome candidates mentioned earlier. The strong overlap between all COPI 
proteomic datasets obtained for different Arf isoforms is visualized by the Venn diagram shown in 
figure 2.14A. Except for eight candidates, all others appear in multiple datasets. Twenty candidates 
are shared between all four datasets, and they are listed in Fig. 2.14B. Among those candidates are 
five members of the p24/TMED, ER-Golgi cycling proteins such as ERGIC1 and 2, ERGIC53/LMAN1, or 
SURF4 and GOLT1B. Also NUCB1 and the SNAREs Sec22b and Stx5 are universally found (Fig. 2.14B). 
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Figure 2.14 Proteomic Comparison of COPI Reconstituted with Different Arf Isoforms 
(A) Venn diagram to visualized the overlap of proteins found twofold enriched in COPI proteomic datasets obtained with 
different isoforms of Arf. Numbers indicate the number of proteins shared between the various datasets. (B) List of the 20 
proteins that fulfill the COPI candidate criteria in all four datasets. Given are full protein and gene names. 
 
In the following tables 8-10 (Arf3, Arf4, Arf5) all candidates which are compared in the Venn diagram 
of Fig. 2.14A are listed more thoroughly. 
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Protein.names Gene.names ratio 1 (H/L) ratio 2 (L/H) Mean SILAC ratio SEM 
Transmembrane emp24 domain-containing protein 9 TMED9 4,48 5,19 4,84 0,35 
Endoplasmic reticulum-Golgi intermediate compartment protein 3 ERGIC3 5,19 4,17 4,68 0,51 
Nucleobindin-1 NUCB1 4,75 4,17 4,46 0,29 
Transmembrane emp24 domain-containing protein 10 TMED10 4,47 4,13 4,30 0,17 
Endoplasmic reticulum resident protein 44 ERP44 4,12 4,46 4,29 0,17 
Protein ERGIC-53 LMAN1 3,85 4,59 4,22 0,37 
Transmembrane emp24 domain-containing protein 2 RNP24;TMED2 4,19 3,67 3,93 0,26 
Transmembrane emp24 domain-containing protein 4 TMED4 3,32 3,70 3,51 0,19 
Transmembrane emp24 domain-containing protein 7 TMED7;TMED7-TICAM2 3,46   3,46   
Vesicular integral-membrane protein VIP36 LMAN2 3,22 3,68 3,45 0,23 
Surfeit locus protein 4 SURF4 3,54 3,09 3,31 0,23 
Vesicle-trafficking protein SEC22b SEC22B 2,98 3,37 3,17 0,19 
Endoplasmic reticulum-Golgi intermediate compartment protein 2 ERGIC2 2,82   2,82   
Solute carrier family 35 member E1 SLC35E1 2,48 3,07 2,78 0,29 
Zinc transporter 7 SLC30A7 2,72   2,72   
Vesicle transport protein GOT1B GOLT1B 2,39 2,80 2,59 0,20 
Immediate early response 3-interacting protein 1 IER3IP1 2,53   2,53   
Protein cornichon homolog 4 CNIH4 2,51   2,51   
Protein YIF1B YIF1B 2,36 2,54 2,45 0,09 
Syntaxin-5 STX5;STX5A 2,28 2,60 2,44 0,16 
Clusterin;Clusterin beta chain;Clusterin alpha chain;Clusterin CLU 1,67 3,05 2,36 0,69 
Endoplasmic reticulum-Golgi intermediate compartment protein 1 ERGIC1 2,38 2,27 2,33 0,06 
Ras-related protein Rab-18 RAB18 2,15 2,03 2,09 0,06 
Zinc finger protein-like 1 ZFPL1 2,04   2,04   
PRA1 family protein 2 PRAF2 2,01   2,01   
Table 8: Candidate Proteins for the Core Proteome of COPI Vesicles Reconstituted with Arf3 
List of candidates for the COPI core proteome from HeLa cells as determined by two independent experiments performed according to Fig. 2.5. CMγ1ζ1, Arf3, and GTP were used for all 
reconstitutions. Given are gene and protein names of the identified proteins, the SILAC ratios (H/L or L/H) from each experiment, the mean SILAC ratio, and standard error of the mean (SEM). 
Displayed are protein with mean SILAC ratios >2 or with a SILAC ratio >2 in one of the two experiments in which the vesicle sample was labeled with heavy isotopes (written in italic in the Mean 
SILAC ratio column). 
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Protein.names Gene.names ratio 1 (H/L) ratio 2 (L/H) Mean SILAC ratio SEM 
Endoplasmic reticulum-Golgi intermediate compartment protein 3 ERGIC3 9,48 6,64 8,06 1,42 
Endoplasmic reticulum-Golgi intermediate compartment protein 2 ERGIC2 9,59 6,11 7,85 1,74 
Zinc transporter 7 SLC30A7 7,65   7,65   
Nucleobindin-1 NUCB1 8,22 6,39 7,31 0,92 
Transmembrane emp24 domain-containing protein 7 TMED7;TMED7-TICAM2 8,50 6,10 7,30 1,20 
Transmembrane emp24 domain-containing protein 10 TMED10 8,00 6,55 7,27 0,73 
Transmembrane emp24 domain-containing protein 9 TMED9 8,14 6,08 7,11 1,03 
Protein ERGIC-53 LMAN1 7,09 7,02 7,06 0,03 
Zinc finger protein-like 1 ZFPL1 6,85   6,85   
Transmembrane emp24 domain-containing protein 4 TMED4 6,77 6,28 6,52 0,25 
Solute carrier family 35 member E1 SLC35E1 7,59 4,91 6,25 1,34 
Calumenin CALU 5,83   5,83   
Endoplasmic reticulum resident protein 44 ERP44 5,48 6,09 5,79 0,30 
Transmembrane emp24 domain-containing protein 2 RNP24;TMED2 6,94 4,30 5,62 1,32 
Transmembrane emp24 domain-containing protein 1 TMED1 7,45 3,62 5,54 1,92 
Vesicular integral-membrane protein VIP36 LMAN2 5,61 5,05 5,33 0,28 
Protein YIF1A YIF1A 5,82 4,79 5,31 0,51 
Protein cornichon homolog 4 CNIH4 5,05   5,05   
Protein RER1 RER1 5,31 4,63 4,97 0,34 
Protein YIPF;Protein YIPF5 YIPF5 4,81 5,00 4,91 0,10 
Surfeit locus protein 4 SURF4 4,45 5,02 4,74 0,28 
VIP36-like protein LMAN2L 4,71   4,71   
Nucleobindin-2;Nesfatin-1 HEL-S-109;NUCB2;Nucb2 4,38 5,00 4,69 0,31 
Vesicle-trafficking protein SEC22b SEC22B 4,84 4,15 4,50 0,35 
Clusterin;Clusterin beta chain;Clusterin alpha chain;Clusterin CLU 4,25 4,35 4,30 0,05 
Vesicle transport protein GOT1B GOLT1B 4,04 4,40 4,22 0,18 
Protein kish-A TMEM167A 3,97   3,97   
Transmembrane emp24 domain-containing protein 3 TMED3 3,92   3,92   
BET1 homolog BET1;DKFZp781C0425 3,83   3,83   
Immediate early response 3-interacting protein 1 IER3IP1 4,01 3,41 3,71 0,30 
Protein YIF1B YIF1B 3,92 3,49 3,70 0,22 
Endoplasmic reticulum-Golgi intermediate compartment protein 1 ERGIC1 3,43 3,88 3,66 0,23 
Serpin H1 SERPINH1 3,55 3,05 3,30 0,25 
Golgi SNAP receptor complex member 2 GOSR2 2,15 4,20 3,18 1,03 
PRA1 family protein 2 PRAF2 3,17   3,17   
45 kDa calcium-binding protein SDF4 3,32 2,92 3,12 0,20 
ER lumen protein-retaining receptor;ER lumen protein-retaining receptor 2 KDELR2 3,52 2,65 3,08 0,43 
Syntaxin-5 STX5;STX5A 3,03 3,12 3,07 0,05 
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Protein.names Gene.names ratio 1 (H/L) ratio 2 (L/H) Mean SILAC ratio SEM 
Ras-related protein Rab-18 RAB18 2,85 2,78 2,81 0,04 
Ras-related protein Rab-2A RAB2;RAB2A 2,49 2,79 2,64 0,15 
Transmembrane 9 superfamily member 3 TM9SF3;SMBP 2,17 2,71 2,44 0,27 
Neutral alpha-glucosidase AB HEL-S-164nA;GANAB 2,18 2,53 2,35 0,17 
Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 B3GAT3 2,30   2,30   
Protein YIPF4 YIPF4 2,39 2,06 2,22 0,16 
Peptidyl-prolyl cis-trans isomerase;Peptidyl-prolyl cis-trans isomerase B HEL-S-39;PPIB 2,12 2,14 2,13 0,01 
ER lumen protein-retaining receptor 1;ER lumen protein-retaining receptor KDELR1 1,98 2,19 2,09 0,11 
Protein YIPF3;Protein YIPF3, 36 kDa form III;Protein YIPF YIPF3 1,72 2,43 2,07 0,36 
Ras-related protein Rab-1A RAB1A 1,90 2,15 2,02 0,13 
Polypeptide N-acetylgalactosaminyltransferase;Polypeptide N-
acetylgalactosaminyltransferase 1;Polypeptide N-
acetylgalactosaminyltransferase 1 soluble form GALNT1 2,03 2,00 2,01 0,01 
Endoplasmin TRA1;HEL-S-125m;HSP90B1 1,44 2,58 2,01 0,57 
Table 9: Candidate Proteins for the Core Proteome of COPI Vesicles Reconstituted with Arf4 
List of candidates for the COPI core proteome from HeLa cells as determined by two independent experiments performed according to Fig. 2.5. CMγ1ζ1, Arf4, and GTP were used for all 
reconstitutions. Given are gene and protein names of the identified proteins, the SILAC ratios (H/L or L/H) from each experiment, the mean SILAC ratio, and standard error of the mean (SEM). 
Displayed are protein with mean SILAC ratios >2 or with a SILAC ratio >2 in one of the two experiments in which the vesicle sample was labeled with heavy isotopes (written in italic in the Mean 
SILAC ratio column). 
 
Protein.names Gene.names ratio 1 (H/L) ratio 2 (L/H) Mean SILAC ratio SEM 
Transmembrane emp24 domain-containing protein 7 TMED7;TMED7-TICAM2 13,99 6,61 10,30 3,69 
Zinc finger protein-like 1 ZFPL1 9,32   9,32   
Transmembrane emp24 domain-containing protein 10 TMED10 9,70 7,24 8,47 1,23 
Nucleobindin-1 NUCB1 10,47 5,96 8,21 2,26 
Transmembrane emp24 domain-containing protein 9 TMED9 7,76 8,16 7,96 0,20 
Endoplasmic reticulum-Golgi intermediate compartment protein 2 ERGIC2 8,59 5,85 7,22 1,37 
Transmembrane emp24 domain-containing protein 2 RNP24;TMED2 9,12 4,31 6,72 2,40 
Transmembrane emp24 domain-containing protein 4 TMED4 7,24 6,10 6,67 0,57 
Protein YIF1A YIF1A 7,36 5,17 6,26 1,10 
Protein ERGIC-53 LMAN1 6,71 5,45 6,08 0,63 
Transmembrane 9 superfamily member 3 TM9SF3;SMBP 5,83 6,18 6,00 0,17 
Transmembrane emp24 domain-containing protein 1 TMED1 7,13 3,93 5,53 1,60 
45 kDa calcium-binding protein SDF4 4,93 5,86 5,39 0,46 
Vesicular integral-membrane protein VIP36 LMAN2 5,94 4,80 5,37 0,57 
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Protein.names Gene.names ratio 1 (H/L) ratio 2 (L/H) Mean SILAC ratio SEM 
Endoplasmic reticulum resident protein 44 ERP44 5,91 4,64 5,27 0,64 
Vesicle-trafficking protein SEC22b SEC22B 5,17 4,12 4,64 0,52 
Solute carrier family 35 member E1 SLC35E1 4,62   4,62   
Protein YIPF;Protein YIPF5 YIPF5 5,51 3,65 4,58 0,93 
Surfeit locus protein 4 SURF4 5,14 3,97 4,56 0,58 
Endoplasmic reticulum-Golgi intermediate compartment protein 1 ERGIC1 5,07 3,14 4,10 0,97 
Nucleobindin-2;Nesfatin-1 HEL-S-109;NUCB2;Nucb2 3,71 4,38 4,05 0,33 
Polypeptide N-acetylgalactosaminyltransferase;Polypeptide N-
acetylgalactosaminyltransferase 1;Polypeptide N-
acetylgalactosaminyltransferase 1 soluble form GALNT1 4,84 3,16 4,00 0,84 
Clusterin;Clusterin beta chain;Clusterin alpha chain;Clusterin CLU 4,55 3,41 3,98 0,57 
Vesicle transport protein GOT1B GOLT1B 4,23 3,56 3,89 0,34 
Protein YIF1B YIF1B 4,43 2,75 3,59 0,84 
Golgi integral membrane protein 4 GOLIM4 3,70 3,40 3,55 0,15 
Serpin H1 SERPINH1 4,50 2,58 3,54 0,96 
Emerin EMD 3,33   3,33   
Peptidyl-prolyl cis-trans isomerase;Peptidyl-prolyl cis-trans isomerase B HEL-S-39;PPIB 3,80 2,83 3,32 0,48 
UbiA prenyltransferase domain-containing protein 1 UBIAD1 3,31   3,31   
Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase MGAT1 2,97 3,61 3,29 0,32 
Protein YIPF3;Protein YIPF3, 36 kDa form III;Protein YIPF YIPF3 2,57 3,35 2,96 0,39 
Polypeptide N-acetylgalactosaminyltransferase 10;Polypeptide N-
acetylgalactosaminyltransferase GALNT10 2,84   2,84   
Probable glutathione peroxidase 8 GPX8 2,87 2,70 2,78 0,09 
Protein RER1 RER1 2,67   2,67   
Transmembrane 9 superfamily member 1 TM9SF1 3,03 2,12 2,58 0,45 
Alpha-mannosidase 2;Alpha-mannosidase MAN2A1 2,23 2,61 2,42 0,19 
Thioredoxin domain-containing protein 5 
hCG_1811539;TXNDC5;STRF8;
DKFZp666I134 1,70 3,10 2,40 0,70 
Golgi SNAP receptor complex member 1 GOSR1 3,21 1,48 2,34 0,87 
Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase MGAT2 1,91 2,77 2,34 0,43 
Ras-related protein Rab-18 RAB18 2,79 1,82 2,30 0,49 
Calcium-transporting ATPase;Calcium-transporting ATPase type 2C member 1 ATP2C1 2,58 1,98 2,28 0,30 
78 kDa glucose-regulated protein HEL-S-89n;HSPA5 1,94 2,57 2,25 0,32 
Transmembrane 9 superfamily member 4 TM9SF4 2,40 1,85 2,13 0,27 
Golgin subfamily B member 1 GOLGB1 2,41 1,82 2,12 0,30 
Polypeptide N-acetylgalactosaminyltransferase 2;Polypeptide N-
acetylgalactosaminyltransferase 2 soluble form;Polypeptide N-
acetylgalactosaminyltransferase GALNT2 2,36 1,78 2,07 0,29 
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Protein.names Gene.names ratio 1 (H/L) ratio 2 (L/H) Mean SILAC ratio SEM 
Protein disulfide-isomerase A6 PDIA6 1,62 2,52 2,07 0,45 
Ras-related protein Rab-2A RAB2;RAB2A 2,20 1,91 2,05 0,14 
60S ribosomal protein L13 RPL13 2,03 2,07 2,05 0,02 
Ras-related protein Rab-6B RAB6A;RAB6B 2,02 2,06 2,04 0,02 
N-acetylgalactosaminyltransferase 7 GALNT7 2,28 1,80 2,04 0,24 
Syntaxin-5 STX5;STX5A 1,88 2,18 2,03 0,15 
Inositol monophosphatase 3 IMPAD1 2,02   2,02   
Golgi membrane protein 1 GOLPH2;GOLM1 1,81 2,21 2,01 0,20 
60S ribosomal protein L18 RPL18 1,45 2,54 2,00 0,54 
Table 10: Candidate Proteins for the Core Proteome of COPI Vesicles Reconstituted with Arf5 
List of candidates for the COPI core proteome from HeLa cells as determined by two independent experiments performed according to Fig. 2.5. CMγ1ζ1, Arf5, and GTP were used for all 
reconstitutions. Given are gene and protein names of the identified proteins, the SILAC ratios (H/L or L/H) from each experiment, the mean SILAC ratio, and standard error of the mean (SEM). 
Displayed are protein with mean SILAC ratios >2 or with a SILAC ratio >2 in one of the two experiments in which the vesicle sample was labeled with heavy isotopes (written in italic in the Mean 
SILAC ratio column). 
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2.5 The COPI Core Proteome of HepG2 Cells and Murine Macrophages 
 
Cells of higher organisms are often highly specialized. In order to fulfill a particular function the 
morphology, metabolic activity, protein and lipid composition can deviate strongly between different 
cell types. Hence, after having established a robust COPI proteomics workflow with HeLa cells, we 
decided to apply our strategy to other, specialized cell types. This was done in order to investigate 
whether the cell type specialization is reflected by a divergent composition of COPI vesicles. As 
additional specialized cell types, hepatocellular carcinoma HepG2 cells and immortalized murine 
macrophages (iMΦ) were chosen, as both of them differ functionally from one another and from 
HeLa cells. As for HeLa cells, vesicles were produced from unlabeled and labeled HepG2 cells and 
iMΦ in parallel to a mock reaction without CM. Two experiments, performed with switched labels 
gave rise to the scatter plots shown in figure 2.15. In all four experiments an average of roughly 3500 
peptides and ~600-700 proteins could be identified, which is in the range of what has been 
previously obtained for experiments with HeLa cells. The correlation of the two experiments with 
HepG2 cells, which result in an R2 value of 0.61, was lower than in the same experiment performed 
with HeLa cells(R2=0.7) and iMΦ (R2=0.79), but still decent. Noteworthy, the SILAC ratios obtained 
from experiments with HepG2 were on average lower compared to both HeLa cells and murine 
macrophages (compare Fig. 2.15A with Fig. 2.15B and Fig. 2.6). 
Some of the highest scoring proteins are highlighted with coloring in the scatter plots of figure 2.15. 
Again, multiple members of the p24/TMED protein family and nucleobindin 1/2 are amongst the 
candidates with the highest SILAC ratios. Moreover, the cis-Golgi protein ZFPL1 as well as several 
solute carrier proteins (SLCs) exhibit high ratios. Apart from the zinc transporters SLC30A5/6 
highlighted in the scatter blots of HeLa (Fig. 2.6) and iMΦ (Fig. 2.15B), the putative transporter with 
undefined substrate SLC35E1 and the putative sodium-coupled neutral amino acid transporter 10 
(SLC38A10) show strong enrichment in the COPI vesicle samples. Furthermore, the ER-retrieval 
receptor RER1 and the nonaspanin family member TM9SF3 in case of HepG2 (Fig. 2.15A) and the 
glycosyltransferase GALNT1 as well as the Sulfhydryl oxidase 2 (QSOX2) in the iMΦ datasets 
(Fig. 2.15B) are among the highest scoring proteins. 
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Figure 2.15 The COPI Proteome of HepG2 Cells and Immortalized Murine Macrophages (iMΦ)  
(A-B) Scatter plot of SILAC ratios obtained from two independent experiments performed according to figure 2.5 using 
either SIC HepG2 cells (A) or iMΦ (B) as donor membranes. Experiments were performed with switched labels. 
Contaminants were removed from the datasets. Some proteins/protein families are highlighted in color. R
2
 values of the 
datasets are 0.61 (A) and 0.79 (B). 
 
From a more general perspective, 69 proteins found in the HepG2 datasets and 144 proteins 
identified in the iMΦ COPI proteomic experiments fulfill the criteria of twofold enrichment in both 
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samples or the heavy vesicle sample that had led to our candidate list of the HeLa cell COPI proteome 
of 122 proteins (see 2.1). A comparison of the COPI proteome candidates from all three tested cell 
lines is display in the Venn diagram of Fig. 2.16A. A total of 39 proteins is found in all three datasets 
and listed in Fig. 2.16B. In addition to these ubiquitously identified proteins, 44 proteins are found in 
two of the three datasets. Due to the great overlap between the datasets, only five of the 69 
candidates are uniquely found in the HepG2 COPI proteome. The number of proteins unique to HeLa, 
HepG2, or iMΦ scales with the total number of candidate proteins identified for the respective cell 
line. Hence, roughly one third of the HeLa cell COPI proteome candidates (46 proteins) and slightly 
more than half of the candidates for iMΦ (79 proteins) are found exclusively on the lists of 
candidates for either cell line. 
The list of candidates shared between all three cell lines (Fig. 2.16B) is particularly enriched in ER-
Golgi cycling proteins e.g. six members of the p24/TMED family, ERGIC1/2/3, RER1, SURF4, ERGIC53, 
and KDEL receptor 1. Also ubiquitously found are proteins that serve glycosylation, e.g. B3GAT3, 
CHST14, MAN1A2, MGAT2, or POMGNT1 (Fig. 2.16B). Furthermore, the ER-Golgi SNAREs Sec22b and 
Stx5 as well as other proteins implicated in vesicle targeting and fusion (e.g. Rab18, YIPF3, ZFPL1) 
were found alongside several transporters for calcium (ATP2C1), zinc (SLC30A6/7), or of unknown 
substrate (SLC35E1). These candidates likely constitute the core machinery of a COPI vesicle. 
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Figure 2.16 Proteomic Comparison of COPI Reconstituted from Different Cell Types 
(A) Venn diagram to visualized the overlap of proteins found twofold enriched in COPI proteomic datasets obtained from 
different cell lines used as donor membranes. Numbers indicate the number of proteins shared between the various 
datasets. (B) List of the 39 proteins that fulfill the COPI candidate criteria in all three datasets. Given are full protein and 
gene names. 
 
Complete lists of the 69 candidates for HepG2 cell COPI proteome (Tab. 11) as well as the 144 
candidate identified in iMΦ (Tab. 12) are given below. 
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Protein.names Gene.names ratio 1 (H/L) ratio 2 (L/H) Mean SILAC ratio SEM 
Solute carrier family 35 member E1 SLC35E1 7,03 3,42 5,23 1,80 
Vesicle-trafficking protein SEC22a SEC22A 4,87   4,87   
Zinc finger protein-like 1 ZFPL1 4,43 4,84 4,63 0,20 
Protein RER1 RER1 6,07 3,05 4,56 1,51 
Transmembrane 9 superfamily member 3 TM9SF3;SMBP 3,63 4,27 3,95 0,32 
Endoplasmic reticulum-Golgi intermediate compartment protein 2 ERGIC2 5,43 2,21 3,82 1,61 
Transmembrane emp24 domain-containing protein 9 TMED9 4,87 2,59 3,73 1,14 
Nucleobindin-1 NUCB1 4,42 2,99 3,70 0,72 
Transmembrane emp24 domain-containing protein 1 TMED1 4,72 2,54 3,63 1,09 
cDNA FLJ76981, highly similar to Homo sapiens golgi autoantigen, golgin 
subfamily a, 5 (GOLGA5), mRNA GOLGA5 3,47 3,73 3,60 0,13 
Transmembrane emp24 domain-containing protein 10 TMED10 4,27 2,74 3,51 0,76 
Transmembrane emp24 domain-containing protein 7 TMED7;TMED7-TICAM2 3,70 2,94 3,32 0,38 
Alpha-(1,6)-fucosyltransferase FUT8 3,41 3,15 3,28 0,13 
Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-
mannosidase;alpha-1,2-Mannosidase MAN1B1 2,96 3,48 3,22 0,26 
GPI ethanolamine phosphate transferase 2 PIGG 3,28 3,12 3,20 0,08 
Surfeit locus protein 4 SURF4 3,95 2,39 3,17 0,78 
Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 B3GAT3 3,49 2,73 3,11 0,38 
Xylosyltransferase 2 XYLT2 3,10   3,10   
Transmembrane emp24 domain-containing protein 4 TMED4 3,43 2,72 3,07 0,35 
Beta-1,4-galactosyltransferase 7;Xylosylprotein 4-beta-galactosyltransferase B4GALT7 3,07   3,07   
Zinc transporter 6 SLC30A6 3,51 2,59 3,05 0,46 
Glutaminyl-peptide cyclotransferase-like protein QPCTL 2,96 3,01 2,99 0,03 
Alpha-fetoprotein AFP 3,67 2,22 2,95 0,73 
Polypeptide N-acetylgalactosaminyltransferase;Polypeptide N-
acetylgalactosaminyltransferase 1;Polypeptide N-
acetylgalactosaminyltransferase 1 soluble form GALNT1 2,92 2,90 2,91 0,01 
Golgi SNAP receptor complex member 2 GOSR2 4,01 1,77 2,89 1,12 
Transmembrane emp24 domain-containing protein 2 RNP24;TMED2 3,79 1,94 2,86 0,92 
UbiA prenyltransferase domain-containing protein 1 UBIAD1 2,51 3,21 2,86 0,35 
Nucleobindin-2;Nesfatin-1 HEL-S-109;NUCB2;Nucb2 3,41 2,24 2,82 0,58 
Transmembrane emp24 domain-containing protein 5 TMED5 3,68 1,94 2,81 0,87 
Protein YIPF;Protein YIPF5 YIPF5 3,28 2,30 2,79 0,49 
Protein ERGIC-53 LMAN1 3,41 2,13 2,77 0,64 
Palmitoyltransferase;Palmitoyltransferase ZDHHC17 ZDHHC17 2,72   2,72   
Vesicle-trafficking protein SEC22b SEC22B 3,09 2,31 2,70 0,39 
Protein kish-A TMEM167A 2,66   2,66   
Results
 
72 
 
Protein.names Gene.names ratio 1 (H/L) ratio 2 (L/H) Mean SILAC ratio SEM 
Zinc transporter 7 SLC30A7 2,62   2,62   
VIP36-like protein LMAN2L 3,28 1,95 2,62 0,66 
Calcium-transporting ATPase;Calcium-transporting ATPase type 2C member 1 ATP2C1 2,63 2,54 2,58 0,05 
Endoplasmic reticulum-Golgi intermediate compartment protein 3 ERGIC3 3,14 2,02 2,58 0,56 
Vesicular integral-membrane protein VIP36 LMAN2 3,09 2,04 2,57 0,53 
Vesicle transport protein GOT1B GOLT1B 3,51 1,59 2,55 0,96 
Calumenin CALU 2,55   2,55   
Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 POMGNT1 2,12 2,97 2,54 0,42 
Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB MAN1A2 2,52 2,53 2,53 0,01 
Ras-related protein Rab-18 RAB18 2,82 2,16 2,49 0,33 
Transmembrane emp24 domain-containing protein 3 TMED3 3,29 1,63 2,46 0,83 
Polypeptide N-acetylgalactosaminyltransferase 2;Polypeptide N-
acetylgalactosaminyltransferase 2 soluble form;Polypeptide N-
acetylgalactosaminyltransferase GALNT2 2,29 2,61 2,45 0,16 
Endoplasmic reticulum resident protein 44 ERP44 3,17 1,66 2,42 0,75 
Adenosine 3-phospho 5-phosphosulfate transporter 2 SLC35B3 2,33 2,43 2,38 0,05 
Protein FAM198B FAM198B 2,42 2,30 2,36 0,06 
Protein YIF1A YIF1A 2,49 2,03 2,26 0,23 
Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A MGAT5 1,84 2,68 2,26 0,42 
Endoplasmic reticulum-Golgi intermediate compartment protein 1 ERGIC1 2,59 1,92 2,26 0,33 
Sulfhydryl oxidase 2 QSOX2 2,26 2,24 2,25 0,01 
Syntaxin-5 STX5;STX5A 2,44 2,04 2,24 0,20 
Putative sodium-coupled neutral amino acid transporter 10 SLC38A10 2,23   2,23   
Protein YIPF3;Protein YIPF3, 36 kDa form III;Protein YIPF YIPF3 2,23 2,15 2,19 0,04 
Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase MGAT2 2,12 2,24 2,18 0,06 
Beta-1,3-galactosyltransferase 6 B3GALT6 2,16   2,16   
Exostosin-like 2;Processed exostosin-like 2 EXTL2 2,07 2,23 2,15 0,08 
Protein CASP;Homeobox protein cut-like 1 
CUX1;Nbla10317;CUX1-
RETc;CUX1-RETa 2,03 2,27 2,15 0,12 
Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B MGAT4B 1,71 2,58 2,15 0,43 
Protein YIPF4 YIPF4 2,10 2,17 2,14 0,04 
ER lumen protein-retaining receptor 1;ER lumen protein-retaining receptor KDELR1 2,80 1,46 2,13 0,67 
Thioredoxin domain-containing protein 5 
hCG_1811539;TXNDC5;STRF8;
DKFZp666I134 2,11   2,11   
Fukutin-related protein FKRP 1,99 2,17 2,08 0,09 
Protein YIF1B YIF1B 2,47 1,67 2,07 0,40 
Carbohydrate sulfotransferase 14 CHST14 2,09 2,02 2,05 0,04 
Transmembrane 9 superfamily member 1 TM9SF1 1,88 2,17 2,03 0,14 
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Protein.names Gene.names ratio 1 (H/L) ratio 2 (L/H) Mean SILAC ratio SEM 
Glycoprotein endo-alpha-1,2-mannosidase-like protein MANEAL 2,29 1,74 2,01 0,27 
Table 11: Candidate Proteins for the Core Proteome of COPI Vesicles of HepG2 Cells 
List of candidates for the COPI core proteome from HepG2 cells as determined by two independent experiments performed according to Fig. 2.5. CMγ1ζ1, Arf1, and GTP were used for all 
reconstitutions. Given are gene and protein names of the identified proteins, the SILAC ratios (H/L or L/H) from each experiment, the mean SILAC ratio, and standard error of the mean (SEM). 
Displayed are protein with mean SILAC ratios >2 or with a SILAC ratio >2 in one of the two experiments in which the vesicle sample was labeled with heavy isotopes (written in italic in the Mean 
SILAC ratio column). 
 
Protein.names Gene.names ratio 1 (H/L) ratio 2 (L/H) Mean SILAC ratio SEM 
Nucleobindin-1 NUCB1 7,60 16,29 11,94 4,34 
Transmembrane emp24 domain-containing protein 7 TMED7 8,45 14,49 11,47 3,02 
Transmembrane emp24 domain-containing protein 9 TMED9 7,22 12,62 9,92 2,70 
Transmembrane emp24 domain-containing protein 10 TMED10 7,20 10,70 8,95 1,75 
Transmembrane emp24 domain-containing protein 2 TMED2 6,40 11,28 8,84 2,44 
Nucleobindin-2;Nesfatin-1 NUCB2 7,78 9,89 8,83 1,05 
Transmembrane emp24 domain-containing protein 4 TMED4 7,41 9,76 8,58 1,18 
Zinc transporter 5 SLC30A5 10,01 6,64 8,33 1,69 
Putative sodium-coupled neutral amino acid transporter 10 SLC38A10 8,00 8,56 8,28 0,28 
Zinc transporter 7 SLC30A7 7,94 7,50 7,72 0,22 
Solute carrier family 35 member E1 SLC35E1 7,45   7,45   
Polypeptide N-acetylgalactosaminyltransferase 1;Polypeptide N-
acetylgalactosaminyltransferase 1 soluble form GALNT1 7,21 6,93 7,07 0,14 
Sulfhydryl oxidase 2 QSOX2 6,61 7,41 7,01 0,40 
Endoplasmic reticulum-Golgi intermediate compartment protein 2 ERGIC2 6,07 7,49 6,78 0,71 
Alpha-mannosidase 2 MAN2A1 6,12 6,36 6,24 0,12 
Golgi integral membrane protein 4 GOLIM4 6,23 5,99 6,11 0,12 
Hexosyltransferase CHPF2 6,04   6,04   
Transmembrane 9 superfamily member 3 TM9SF3 5,74 6,23 5,99 0,25 
Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase MGAT1 5,28 6,68 5,98 0,70 
Chondroitin sulfate N-acetylgalactosaminyltransferase 2 CSGALNACT2 5,93   5,93   
Endoplasmic reticulum-Golgi intermediate compartment protein 3 ERGIC3 6,57 5,22 5,89 0,68 
Xylosyltransferase 2 XYLT2 3,94 7,50 5,72 1,78 
Glucoside xylosyltransferase 1 GXYLT1 5,71   5,71   
GDP-fucose transporter 1 SLC35C1 5,66   5,66   
Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase MAN1B1 5,88 5,20 5,54 0,34 
Beta-1,4-glucuronyltransferase 1 B4GAT1 5,53   5,53   
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Protein.names Gene.names ratio 1 (H/L) ratio 2 (L/H) Mean SILAC ratio SEM 
Palmitoyltransferase ZDHHC13;Palmitoyltransferase ZDHHC13 4,46 6,36 5,41 0,95 
Vesicular integral-membrane protein VIP36 LMAN2 4,90 5,85 5,38 0,47 
Alpha-mannosidase 2x MAN2A2 5,16 5,32 5,24 0,08 
N-acetylglucosamine-1-phosphotransferase subunits alpha/beta;N-
acetylglucosamine-1-phosphotransferase subunit alpha;N-acetylglucosamine-1-
phosphotransferase subunit beta GNPTAB 3,67 6,73 5,20 1,53 
Transmembrane 9 superfamily member 1 TM9SF1 5,47 4,78 5,13 0,34 
Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A MGAT5 4,98 5,23 5,11 0,12 
Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB MAN1A2 5,00 5,12 5,06 0,06 
Golgi membrane protein 1 GOLM1 4,83 5,23 5,03 0,20 
Ceramide glucosyltransferase UGCG 5,02   5,02   
Protein RER1 RER1 5,64 4,16 4,90 0,74 
Transmembrane emp24 domain-containing protein 5 TMED5 5,09 4,63 4,86 0,23 
Ectonucleoside triphosphate diphosphohydrolase 7 ENTPD7 4,79 4,91 4,85 0,06 
Osteopontin SPP1 4,85   4,85   
Zinc finger protein-like 1 ZFPL1 4,81   4,81   
Surfeit locus protein 4 SURF4 5,57 4,01 4,79 0,78 
alpha-1,2-Mannosidase;Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA MAN1A;MAN1A1 4,89 4,68 4,78 0,11 
Polypeptide N-acetylgalactosaminyltransferase 2;Polypeptide N-
acetylgalactosaminyltransferase 2 soluble form GALNT2 4,49 5,07 4,78 0,29 
Adipocyte plasma membrane-associated protein APMAP 4,77   4,77   
Golgin subfamily A member 5 GOLGA5 5,08 4,40 4,74 0,34 
Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase MGAT2 4,52 4,89 4,71 0,18 
Protein ERGIC-53 LMAN1 4,91 4,42 4,67 0,25 
Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 B3GAT3 4,67   4,67   
Vesicle-trafficking protein SEC22b SEC22B 5,00 4,18 4,59 0,41 
RING finger and transmembrane domain-containing protein 1 RNFT1 4,58   4,58   
Carbohydrate sulfotransferase 14 CHST14 4,60 4,46 4,53 0,07 
Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B MGAT4B 5,74 3,24 4,49 1,25 
Phosphatidylinositol glycan anchor biosynthesis, class G PIGG 5,89 3,01 4,45 1,44 
Probable palmitoyltransferase ZDHHC21 ZDHHC21 4,45   4,45   
Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A;Alpha-
1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A soluble form MGAT4A 4,41   4,41   
Dermatan-sulfate epimerase DSE 4,96 3,74 4,35 0,61 
Complement C1q subcomponent subunit B C1QB 3,04 5,49 4,27 1,23 
Syntaxin-5 STX5A;STX5 4,23   4,23   
Protein CASP;Homeobox protein cut-like;Homeobox protein cut-like 1 CUX1 4,15 4,28 4,22 0,06 
Molybdate-anion transporter MFSD5 4,77 3,67 4,22 0,55 
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Protein.names Gene.names ratio 1 (H/L) ratio 2 (L/H) Mean SILAC ratio SEM 
Endoplasmic reticulum resident protein 44 ERP44 3,87 4,52 4,20 0,32 
Transmembrane 9 superfamily member 4 TM9SF4 4,29 4,08 4,18 0,11 
Protein YIPF3;Protein YIPF3, N-terminally processed YIPF3 4,13 4,09 4,11 0,02 
ER lumen protein-retaining receptor;ER lumen protein-retaining receptor 1;ER 
lumen protein-retaining receptor 2 KDELR1;KDELR2 4,04   4,04   
Glycosyltransferase 8 domain-containing protein 1 GLT8D1 3,87 4,19 4,03 0,16 
Transmembrane protein 165 TMEM165 4,31 3,61 3,96 0,35 
Ectonucleoside triphosphate diphosphohydrolase 4 ENTPD4 3,36 4,52 3,94 0,58 
Palmitoyltransferase ZDHHC17 ZDHHC17 3,92   3,92   
UDP-glucuronic acid decarboxylase 1 UXS1 3,85   3,85   
Adenosine 3-phospho 5-phosphosulfate transporter 1 SLC35B2 3,83 3,84 3,83 0,00 
Golgi SNAP receptor complex member 1 GOSR1 3,89 3,76 3,83 0,07 
N-acetylgalactosaminyltransferase 7 GALNT7 4,05 3,43 3,74 0,31 
Xylosyltransferase 1 XYLT1 3,64 3,83 3,74 0,10 
Golgi autoantigen, golgin subfamily b, macrogolgin 1 GOLGB1 3,90 3,57 3,73 0,16 
Transmembrane protein 115 TMEM115 3,68   3,68   
Protein-tyrosine sulfotransferase 2 TPST2 3,67   3,67   
Beta-1,4 N-acetylgalactosaminyltransferase 1 B4GALNT1 3,89 3,46 3,67 0,22 
Heparan sulfate 2-O-sulfotransferase 1 HS2ST1 4,02 3,32 3,67 0,35 
Glycosyltransferase-like protein LARGE1;Xylosyltransferase LARGE;Beta-1,3-
glucuronyltransferase LARGE;Glycosyltransferase-like protein 
LARGE2;Xylosyltransferase LARGE2;Beta-1,3-glucuronyltransferase LARGE2 LARGE;GYLTL1B 3,63   3,63   
Extracellular serine/threonine protein kinase FAM20C FAM20C 3,16 4,03 3,60 0,43 
Endoplasmic reticulum-Golgi intermediate compartment protein 1 ERGIC1 4,06 3,12 3,59 0,47 
Polypeptide N-acetylgalactosaminyltransferase;Polypeptide N-
acetylgalactosaminyltransferase 12 GALNT12 3,50 3,58 3,54 0,04 
Renin receptor ATP6AP2 3,52   3,52   
alpha-1,2-Mannosidase MAN1C1 3,40 3,57 3,49 0,08 
Golgin subfamily A member 2 GOLGA2 3,45 3,43 3,44 0,01 
Calcium-transporting ATPase;Calcium-transporting ATPase type 2C member 1 ATP2C1 3,97 2,82 3,39 0,57 
Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2;Heparan sulfate N-
deacetylase 2;Heparan sulfate N-sulfotransferase 2 NDST2 3,57 3,20 3,38 0,18 
GPI transamidase component PIG-S PIGS 3,29   3,29   
Soluble calcium-activated nucleotidase 1 CANT1 3,19   3,19   
Fukutin-related protein FKRP 3,19   3,19   
Ras-related protein Rab-6B;Ras-related protein Rab-6A RAB6B;RAB6A 3,01 3,30 3,16 0,15 
Phosphatidylinositide phosphatase SAC1 SACM1L 3,08   3,08   
V-type proton ATPase subunit S1 ATP6AP1 3,07   3,07   
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Protein.names Gene.names ratio 1 (H/L) ratio 2 (L/H) Mean SILAC ratio SEM 
Uncharacterized protein KIAA2013 KIAA2013 3,14 2,90 3,02 0,12 
Lysosomal alpha-glucosidase GAA 3,02 2,94 2,98 0,04 
ADP-ribosylation factor-related protein 1 ARFRP1 2,97   2,97   
Beta-1,4-galactosyltransferase 5 B4GALT5 3,27 2,60 2,94 0,33 
Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 POMGNT1 2,93   2,93   
CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase ST8SIA4 2,98 2,87 2,92 0,05 
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 B3GNT2;B3GNT2 2,88   2,88   
Ectonucleoside triphosphate diphosphohydrolase 6 ENTPD6 2,89 2,84 2,87 0,02 
Protein FAM134C FAM134C 2,84   2,84   
UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1 B3GALNT1 2,84   2,84   
Polypeptide N-acetylgalactosaminyltransferase 6 GALNT6 2,71 2,95 2,83 0,12 
PRA1 family protein 3 ARL6IP5 2,82   2,82   
Neuropilin-2 NRP2 2,80   2,80   
Prenylated Rab acceptor protein 1 RABAC1 2,77   2,77   
Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating NSDHL 2,72   2,72   
Lactosylceramide alpha-2,3-sialyltransferase ST3GAL5 2,69   2,69   
Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 C1GALT1 2,65   2,65   
Transmembrane protein 168 TMEM168 3,08 2,19 2,64 0,44 
Trans-Golgi network integral membrane protein 1;Trans-Golgi network integral 
membrane protein 2 TGOLN1;TGOLN2 2,63   2,63   
Protein FAM134B FAM134B 2,63   2,63   
Protein FAM3C FAM3C 2,59 2,67 2,63 0,04 
Lanosterol synthase LSS 3,17 2,04 2,61 0,56 
AHNAK nucleoprotein (desmoyokin) AHNAK2 2,59   2,59   
Deleted in autism protein 1 homolog DIA1 3,04 2,13 2,59 0,45 
Polypeptide N-acetylgalactosaminyltransferase;Polypeptide N-
acetylgalactosaminyltransferase 10 GALNT10 2,58   2,58   
N-acetyllactosaminide alpha-1,3-galactosyltransferase GGTA1 2,54   2,54   
Zinc transporter 6 SLC30A6 2,54   2,54   
Inositol monophosphatase 3 IMPAD1 2,53   2,53   
Beta-1,4-galactosyltransferase 1;Lactose synthase A protein;N-acetyllactosamine 
synthase;Beta-N-acetylglucosaminylglycopeptide beta-1,4-
galactosyltransferase;Beta-N-acetylglucosaminyl-glycolipid beta-1,4-
galactosyltransferase;Processed beta-1,4-galactosyltransferase 1 B4GALT1 2,71 2,34 2,53 0,18 
Protein FAM3A FAM3A 2,51   2,51   
Transmembrane 9 superfamily member 2 TM9SF2 2,65 2,33 2,49 0,16 
Alpha/beta hydrolase domain-containing protein 14A ABHD14A 2,48   2,48   
Endonuclease domain-containing 1 protein ENDOD1 2,45   2,45   
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Protein.names Gene.names ratio 1 (H/L) ratio 2 (L/H) Mean SILAC ratio SEM 
D-glucuronyl C5-epimerase GLCE 2,12 2,73 2,42 0,31 
Ras-related protein Rab-18 RAB18 2,23 2,53 2,38 0,15 
Long-chain-fatty-acid--CoA ligase 5 ACSL5 2,33   2,33   
Cathepsin B;Cathepsin B light chain;Cathepsin B heavy chain CTSB 1,92 2,72 2,32 0,40 
Golgi apparatus protein 1 GLG1 2,52 2,09 2,31 0,21 
Protein GPR107 GPR107 2,75 1,78 2,27 0,49 
Protein FAM177A1 FAM177A1 2,34 2,13 2,23 0,10 
Alpha-2-macroglobulin receptor-associated protein LRPAP1 1,93 2,52 2,23 0,30 
Membrane-associated progesterone receptor component 2 PGRMC2 2,18   2,18   
Neutral cholesterol ester hydrolase 1 NCEH1 2,13   2,13   
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 ST3GAL1 1,94 2,33 2,13 0,19 
Granulins;Acrogranin;Granulin-1;Granulin-2;Granulin-3;Granulin-4;Granulin-
5;Granulin-6;Granulin-7 GRN 2,40 1,84 2,12 0,28 
Lipoprotein lipase LPL 2,10   2,10   
Macrophage metalloelastase MMP12 2,04   2,04   
Prostaglandin G/H synthase 1 PTGS1 2,04   2,04   
Monoacylglycerol lipase ABHD12 ABHD12 2,04   2,04   
Keratinocyte-associated transmembrane protein 2 9530068E07RIK;KCT2 2,13 1,92 2,03 0,10 
Protein GPR108 GPR108 2,02   2,02   
Table 12: Candidate Proteins for the Core Proteome of COPI Vesicles of iMΦ 
List of candidates for the COPI core proteome from iMΦ cells as determined by two independent experiments performed according to Fig. 2.5. CMγ1ζ1, Arf1, and GTP were used for all 
reconstitutions. Given are gene and protein names of the identified proteins, the SILAC ratios (H/L or L/H) from each experiment, the mean SILAC ratio, and standard error of the mean (SEM). 
Displayed are protein with mean SILAC ratios >2 or with a SILAC ratio >2 in one of the two experiments in which the vesicle sample was labeled with heavy isotopes (written in italic in the Mean 
SILAC ratio column). 
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2.6 Sec24D Mutations Causing Syndromic Osteogenesis Imperfecta 
 
In addition to the investigation of the COPI vesicle proteome and coatomer and Arf isoforms, as part 
of this work most recently identified mutations within the COPII coat components Sec24D that cause 
a syndromic form of osteogenesis imperfecta (OI) were studied, using biochemical tools. In the 
affected families, three mutations were identified, causing either a premature stop-codon (Q208*), a 
glutamine-proline-conversion (Q978P), or the conversion of serine to phenylalanine in position 1015 
(S1015F). Carrying the Q208* and S1015F mutations leads to syndromic OI. A combination of the 
mutations Q978P and S1015F lead to pregnancy loss (Garbes et al., 2015). 
The positions of these point mutations within the crystal structure solved by Mancias and Goldberg 
(2008) are illustrated in figure 2.17. As indicated, the dimeric Sec23A/Sec24D complex forms an arch 
on the membrane (Fig. 2.17A). The side view of Sec24D (blue), shown in Fig. 2.17B, reveals a 
predominantly alpha-helical interaction surface on the edge of the cargo binding COPII subunit. On 
this side, Sec24D binds to the IxM motif present in Syntaxin5 (Stx5) involving the key residues 
834LIL836 (Fig. 2.17C). The point mutations, highlighted in the structure and also in the following are 
shifted by one amino acid because a Sec24D variant with one additional alanine in position 224 was 
used for the experiments. Mutation Q979P localizes to an alpha helix very distant from the 
membrane. Also, the conversion S1016F hits the very end of an alpha helix, closer to the membrane 
and the Stx5 binding site (Fig. 2.17C). 
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Figure 2.17 Crystal Structure of the Sec23A/Sec24D Complex 
(A-C) Crystal structures of the Sec23A/Sec24D complex determined by Mancias and Goldberg (2008): Protein Data Bank 
accession code 3EFO. Sec23A is colored pink, Sec24D shown in blue. (A) Side view of the dimeric complex with a schematic 
representation of membrane. (B) Side view of Sec24D after 90° rotation of the structure shown in (A). Sec23A can be seen 
in the background, a schematic membrane is displayed for orientation. (C) Enlarged side view of Sec24D shown in (B) 
without Sec23A. The point mutations S1016F, Q979P (both red), as well as the amino acid stretch 834LIL836 (green) that 
binds to Syntaxin5 (yellow) are highlighted. 
 
In order to study these mutations, we introduced them into the coding sequences of Sec23A/Sec24D 
expression plasmids. The Q208* mutation that gives rise to a protein shortened by 825 amino acids 
was excluded from the analysis as the resulting polypeptide surely is non-functional. 
Proteins complexes carrying either one of the remaining mutations could effectively be purified 
(Fig. 2.18). The Sec24D subunit of both variants Sec24DQ979P and Sec24DS1016F is partially degraded. 
However, the level of degradation is very comparable to the level of degradation observed for wild 
type Sec24D (Sec24Dwt) and the synthetic SNARE-binding mutant (Sec24DLIL834AAA). Also shown are 
recombinant Sar1B and the outer COPII coat Sec13/Sec31A (Fig. 2.18). These proteins were used in 
further experiments. 
Results 
80 
 
 
Figure 2.18 Recombinant Wild Type and Mutant COPII Coat Proteins 
Coomassie-stained SDS gel loaded with the recombinant COPII coat proteins indicated. Degradation products of the various 
Sec24D variants are marked by an asterisk (*). 
 
2.7 Mutant Sec24DS1016F is Deficient in ER-Golgi SNARE-Packing 
 
In order to obtain functional insight into the effect of the various mutations, recombinant proteins 
(Fig. 2.18) were tested in COPII in vitro reconstitution experiments. Vesicles were reconstituted from 
SIC HeLa cells (according to Fig. 2.1) and harvested by high-speed centrifugation at 100.000 ×g as 
previously described by Adolf et al. (2013). The vesicle samples were subsequently analyzed for the 
presence of the ER-Golgi cycling protein ERGIC53, as well as the three ER-Golgi SNAREs Syntaxin5, 
GS27, and Bet1 by Western blot (Fig. 2.19). 
Whereas all four variants incorporated highly similar fractions of ERGIC53, packing of SNARE proteins 
varied significantly between them (Fig. 2.19A and B). COPII samples prepared with Sec24Dwt 
contained between 5.8 and 6.9 % of the SNARE proteins present in the donor SIC. Slightly lower 
percentages of SNARE-packing were observed for the OI-related variant Sec24DQ979P, ranging from 
5.3 to 6.5 % (Fig. 2.19B). The synthetic mutant, Sec24DLIL834AAA is deficient in packing of SNAREs, as 
has been described earlier (Adolf et al., 2016; Mancias and Goldberg, 2008). This is reflected by the 
markedly reduced uptake of all three ER-Golgi Q-SNAREs, which drops to 3.5-2.4 % (Fig. 2.19B). A 
highly similar level of reduction of SNARE-uptake was observed for OI-related variant Sec24DS1016F. 
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Uptake of all three SNARE proteins was reduced by ~50% with 2.9-3.9 % incorporation of SNAREs 
present in the SIC (Fig. 2.19B). 
 
Figure 2.19 Sec24D Variants: Incorporation of ERGIC53 and ER-Golgi SNAREs into COPII Vesicles 
(A) Representative Western blot analysis of a COPII vesicles reconstituted from SIC HeLa using recombinant Sar1B, 
Sec13/Sec31A, Sec23A/Sec24D, GTP, and ATP regenerating system (ATPr) with 5 µg of SIC loaded as input. Samples were 
probed for the presence of the proteins indicated on the left. Vesicles were isolated via differential centrifugation. (B) 
Quantification of (A); n=5; error bars=SEM. 
 
To further investigate the SNARE-packing defect observed for the OI-related Sec24DS1016F mutant, 
pulldown experiments were performed. As has been shown by Mancias and Goldberg (2008), a short 
peptide motif present in Stx5 binds to Sec24D (see Fig. 2.17C). The binding motif is occluded by a 
closed conformation that Syntaxins can adopt when the N-terminal Habc domain folds back onto the 
membrane-proximal region (MacDonald et al., 2010). To overcome this auto-inhibitory state, a 
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shortened GST-tagged version, Syntaxin5205-328-GST, was used for the pulldown experiments lacking 
both the Habc region and the transmembrane domain. In figure 2.20A, schematic representations of 
the full length protein (top) and the shortened version used for pulldowns (bottom) are shown. The 
Stx5 construct was coupled to beads and incubated with the different Sec23A/Sec24D variants. After 
the incubation, the beads were washed and the bound material analyzed through Western blotting 
with an antibody against Sec23 and Coomassie staining (CBB). As can be seen in Fig. 2.20B, equal 
amounts of the Stx5 construct were bound in the different pulldown reactions (compare signals in 
CBB). Syntaxin5205-328-GST pulled down with high efficiency both wild type Sec23A/Sec24D (14.6 %) 
and the OI-mutant Sec23A/Sec24DQ979P (11.4 %) as deduced from the Sec23 signal (Fig. 2.20B and C). 
Binding of either Sec23A/Sec24DLIL834AAA (2.8 %) or the second OI-mutant Sec23A/Sec24DS1016F (2.9 %) 
dropped to the level of the GST control which was 2.7 % of the input (Fig. 2.20B and C). 
 
Figure 2.20 Pulldown Experiments: Binding of Sec24D Variants to Syntaxin5 
(A) Schematic representation of full length Syntaxin5 (top) with its N-terminal Habc domain, the SNARE motif and the 
transmembrane (TM) region as well as Syntaxin5
205-328
 used as C-terminal GST-fusion for pulldown experiments. (B) 
Representative pulldown experiment. Syntaxin5
205-328
-GST and GST control were coupled to beads and incubated with the 
inner COPII coat variant indicated. Bound material was eluted from the beads with SDS sample buffer, subjected to 
SDS-PAGE and probed for bound COPII via detection of Sec23 with an antibody. Forty percent of each pulldown reaction (P) 
was loaded together with 1 % of input (I). Equal loading of the beads was assessed through Coomassie staining (CBB) of the 
lower part of the gel. (C) Quantification of (B); n=4; error bars=SEM. 
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2.8 Sec24D Deficient Cells Have Less but Normally Localized ER-Golgi 
SNAREs 
 
In order to investigate the effect of the mutations in a cellular context, cells from an OI patient 
(“Lukas”) who carries both the Q208* and the S1015F mutation were studied. The cells, which had 
previously been shown to contain less Sec24D (Garbes et al., 2015), were probed for the presence of 
transmembrane marker proteins of the early secretory pathway. The amount of Histone H3 (91 %), 
ER marker protein Calnexin (99 %) and the Golgi SNARE Ykt6 (107 %) were very similar in patient cells 
compared to CRL-2091 control fibroblasts (Fig. 2.21). The expression of p24 and the ER-Golgi SNARE 
GS27 were reduced by ~25 % in patient fibroblasts when put into relation to control cells. For the 
other SNAREs of the ER/Golgi tested, a more strongly reduced protein level was observed. The 
expression level of GS28 and Sec22b were reduced by more than 40 % in patient cells compared to 
control fibroblasts. The most significant divergence of protein level was observed for Stx5 and Bet1. 
For both proteins, a decrease in protein level in patient cell of ~50 % was observed (Fig. 2.21). 
 
Figure 2.21 Protein Levels of Early Secretory Pathway Membrane Proteins in OI patient Cells and Normal Fibroblasts 
Western blot analysis of SIC control fibroblasts (CRL-2091) and OI patient cells (“Lukas”). Of each sample 5 µg were loaded. 
Proteins detected are indicated on the left side of each blot. Quantifications of the signals in relation to the control cells 
(100%) are given on the right side of each blot; n=3; error bars=SEM. 
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In order to investigate if, in addition to a reduced protein level, also the steady state localization of 
ER-Golgi-SNAREs was changed, confocal immunofluorescence microscopy (IFA) experiments were 
performed. The Q-SNARE Syntaxin5, the expression of which in patient cells is reduced by almost 
50 % (Fig. 2.21), was co-localized with the ER-resident Calnexin (Fig. 2.22) and the ER-Golgi cycling 
protein p24 (Fig. 2.23). As can be seen in both patient and control cells, there is a strict separation of 
the signals for Calnexin and Syntaxin5. Calnexin stains the reticular network that fills almost all 
sections of the cells body, whereas the Syntaxin5 signal is restricted to the Golgi adjacent to the 
nucleus and additionally dot-like structures (Fig. 2.22). 
 
 
Figure 2.22 IFA: Co-localization of Syntaxin5 and Calnexin in OI patient and control fibroblasts 
Methanol-fixated control fibroblasts (CRL-2091) and OI patient fibroblasts (“Lukas”) were immune-stained with anti-
Calnexin and anti-Syntaxin5 antibodies. Shown are representative images acquired with a spinning disc confocal 
microscope. Magnification 100×; inlets are marked. 
 
IFA experiments with antibodies against Stx5 and p24 revealed some degree of co-localization, 
although no perfect merge of signals for the two proteins could be observed (Fig. 2.23). This is 
generally in line with the fact that p24 cycles in the early secretory pathway and hence localizes at 
cis-Golgi and the ERGIC under steady-state conditions (Dominguez et al., 1998). Stx5 on the other 
hand is engaged in at least two different SNARE complexes and is believed to act at the ER-Golgi 
interface and along the whole cis-to-trans axis of the Golgi (Hong, 2005; Malsam and Söllner, 2011). 
In general there was no major difference in Stx5/p24 localization between patient cells and control 
fibroblasts to be observed, except possibly a slightly higher level of co-localization in patient cells. 
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A more general observation was that control fibroblasts displayed more distinct Stx5-positive 
punctae compared to Sec24D-deficient “Lukas” patient cells (compare Stx5 signals CRL-2091/”Lukas” 
in Fig. 2.22 and 2.23). 
 
Figure 2.23 IFA: Co-localization of Syntaxin5 and p24 in OI patient and control fibroblasts 
Methanol-fixated control fibroblasts (CRL-2091) and OI patient fibroblasts (“Lukas”) were immune-stained with anti-
Calnexin and anti-Syntaxin5 antibodies. Shown are representative images acquired with a spinning disc confocal 
microscope. Magnification 100×; inlets are marked. 
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3 Discussion 
 
Section 2 shows our results gathered on the proteome of COPI vesicles, the role of coatomer and Arf 
isoforms, as well as OI-related mutations in Sec24D. In the following these results are discussed with 
respect to the current knowledge, and I try to suggest how open questions could be addressed 
further. 
 
3.1 A Novel Proteomic Setup 
 
In section 2.1, our novel proteomic setup to investigate COPI is outlined. Noteworthy, the described 
setup has been employed to study COPII vesicles in parallel to the presented work on COPI (Adolf et 
al., unpublished data). With this setup we have unified various aspects of earlier proteomic studies of 
vesicular carriers and thus generated a simple, reliable, and adjustable workflow for proteomics of 
vesicles. Many MS studies of transport vesicles used endogenous vesicles, purified from tissue or cell 
culture (Borner et al., 2006; Hirst et al., 2012; Takamori et al., 2006). The great advantage of this 
approach is that native vesicles formed not in vitro but in vivo are captured. For special cases such as 
synaptic vesicles (SVs), which can be purified with high fidelity, this setup has proven very useful 
(Takamori et al., 2006). As purification of SVs is performed from brain tissue, however, experiments 
become more difficult to modulate because of the high demands for genetic manipulation of a whole 
organism e.g. by knockout/knockin. 
Purification of endogenous vesicles from cell culture faces one major experimental challenge: Most 
vesicle types are ubiquitously found in all cell types and cannot be easily separated from all other 
classes of vesicles. Hence, there is a distinct issue of vesicle cross-contamination, which needs to be 
considered. The common vesicle types, COPI, COPII, and CCVs behave very similar during purification 
procedures such as differential or density gradient centrifugation. This can be deduced from the fact 
that COPII vesicles, formed in vitro, float up to the exact same fractions (2 and 3) of the density 
gradient shown in figure 2.3 as do COPI vesicles (M.Sc. thesis Manuel Rhiel, Adolf et al., unpublished 
data). Moreover, in almost all MS datasets presented here, AP-1 and AP-2 complex subunits were 
identified, indicating that these carriers are not easily separated from COPI and COPII vesicles. Other, 
earlier purification protocols, e.g. for CCVs (Hirst et al., 2004), or COPI (Gilchrist et al., 2006) were not 
systematically controlled for the presence of other contaminating vesicle types.  
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While co-purification of endogenous vesicles is a problem common to all vesicle proteomic setups, 
unwanted formation of other vesicles is a problem only of in vitro reconstitution systems. For 
example, when cytosol is used to produce COPI vesicles from a Golgi-enriched membrane fraction, 
formation of other vesicle types is unpreventable as Golgi membranes cannot be purified entirely 
omitting ER and other membrane contaminants. As a consequence, in a very comprehensive MS 
study of the ER, Golgi, and COPI vesicles, COPII coat subunits displayed high MS scores in the donor 
Golgi fraction and the COPI (GTPγS) fraction formed from this Golgi with cytosol (Gilchrist et al., 
2006).  
While contamination by other classes of newly formed vesicles can be prevented by using purified 
coat components, as has for example been done for COPII vesicles in yeast (Margulis et al., 2016), 
removing endogenous contaminations is more difficult. In this concern it has been proven useful to 
employ a “subtractive” setup. Borner et al. purified a fraction enriched in CCVs from wild type cells 
and from cells after knockdown of the pivotal CCV component Clathrin heavy chain (Borner et al., 
2006). In a comparison of both fractions, the lost/subtracted proteins are the putative CCV proteins. 
Building on this, the same lab has refined this method by rapidly knocking CCV adaptors “sideways”, 
i.e. tethering them to mitochondria, to investigate their function (Hirst et al., 2012). In the latter 
study, SILAC labeling was further introduced as the most direct means for quantitative MS in cell 
culture. With this setup, it is possible to assess the role of single factors during vesicle biogenesis. 
However, investigating the interplay of several factors at once requires preparation of cell lines with 
multiple knockins/knockouts and thus advanced genetic manipulation. Moreover, investigating 
dose-effects for chosen candidates would require fine-tuning of expression levels, e.g. by means of 
different promoters, complicating the experimental setup further. 
In our proteomic setup (Fig. 2.5) we have tried to combine different aspects of vesicular proteomics 
into a novel, improved workflow. The beneficial aspects of our protocol as well as the drawbacks in 
comparison to other protocols are listed below. 
 
Benefits of the novel setup: -Simple cell culture methods; no need for genetic manipulation 
    -Simple/clear interpretation of MS data (SILAC ratios) 
-Highly reproducible (R2 values between runs usually ~0.7-0.9) 
-Unlimited combinations/concentrations of vesicle biogenesis factors 
can be tested 
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-Dissection of molecular mechanisms in detail (e.g. through 
competition/titration of various factors)  
 
Drawbacks of the novel setup: -Requires advanced protein expression/purification skills 
-Vesicles are formed in vitro (not endogenous) 
-potential limitations in capturing cytosolic factors 
-Not suitable for new vesicle classes; requires fundamental 
knowledge of the biogenesis process (in vitro reconstitution system) 
 
3.2 What Makes a COPI Vesicle 
 
Sections 2.2 and 2.5 provide insight into protein content of COPI vesicles that were produced in a 
minimal system from donor membranes of various cell types. Using SILAC-based proteomics, we 
compared vesicles from reconstitution reactions with a mock vesicles fraction. In the mock fraction, 
SIC cells were treated with nucleotides and Arf1. The addition of Arf1 to the mock control became 
necessary as initial experiments, in which the small GTPase was omitted in the mock reaction, 
showed an enrichment of AP-1, another coat protein known to interact with Arf1 (Stamnes and 
Rothman, 1993). Having coatomer as the sole difference between both reactions solved this issue. 
Using the common criterion of a >twofold enrichment for protein to be considered as candidates for 
the vesicle proteome resulted in a list of 122 candidate proteins in HeLa cells (Tab. 1). Most of these 
proteins (102) were identified in 2-3 independent experiments; a minor fraction of 20 proteins was 
identified in only one MS run. Since these 20 proteins were identified in a vesicles sample from 
isotope-labeled cells, and thus are no exterior contaminations, they were included as potential 
candidates into further analyses. The same vesicle versus mock setup was furthermore used to 
investigate the proteomes of COPI vesicles reconstituted from HepG2 cells (hepatocarcinoma) and 
iMΦ (murine macrophages). In HepG2 cells, 69 proteins (Tab. 11) and in iMΦ 144 proteins (Tab. 12) 
could be determined as candidates for the respective COPI proteome within two independent 
experiments. Of the three candidate lists the mean SILAC ratio was highest for HeLa (mean SILAC 
ratio 4.5) and lowest for HepG2 cells (mean SILAC ratio 2.82). The 144 candidates identified in iMΦ 
showed an average SILAC ratio of 4.18. The relatively small number of proteins that fulfill the twofold 
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enrichment criterion and their low mean SILAC ratio for COPI candidates proteins in HepG2 cells can 
be explained in several ways. Either, in vitro reconstitution of COPI vesicles in these cells is less 
efficient than in the other two cells lines, or the background that is produced by endogenous, Arf-
independent coat proteins and the unspecific release of small membrane fragments during the 
assays is much higher in HepG2 cells. Conversely, the long list of candidates obtained for murine 
macrophages possibly reflects a very high suitability of these cells for this assay. Potentially, 
combining murine cells and murine coatomer enhances the productivity of the assay despite the fact 
the human and murine coatomer are highly similar (i.e. the largest subunit α-COP is 98.5 % identical). 
Of the three candidate lists, 39 proteins are found in all three datasets defining them, with a very 
high level of fidelity, as core components of COPI vesicles. Another 44 proteins are enriched >twofold 
in two out of the three datasets, marking them as very good additional candidates for the COPI 
proteome (Fig. 2.16). Thus, of the 213 individual candidate proteins identified across three cell lines 
and two species roughly 40 % (83 proteins) are recurring. 
The very core of the recurring proteins, the 39 ubiquitously shared proteins, contain a lot of 
expected, classical COPI proteins but still hint towards an important role for some proteins that has 
not been appreciated thus far. Classical COPI proteins are for example the various members of the 
p24/TMED family, which are well characterized single transmembrane proteins that cycle in the early 
secretory pathway, where they assist COPI biogenesis and transport of GPI anchored proteins 
(Belden and Barlowe, 2001; Bonnon et al., 2010; Bremser et al., 1999; Dominguez et al., 1998; 
Gommel et al., 2001). Additional ER-Golgi cycling proteins such as the cargo adaptors ERGIC53 
(LMAN1) (Kappeler et al., 1997), the SNAREs Sec22b and Stx5 (Adolf et al., 2016; Hay et al., 1998), or 
the KDEL receptor (Lewis and Pelham, 1992; Munro and Pelham, 1987) (Fig. 2.16B) are also 
conserved COPI components. Other proteins, such as the nonaspanins TM9SF1/3, which we define as 
core components of COPI vesicles (Fig. 2.16B), were only recently characterized and shown to carry 
distinct KxD/E interaction motifs for COPI transport (Woo et al., 2015). This motif, which is conserved 
from yeast to human, confers Golgi-retention through interaction with coatomer. Apart from the 
various cycling proteins, and not unexpected, multiple glycosylation enzyme, i.e. MAN1A2, MAN1B1, 
MGAT2, MGAT4B, POMGNT1 (Fig. 2.16B) were among the proteins found in COPI vesicles of various 
cell lines. Whether Golgi-resident enzymes are enriched in COPI vesicles has been controversial since 
studies that based on the same methodology (immunogold labeling EM) came to opposing 
conclusion (Martinez-Menarguez et al., 2001; Orci et al., 2000). Several Golgi enzymes within the 
core COPI proteome strongly argues towards an active uptake of these proteins into COPI vesicles, in 
line with more recent studies (Eckert et al., 2014; Gilchrist et al., 2006; Rutz et al., 2009). 
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In general, there is a clear enrichment of putative or known cargo adaptors, vesicle targeting factors, 
and enzymes among the 39 shared proteins. These core components are strongly enriched in 
membrane proteins (35 proteins). Most of them have a single TM domain (20 proteins), however, the 
number of transmembrane spans can go up to ten in case of the calcium-transporting ATPase 
ATP2C1. The five proteins lacking a TM domain are ERP44, NUCB1/2, and Rab18. ERP44 is an 
ER-retention factor which possess a C-terminal RDEL signal and forms mixed disulfide bonds in order 
to retrieve its substrates (Anelli et al., 2003). NUCB1 and NUCB2 are major calcium-binding proteins 
of the ERGIC and cis-Golgi (Lin et al., 1998). Earlier proteomic studies of the ERGIC (Breuza et al., 
2004) and the ER/Golgi and COPI vesicles (Gilchrist et al., 2006) support these findings. Interestingly, 
Coomassie staining of a fraction enriched in COPI vesicles reveals a distinct band with intensity 
comparable to those seen for membrane machinery proteins such as p24 and p25 (Rutz et al., 2009). 
Together with the recurring identification of both proteins with very high SILAC ratios (see Tab. 1, 
11-12) this strongly argues for a high concentration of NUCB1/2 inside the lumen of COPI vesicles and 
a direct link between COPI vesicle transport and calcium homeostasis. Since the overall 
concentration of nucleobindin in the Golgi lumen is high (Lin et al., 1998) further experiments are 
required to investigate an active sorting into vesicles. 
Another attractive hypothesis is that NUCB1/2 functions as calcium-switchable cargo receptors 
possibly in addition to its function as buffer for luminal calcium in the Golgi. As the concentration of 
calcium decreases from the ER towards the TGN (Pizzo et al., 2011), nucleobindins could bind certain 
proteins at a low calcium concentration (e.g. TGN), and release them at higher concentration (e.g. ER 
or CGN), or vice versa. Such a mechanism would resemble the pH-dependent binding/release of KDEL 
clients by their receptor (Wilson et al., 1993). 
Of the COPI vesicle core proteome without a TM domain, Rab18 is the only protein localized to the 
outer leaflet of the vesicle membrane. The fact that Rab18 shows the tightest and most conserved 
association with COPI is partially surprising. Rab18 has mainly been implicated in lipid droplet (LD) 
homeostasis (Ozeki et al., 2005), a process in which it seems to interact also with COPI and the 
tethering complex TRAPPII (Li et al., 2017; Zappa et al., 2017). The identification of this particular Rab 
family member in our proteomic datasets points towards a significant role for Rab18 in addition to 
LD homeostasis, potentially in intra-Golgi and ER-Golgi transport. Such a function would be in line 
with observations made during overexpression and knockdown studies that revealed trafficking 
defects at these organelles when Rab18 levels were altered (Dejgaard et al., 2008). 
One of the recurrent transmembrane proteins worth highlighting is QSOX2 (quiescin 
Q6/FAD-dependent sulfhydryl oxidase 2). QSOX2 has a single TM domain at its very C-terminus and 
thus a short cytoplasmic tail with the sequence RVRSRRWKVKHHHPAV (N- to C-terminus). Proteins of 
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this family serve formation of disulfides and have been previously placed in part to the Golgi complex 
(Mairet-Coello et al., 2004; Wittke et al., 2003). Here we can show for the first time that QSOX2 is a 
conserved component of COPI vesicles. Together with its intracellular localization, much argues for a 
role of COPI in its retention at the Golgi apparatus. As the cytoplasmic tail does not display any of the 
classical retrieval motifs (e.g. KKxx, KxKxx, KxD/E) further studies are required to determine how 
QSOX2 is kept at the Golgi complex. 
As only Rab proteins (Tab. 1) were be identified as cytosolic factors associated with COPI vesicles, we 
decided to refine the assay by introducing cytosol to the budding reaction. The cytosol, which was 
prepared from SILAC-labeled HeLa cells, was depleted in membrane proteins but contained also 
luminal ER content (Fig. 2.7). In order to capture cytosolic proteins that interact with the COPI coat, 
vesicles were either prepared with GTP or GTPγS. The use of non-hydrolysable analogs instead of 
GTP did not result in a decreased level of COPI marker proteins release (Fig. 2.3). 
When comparing COPI vesicles made in the presence of cytosol and GTPγS with COPI vesicles made 
in the presence of cytosol and GTP, 72 proteins showed a twofold enrichment in one to two 
experiments (Fig. 2.7B and Tab. 1). Unlike expected, the vast majority of these proteins have 
transmembrane domains and reside in the ER. With the exception of Arfaptin-1, no potential 
cytosolic COPI interactors could be identified. Arfaptin-1 has been shown to interact with the COPI 
coat component Arf and to be associated with the Golgi apparatus (Kanoh et al., 1997; Williger et al., 
1999). However, as more recent studies place Arfaptin at the TGN (Cruz-Garcia et al., 2013; Man et 
al., 2011) and the fact that AP-1 coat subunits are enriched in the COPI vesicle fraction produced with 
GTPγS vesicles (Tab. 2), one cannot conclude with certainty that Arfaptin-1 is a cytosolic interactor of 
COPI vesicles. 
The unexpected finding that many ER resident transmembrane proteins were enriched in the COPI 
vesicle fraction produced with GTPγS and cytosol prompted us to investigate this observation in 
more depth. A control experiment without coatomer revealed that many of these ER proteins are 
released from SIC in the absence of the coat complex (Tab. 3). Notably, many constituents of the 
tubular ER (reticulons and atlastins) were identified. As atlastins, which are involved in regulation of 
ER morphology (Zhao et al., 2016) are large GTPases, one possible explanation for this observation is 
that the tubular ER undergoes shredding due to a constitutive activation of these proteins. 
Earlier reports performed with Golgi-enriched membrane fractions and cytosol suggested that 
non-hydrolysable GTP analogs interfere with the uptake of retrograde and anterograde cargo into 
COPI vesicles (Lanoix et al., 1999; Nickel et al., 1998). Our proteomic comparison of GTP and GTPγS 
vesicles and also WB analysis of known COPI marker proteins (Fig. 2.3B) did not hint towards a 
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defective uptake of these marker proteins when assays are performed with recombinant proteins 
and SIC. 
In a nutshell, what a minimal model COPI vesicle could look like based upon our high fidelity core 
proteome is shown in figure 3.1. Many of the components are expected and are in agreement with 
previous findings. Other components, which we could identify consistently in multiple datasets, had 
not been appreciated as core components of COPI vesicles before. 
 
 
Figure 3.1 Schematic of a Model COPI Vesicle 
Schematic drawing of a COPI vesicle based on our proteomic data (Fig. 2.14 and Tab. 1, Tab. 11, and Tab. 12) that highlights 
commonly known and new features. The vesicle contains mainly TM proteins that cycle between the ER and the Golgi. Our 
data together with previous observations (see 3.2) suggests that NUCB1/2 are major constituents of the COPI lumen. 
NUCB1/2 potentially interact with similarly abundant TM proteins for packing into vesicles (e.g. p24 proteins) and serve as 
cargo-adaptors. Secreted cargo, if present, is found only at low concentration. Glycosylation enzymes are retained by COPI. 
Targeting/fusion of the vesicle is performed by SNAREs (most prominently Stx5 and Sec22b) as well as tethering factors 
(ZFPL1) and Rab proteins. Rab18, was the most frequently identified Rab family member associated with COPI. Some core 
components of COPI vesicles, e.g. QSOX2, are likely retained in the Golgi through interaction with the COPI coat via an 
unknown mechanism/motif. 
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However, many open questions concerning the protein content of COPI vesicles remain. Some 
questions that future research, especially with respect to coatomer and Arf isoforms, could try and 
answer are mentioned in sections 3.3 and 3.4. Two more general aspects of COPI that could be 
addressed by future research are discussed below. 
i) Role of COPI in the endosomal system 
A most recent study in yeast provides strong evidence that COPI plays a role in recycling of the 
exocytic SNARE Snc1 through recognition of its ubiquitinated form and subsequent trafficking 
through the endosomal system (Xu et al., 2017). This is in line with earlier studies in mammalian cells 
which provided evidence for the localization of COPI on endosomes and even suggested vesicle 
budding at these sites (Aniento et al., 1996; Whitney et al., 1995). A possible role of COP in the 
endosomal system in mammals could be studied further e.g. by the following experiments: 
 -Using isolated endosomal membrane fractions for COPI binding/budding studies 
 -MS analysis of potential endosomal COPI vesicles 
 -MS of COPI vesicles after temperature block at the TGN (Saraste and Kuismanen, 
1984) 
 -Knocksideways of COPI and monitoring of the effect on the endosomal system 
(Robinson et al., 2010) 
 
ii) COPI on lipid droplets 
Lipid droplets are cellular inclusions that serve the storage of neutral lipids (Guo et al., 2009). LD 
homeostasis has been previously linked to COPI (Beller et al., 2008; Guo et al., 2008). Transport of 
proteins to LDs (Soni et al., 2009) and localization and activity of COPI proteins on LDs (Wilfling et al., 
2014) has been shown earlier. Most recent studies further linked the tethering complex TRAPP and 
Rab18 to LD homeostasis (Li et al., 2017; Zappa et al., 2017). This could be further addressed by: 
 -Using isolated LDs to perform micro LD budding with COPI with subsequent 
proteomic analysis (Wilfling et al., 2014) 
 -Interaction studies between LD proteins and the COPI coat components (targeting 
motifs?) 
 -Lipidomic analysis of COPI-budded micro LDs and their parental donor LDs 
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3.3 The Role of Coatomer isoforms 
 
As mentioned in the introduction, coatomer is a heptameric complex. Two of its seven subunits, γ- 
and ζ-COP, exist as two isoforms. What function these isoforms serve remains largely elusive. A main 
function that isoforms of coat proteins have been shown to serve is sorting of cargo and machinery. 
Prominent examples are the isoforms of mammalian Sec24, which pack the ER-Golgi SNAREs 
(Mancias and Goldberg, 2007, 2008), transporters of the plasma membrane (Farhan et al., 2007; 
Sucic et al., 2011), and many ER-Golgi cycling proteins (M.Sc. thesis Manuel Rhiel, Adolf et al., 
unpublished data) into COPII vesicles in an isoform-specific manner. In order to investigate an 
equivalent function for the isoforms of the COPI coat, we have compared hundreds of COPI vesicle 
proteins at once in our novel MS setup (Fig. 2.5). 
In a direct comparison of γ1ζ1- and γ2ζ1-vesicles all proteins crowd around a SILAC ratio of one. No 
proteins are >twofold enriched in vesicles reconstituted with γ1ζ1 over γ2ζ1-vesicles (Tab. 4). A few 
proteins display a slight enrichment in vesicles formed using γ2ζ1 (Fig. 2.9 and Tab. 5), however, the 
most promising candidates based on their SILAC ratios are mitochondrial proteins (HSPD1, ATP5B, 
and ATP5A1). Abundant proteins such as p24 and ERGIC53, which give highly similar signals in 
Western blot analyses (Fig. 2.8), display equally similar SILAC ratios in MS experiments. In our 
datasets ERGIC53 and p24 are slightly more enriched in γ1ζ1-vesicles as compared to γ2ζ1-vesicles, 
showing mean SILAC ratios of 1.11 (ERGIC53) and 1.16 (p24). Since there was a slightly higher 
incorporation of both proteins by γ2ζ1 in vesicles assays analyzed by Western blot (Fig. 2.8), these 
subtle differences, especially since both proteins behave in the same way, are not significant and in 
the margin of error of this system. 
Similarly, a proteomic comparison of COPI vesicles reconstituted with recombinant coatomer 
containing either ζ1- or ζ2-COP did not reveal any major differences. A few proteins (i.e. TM9SF1, 
TPBG, POMGNT1, and ZDHHC13) are somewhat more enriched in γ1ζ1- compared to γ1ζ2-vesicles (Fig. 
2.10 and Tab. 6). Of these four potential candidates, TPBG can be discarded because it was not 
enriched in COPI vesicles made with γ1ζ1 compared to a control (Tab. 1). The remaining three 
proteins were found >twofold enriched in COPI vesicles in the same experiments and are thus 
candidates for the COPI proteome. However, also ERGIC53 (SILAC ratio 1.11) and p24 (SILAC ratio 
1.09) were slightly enriched in COPI vesicles prepared with γ1ζ1- compared to γ1ζ2 coatomer. Hence, 
the observed differences for TM9SF1, POMGNT1, and ZDHHC13 are likely to result from a slightly 
better budding efficacy during these experiments, rather than differential sorting of these proteins 
by ζ1-COP. In isotypic vesicles formed by ζ2-COP, only one protein, the monocarboxylate transporter 1 
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(SLC16A1) stood out with a rather high mean SILAC ratio of 3.75 (Fig. 2.10 and Tab. 7). However, the 
two individual SILAC ratios for this protein (6.13 and 1.37) are highly diverging, rendering it a rather 
weak candidate for being a ζ2-COP specific client. In summary, it can be concluded that the isoforms 
of coatomer do not seem to sort the COPI core components differentially. 
We furthermore investigated a potential influence of coatomer isoforms on the size of vesicles. In 
the CCV system it has been shown previously that clathrin adaptor proteins such as AP180 (Zhang et 
al., 1998) or clathrin assembly lymphoid myeloid leukemia protein (CALM) (Miller et al., 2015) 
influence the size of endocytic vesicles. Contrary, isoforms of the COPII coat subunit Sec24 in yeast 
(Sec24p and Lst1p) have been shown to give rise to vesicles with highly similar size and morphology 
(Miller et al., 2002). To explore this putative function, negatively stained EM images of isotypic COPI 
vesicles were analyzed systematically using bioinformatics tools for accurate segmentation of 
objects. The compiled data, presented in figure 2.11, shows that neither isoforms of γ- nor ζ-COP 
have a substantial influence on the size of COPI vesicles. Indeed, the size of isotypic vesicles was 
almost identical to that of vesicles reconstituted using an endogenous mix of all CM isoforms 
represented by rat CM (Fig. 2.11). Noteworthy, the average size of vesicles determined by our 
approach (~74 nm) matches the size of COPI vesicles determined at the time of their initial discovery 
(74-76 nm) (Orci et al., 1989). A most recent in situ study revealed that COPI vesicles are not uniform 
with respect to their size and the luminal density under the electron microscope (Bykov et al., 2017). 
This plasticity is reflected by the standard deviations which range from 7.7 to 8.9 nm (Fig. 2.11). 
With our MS and EM data presented throughout this thesis, we can exclude two major functions for 
the isoforms of CM subunits: i) the uptake of core components into vesicles, and ii) the modulation 
of COPI vesicle size. This leaves the question regarding a function of these isoforms unanswered. Two 
previous studies point towards a diverging function of CM isoforms. First, an EM-based study of 
intracellular coatomer isoform distribution showed that γ1ζ1 and γ1ζ2 were preferentially at the 
cis-Golgi, whereas γ2ζ1 concentrated at the trans-side (Moelleken et al., 2007). A later study by 
Hamlin et al. showed that Scyl1, an inactive cytosolic kinase, interacts preferentially with γ2-COP and 
class II Arfs (Hamlin et al., 2014). Mutations in Scyl1 have been implicated in the development of 
neuropathies and liver failure (Schmidt et al., 2007; Schmidt et al., 2015). Scyl1 has furthermore been 
shown to interact with coatomer (Burman et al., 2008; Ma and Goldberg, 2013), co-localizes with the 
ERGIC and cis-Golgi as well as COPI coat proteins (Burman et al., 2008), and to influence Golgi 
apparatus morphology (Burman et al., 2010). Despite these observations, a functional link between 
COPI and Scyl1 is missing. 
The fact that COPI vesicles are not entirely uniform was observed earlier as they can vary largely with 
respect to their appearance in the electron microscope (Bykov et al., 2017; Donohoe et al., 2007). 
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Donohoe et al. defined COPIa vesicles in algae and plants, which show a light content and form at the 
cis-Golgi, and COPIb vesicles that display a strongly stained lumen in EM studies and form at the 
medial- and trans-Golgi. As we could not observe any visual differences between isotypic vesicles 
(compare vesicles in Fig. 2.11), a link between the mammalian coatomer isoforms and putative 
COPIa/b vesicles is highly unlikely. Moreover, a differential interaction of COPI vesicles with various 
tethers of the Golgi complex have been described (Malsam et al., 2005; Wong and Munro, 2014). 
While the p115/GM130(GOLGA2) tethering complex selectively associated with COPI vesicles 
carrying ER-Golgi cycling proteins such as members of the p24 family, the intra-Golgi tethering pair 
golgin-84(GOLGA5)/CASP(CUX1) was found to tether those vesicles that carry Golgi enzymes 
(Malsam et al., 2005). Three of these proteins, GM130, golgin-84 and CASP were identified in our 
datasets of isotypic COPI vesicles. Two of them, golgin-84 and CASP, were furthermore found 
consistently enriched in COPI vesicles (Fig. 2.16). However, in all comparisons of COPI vesicles made 
with a single isoform of coatomer, none of the three proteins was significantly enriched. Hence, a 
functional link between CM isoforms and Golgi tethers is unlikely. 
As we could not determine a function for γ- or ζ-COP isoforms, further investigations are required. 
Three putative functions of coatomer isoforms and how they could be addressed experimentally are 
listed in the following: 
i) Coatomer isoforms could have a specific role in protein sorting in polarized cell type (i.e. 
neurons) 
Isoforms of CM could function similar to isoforms of adaptor protein complexes (see 1.4.3) in sorting 
of proteins into different trafficking routs. This question could be addressed by: 
 -Comparative COPI proteomics according to Fig. 2.5 using e.g. a neuronal cell line 
 -Knockout of isoforms in specific cell lines 
 -Knocksideways with adjacent purification of endogenous COPI vesicles and MS 
analysis 
 -Immunoprecipitation of endogenous COPI vesicles using isoform-specific antibodies 
 
 
ii) CM isoforms could fulfill a specific function in cargo export or at a certain cellular condition 
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Using our proteomics approach we were able to identify the core machinery of COPI vesicles. We did 
not find many cargo proteins, possibly due to their low concentration. During all experiments cells 
grown under optimal conditions we used. Hence, we did not address a role of CM isoforms under 
challenging conditions or with a focus on uptake of secreted cargo. A possible role of CM isoforms in 
these processes could be further challenged by: 
 -COPI proteomics under stress conditions (e.g. starvation/drug treatment)  
 -Knockdown/knockout of CM isoforms with concomitant starvation/drug treatment 
 -Vesicle proteomics using cells with secreted proteins trapped in the ERGIC (15°C) or 
the TGN (20°C) by temperature block (Saraste and Kuismanen, 1984) 
 -Using a secreted model protein to assess the effect of CM isoforms on protein 
secretion via knockdown/knockout 
 
iii) CM isoforms could act in combination with different isoforms of Arf 
We have not assessed the possibility that isoforms of CM interact differentially with COPI forming 
isoforms of Arf. 
 -COPI proteomics analyzing various combinations of CM/Arf isoforms according to 
Fig. 2.5 
 -Bio-ID of CM/Arf isoforms to fish for potential isoform specific interactors 
 -Competition of different Arfs during vesicle biogenesis (Popoff et al., 2011b) 
 
3.4 The Role Arf Isoforms 
 
In addition to isoforms of the outer COPI coat complex coatomer, we have investigated 
systematically the function of Arf isoforms. To this end, human Arf isoforms Arf3-6 were cloned into 
our improved expression system in which the expression of myristoyltransferase (hNMT1) and 
methionine aminopeptidase (MetAP1) can be induced independently prior to the induction of Arf 
expression (see Material and Methods). This allowed us to produce Arf isoforms with high purity and 
a degree of myristoylation close to 100% (Fig. 2.12A). As has been previously shown by Popoff et al. 
(2011b) in a reconstitution system based on rat liver Golgi membranes and rat liver coatomer, all 
Discussion 
98 
 
isoforms of Arf except Arf6, promote formation of COPI vesicles in vitro (Fig. 2.12B). This is in line 
with the observation that Arf6 localizes to the plasma membrane where it is implicated in playing a 
role in endocytosis rather than promoting COPI transport (Cavenagh et al., 1996; D'Souza-Schorey et 
al., 1995). Popoff et al. (2011b) furthermore showed that Arf3 can be outcompeted from COPI 
vesicles by other Arf isoforms. In agreement with this finding and further studies that place Arf3 at 
the TGN, where it is specifically activated by the GEF protein brefeldin A-inhibited guanine 
nucleotide-exchange protein 1 (BIG1) (Manolea et al., 2010), a significantly lower but still appreciable 
release of ERGIC53 and p24 could be observed when COPI reconstitution from SIC was performed 
with Arf3 compared to Arf1, Arf4, and Arf5 (Fig. 2.12B). Accordingly, endogenous Arf4 and also Arf5 
were found in multiple COPI proteomics datasets (e.g. Arf4 can be found in Tab. 1), while Arf6 was 
never identified. Whether Arf3 was also present cannot be concluded due to its high sequence 
similarity to Arf1 that is not resolved by MS. 
To challenge a putative role of Arf isoforms in modulating the content of COPI vesicles we used our 
SILAC-based mass spectrometry setup (Fig. 2.5) to study the content of these carriers prepared with 
Arf3-5 (Fig. 2.13 and Tab. 8-10). In comparisons of COPI vesicles reconstituted with Arf3-5 with a 
mock reaction, overall less peptides/proteins were identified compared to samples produced with 
Arf1. Least proteins were identified with Arf3, again in agreement with previous observations 
(Fig. 2.12). Only 25 proteins were >twofold enriched in Arf3-COPI vesicles, 50 proteins in COPI 
vesicles made with Arf4, and 55 proteins in vesicles reconstituted with Arf5 (Tab. 8-10). These 25-56 
proteins however, largely overlapped with the COPI proteomics dataset acquired with Arf1 
(Fig. 2.14A). Only 8 proteins were not identified with Arf1. These proteins are among the proteome 
candidates with the lowest SILAC scores. The 6 proteins unique to Arf5 display a mean SILAC ratio of 
2.03 including the ribosomal proteins RPL13 and RPL18 which are obvious contaminants. The list of 
proteins shared between all Arf isoforms (Fig. 2.14B) largely overlaps with the list of proteins 
identified as COPI protein candidates in different cell lines (Fig. 2.16). Of the 20 proteins shared 
among all Arf-isotypic COPI vesicles, 17 are found in COPI vesicles made with Arf1 from three 
different cell types. These proteins include five p24/TMED proteins, the SNAREs Sec22b and Stx5, 
ER-Golgi cycling proteins such as ERGIC1/2 and LMAN1/2 plus additional targeting factors like ZFPL1 
and Rab18 (core components of COPI vesicles as discussed in 3.2). 
It can be concluded that the core content of a given COPI vesicle does not depend on usage of a 
given Arf isoform (Fig. 2.14A), whereas the total yield of reconstituted vesicles, judged by the 
number of identified peptides and proteins, seems to change. These findings indicate that Arf1 is the 
most potent small GTPase for COPI vesicle biogenesis. This is in line with the fact that the expression 
level of Arf1 in rat liver is more than fivefold higher than that of Arf5 and threefold higher than that 
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of Arf3 (Popoff et al., 2011b). Moreover, knockdown studies performed by the lab of Richard Kahn 
highlight the importance of Arf1 for COPI transport (Volpicelli-Daley et al., 2005). They found that 
depletion of a single Arf isoform did not interfere with protein traffic and or Golgi morphology. Only 
when knocking down two Arf isoforms at a time did they observe phenotypes. Knockdowns of 
various combinations of Arf3-5 interfered mainly with recycling of the transferrin receptor at the PM, 
and, when Arf4 was depleted, mislocalization of the KDEL receptor. However, only when Arf1 was 
knocked down in combination with Arf3-5 did they observe changed Golgi morphology or localization 
of coatomer (Volpicelli-Daley et al., 2005). 
A specialized role for Arf4 and Arf5 is supported by the findings that both proteins respond 
differently to class I Arfs during BFA treatment. Their membrane association, especially with the 
ERGIC, seems to much less affected by the drug (Chun et al., 2008; Duijsings et al., 2009). Moreover, 
Arf4 has been shown to play a role in trafficking of Rhodopsin C at the late Golgi/TGN (Deretic et al., 
2005), whereas Arf5 has been implicated in endocytosis of α5β1 intergin (Moravec et al., 2012) and 
the disease gerodermia osteodysplastica that a cause by mutations of golgin GORAB that interacts 
specifically with Rab6 and Arf5 (Egerer et al., 2015). 
Several aspects of how differential roles of Arf isoforms could be challenged experimentally are 
already described in the previous section (3.3). Interaction studies between different isoforms of Arf 
and coatomer as well as uptake of temperature-blocked cargo into COPI vesicles with different Arf 
isoforms could be tested. A focus of further investigations of Arf isoforms, however, should be placed 
on their role in post-Golgi trafficking. Multiple studies, cited in this paragraph, forward a role of 
Arf3-5 in specialized cargo sorting in the TGN/endosomal system. In this respect, the knocksideways 
approach, which has successfully been used to investigate the role of CCV adaptor proteins (Hirst et 
al., 2012), would provide a very useful tool, as it could be used in various cell types of interest. 
 
3.5 Syndromic Osteogenesis Imperfecta Caused by Compromised 
ER-Golgi SNARE Sorting? 
 
As part of this study, a most recently discovered link between a syndromic form of OI and mutations 
within the COPII coat subunit Sec24D was investigated (Garbes et al., 2015). To this end, point 
mutations found in the patients were introduced to recombinant proteins in order to study their 
effect on a molecular level. We found that one of the mutations (S1016F) had a strong negative 
effect on the ability of Sec24D to sort the ER-Golgi Q-SNAREs Stx5, GS27, and Bet1 into COPII vesicles 
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(Fig. 2.19). The ability of the protein to bind and incorporate ERGIC53 was comparable to the wild 
type and all other mutants tested, which emphasizes that various independent binding sites are 
displayed by the COPII coat for active sorting. The second patient-derived mutant COPII variant, 
Sec23A/Sec24DQ979P showed only minor, ~5-15 %, reduced levels of SNARE-uptake. Since ERGIC53 
incorporation was also slightly reduced by ~7 % with this mutant (Fig. 2.19B), it can be concluded 
that the second mutation has no specific effect on SNARE-sorting. The fact that the 
Sec23A/Sec24DQ979P did not display a significant impairment of protein uptake is in line with the 
localization of the regarding glutamate residue in a region distant from the membrane (Fig. 2.17B 
and C). It is not in immediate proximity to any known binding site for ER export signals. Likewise, the 
effect observed for the S1016F-mutation is compatible with its localization within the structure, close 
to the Stx5 binding pocket (Fig. 2.17B and C). 
In a previous study we could provide strong evidence that the ER-Golgi Q-SNAREs are sorted into 
COPII vesicles as a pre-assembled complex via an interaction of Sec24C/D with Syntaxin5 (Adolf et al., 
2016). In order to analyze if the ~50 % reduced SNARE-uptake by Sec23A/Sec24DS1016F was a result of 
a flawed direct interaction between Syntaxin5 and Sec24D, pulldown experiments were performed. 
As has been previously observed for Sec24C (Adolf et al., 2016), the shortened Syntaxin5 construct 
Syntaxin5205-328-GST displays a very strong interaction also with Sec24D (Fig. 2.20). This interaction 
was completely abrogated in experiments performed with the binding site mutant 
Sec23A/Sec24DLIL834AAA (Mancias and Goldberg, 2008) or the OI-patient mutant Sec23A/Sec24DS1016F, 
coherent with the observations made during the vesicle reconstitution experiments. Here, the 
second point mutant, Sec23A/Sec24DQ979P showed a minor defect in Sec23A/Sec24D binding (~20 % 
less than wild type). 
Having amounted functional data that showed a major SNARE-sorting defect of one OI-related point 
mutation, Sec23A/Sec24DS1016F, and no (or potentially a very mild) effect on protein uptake by the 
second mutation Sec23A/Sec24DQ979P, we decided to study Sec24D-deficiency in a cellular context. To 
this end, OI-patient derived fibroblasts “Lukas” (genotype Sec24DQ208*/Sec24DS1015F) were analyzed in 
comparison to a fibroblast control cell line (CRL-2091). Both cells in a first step were studied with 
respect to the protein level of multiple ER/Golgi proteins (Fig. 2.21). As a general loading control 
Histone H3 was detected, which showed only a slightly reduced protein level (91 % of control). Also 
other proteins such as the ER chaperone Calnexin (99 % of control) or the intra-Golgi SNARE Ykt6 
(107 % of control) displayed protein levels in patient fibroblasts highly comparable to control cells. 
Other proteins, such as p24 and GS27 displayed a reduction of ~25 % in “Lukas” fibroblasts. The 
strongest reduction was observed for the SNAREs Stx5, Bet1, Sec22b, and GS28 (>40-50%). This 
observation indicates that an impairment of proper trafficking/ER export of proteins can cause their 
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degradation. Stx5, which binds directly to Sec24D (Fig. 2.20) shows the strongest reduction of protein 
level in patient cells, together with Bet1, the transport of which is also directly coupled to Stx5 (Adolf 
et al., 2016). Surprisingly, GS27, which is also part of the ER-Golgi Q-SNARE complex showed only a 
slightly reduced protein level (Fig. 2.21). Moreover, Sec22b, the R-SNARE that is not sorted by 
Sec24C/D but by Sec24A/B, displayed a substantially lower protein level, as does the Q-SNARE GS28. 
Interestingly, p24 displayed a ~25% reduced protein level in patient cells, similar to GS27. Assuming 
that the reduced protein level of the SNARE-complex partners Stx5, Bet1, GS27, and Sec22b is a 
result of their miss-sorting, a similar observation for p24 would be perfectly in line with unpublished 
observation from our lab that shows a Sec24C/D specific sorting of this protein (Adolf et al., 
unpublished data). Moreover, RNAi experiments from the Hauri lab pointed towards incorporation 
into COPII vesicles of p24 by Sec24C/D (Bonnon et al., 2010). The down-regulation of the SNARE 
GS28 makes sense in the light of its involvement in two SNARE complexes with different combination 
of Stx5, Bet1, Ykt6, and GS15 (Shorter et al., 2002; Xu et al., 2002; Zhang and Hong, 2001). 
Conversely, the fact that Ykt6 protein levels are not affected by the Sec24D mutations points towards 
the de-coupling of the fate of this particular SNARE from other interacting SNAREs. Ykt6 has been 
implicated in ER-Golgi, endosome-TGN, and intra-Golgi transport (Fukasawa et al., 2004; Tai et al., 
2004; Xu et al., 2002; Zhang and Hong, 2001). Apart from its engagement in multiple, different 
trafficking events, Ykt6 is special in that it has no transmembrane domain but is lipidated to enable 
membrane association (Fukasawa et al., 2004). A large proportion of the protein seems to be in a 
cytosolic, potentially inactive state (Hasegawa et al., 2004; Zhang and Hong, 2001). All these 
peculiarities might contribute to its protein levels not responding to perturbation of Sec24D. 
Having observed that the protein levels of multiple proteins, especially the ER-Golgi SNAREs, were 
significantly lower in Sec24D-deficient patient cells compared to control fibroblasts, we decided to 
probe their intra-cellular localization. One possible effect of the reduced SNARE binding and sorting 
observed in vitro (Figs. 2.19 and 2.20) could be a miss-localization of these proteins. However, in 
both, control and patient fibroblasts, Syntaxin5 showed a peri-nuclear stain (Figs. 2.21 and 2.22). This 
is in line with previous IFA observations that localized Stx5 predominantly at the Golgi (Bennett et al., 
1993; Subramaniam et al., 1997). No shift towards the ER, here stained with Calnexin (Fig. 2.22) 
could be observed, as there was no overlap between both signals. Furthermore, both fibroblast lines 
displayed a highly similar level of co-localization between Stx5 and p24 with possibly a slightly higher 
degree of co-localization in patient cells (Fig. 2.21). Moreover, the Stx5-positive punctate structures 
observed in both cell types appeared in general more distinct in OI fibroblasts compared to its 
control (Figs. 2.22 and 2.23). Taken together, the IFA observations lead to the conclusion that Sec24D 
deficiency does not cause a major redistribution of Stx5, Calnexin, and p24. The residual 
incorporation into COPII vesicles, observed for the Sec23/Sec24DS1016F mutant (Fig. 2.19), in addition 
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to the activity of Sec24C, which possesses the same sorting specificity for p24 (Adolf et al., 
unpublished data) and the ER-Golgi Q-SNAREs (Adolf et al., 2016; Mancias and Goldberg, 2008), are 
sufficient to facilitate their proper localization. Potentially, the localization of Stx5 is slightly changed 
in relation to p24, as has been for some cells. However, most of the times patient and control cells 
were non-distinguishable during IF assays using antibodies against Stx5/p24. The second general 
observation, namely weaker, less distinct Stx5 punctae, was made more frequently. Assuming that 
these structures are either vesicles or sites of vesicle biogenesis (i.e. ERES), a lesser staining with Stx5 
is in agreement with the hampered incorporation of this protein into COPII vesicles by the 
Sec23/Sec24DS1016F mutant (Fig. 2.19) and the reduced Sec24D protein level in these cells due to the 
premature stop-codon in the second allele (Garbes et al., 2015). 
In summary, the experiments show that one of the two point mutations found in Sec24D involved in 
the development of a syndromic form of OI shows a SNARE sorting and binding defect (Figs. 2.20 and 
2.21) that is equivalent to a synthetic mutant designed for this very purpose (Mancias and Goldberg, 
2008). The intracellular localization of the Sec24D-interacting SNARE Stx5, however, remained largely 
unaltered (Figs. 2.22 and 2. 23). This leads to the question of a role for Sec24D in the development of 
this syndrome, a hallmark of which is the imperfect built of extracellular collagen networks. 
Mutations within the COPII coat subunit Sec23A were previously linked to Cranio-lenticulo-sutural 
dysplasia (CLSD), which is also marked by a hampered collagen secretion (Boyadjiev et al., 2006; 
Fromme et al., 2007). Noteworthy, disruption of the Sec24D gene in the model organisms medaka 
(Ohisa et al., 2010) and zebrafish (Sarmah et al., 2010) results in highly similar symptoms, namely an 
imperfect skeletal morphogenesis especially of the craniofacial region due to a hampered secretion 
of extracellular matrix proteins. Knockdown of Sec24C, which in terms of SNARE-sorting shows the 
same preferences as Sec24D (Mancias and Goldberg, 2008) did not result in the phenotype of Sec24D 
disruption (Sarmah et al., 2010). Hence, it can be concluded that the isoforms Sec24D plays a crucial 
role in ossification and assembly of the extracellular matrix (ECM), potentially in concert with Sec23A 
(Boyadjiev et al., 2006; Lang et al., 2006). 
The export of large cargoes, especially of (pro)collagen (PC) pivotal for ossification and ECM 
assembly, is highly regulated and involves additional factors such as TANGO1 and cTAGE5 at the ER 
(Malhotra and Erlmann, 2011, 2015). These factors bind to the inner COPII coat via Sec23. Binding to 
Sec24C has also been reported, but remains controversial (Ma and Goldberg, 2016; Saito et al., 2009; 
Saito et al., 2011). In addition, special requirements for vesicle fusion machinery have been pointed 
out. For secretion of collagen I and collagen VII, the protein Sly1 and the SNAREs Stx18 (collagen VII) 
and Stx5 (collagen I and VII) have been shown to be crucial (Nogueira et al., 2014). Noteworthy, Stx5 
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has early been known as one of the SNARE proteins absolutely required for secretion (Gordon et al., 
2010). 
In conclusion different scenarios why Sec24D deficiency leads to OI are possible. Two of these 
scenarios as well as arguments for and against them are listed below together with a few 
experiments that would challenge them: 
 
i) Sec24D is crucial for the formation of large COPII super-carriers. 
Pro:  -Sec24D loss in model organisms and syndromic OI patients leads to skeletal 
morphogenesis defects (Garbes et al., 2015; Ohisa et al., 2010; Sarmah et al., 2010) 
  -Sec24C knockdown does not resemble Sec24D loss in zebrafish (Sarmah et al., 2010) 
-TANGO1/cTAGE5 were shown to interact with both subunits of the inner COPII coat, 
Sec23 and Sec24 in yeast two-hybrid (Saito et al., 2009) 
-Sec24D has been shown to be able and pack procollagen I into COPII vesicles (Gorur 
et al., 2017) 
Contra:  - Positive yeast two-hybrid interaction studies were performed with Sec24C and not 
Sec24D (Saito et al., 2009) 
 -TANGO1/cTAGE5 did not interact with Sec24C in pulldown experiments (Ma and 
Goldberg, 2016) 
 -packing of procollagen I into COPII vesicles was cytosol-dependent in an in vitro 
system (Gorur et al., 2017) 
  
Experiments to address this hypothesis include: 
 -Interaction studies between all Sec24 isoforms, especially Sec24D, and 
TANGO1/cTAGE5 via pulldowns/yeast two-hybrid 
 -Systematic in vitro reconstitution studies to assess packing of procollagens using 
defined recombinant proteins 
 -Overexpression of Sec24C in Sec24D deficient cells/fish to test whether the defect 
can be rescued 
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ii) ER-Golgi SNARE levels are critical for collagen export and partly controlled by Sec24D 
Pro:   -Stx5 has been shown to be critical for PC I and VII export (Nogueira et al., 2014) 
  -ER-Golgi SNAREs expression levels are reduced in OI patient cells (this study) 
  -Stx5 is important for constitutive secretion (Gordon et al., 2010) 
  
Contra: -Sec24C and Sec24D were shown to be functionally redundant in terms of SNARE 
sorting (Mancias and Goldberg, 2008) 
-No abnormal localization of ER/Golgi proteins in patient cells despite a lower SNARE 
protein level (this study) 
-Stx5 and Bet1 expression levels were up-regulated in cells put under ER stress (Suga 
et al., 2015) 
Experiments to address this hypothesis include: 
  -To investigate the expression level of ER-Golgi SNAREs (i.e. Stx5, Bet1) in different 
Sec24 isoform knockdown/knockout cells 
 -To introduce the Stx5-binding mutation into Sec24C via genome editing and evaluate 
PC export from the ER 
 -Overexpression of Stx5/Bet1 in Sec24D-deficient cells 
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4 Materials and Methods 
 
4.1 Chemicals, Commercial Kits, Supplies, and Instruments 
 
Chemicals, kits for molecular biology and cell culture, disposable plastic ware, proteins (antibodies), 
DNA, and instrumentation was purchased from one of the companies listed below. 
Abcam      Cambridge, UK 
Acris (part of OriGene)    Herford, Germany 
Affymetrix (part of TFS)    Santa Clara, USA 
Anthos Mikrosysteme    Friesoythe, Germany 
Assistent     Sondheim, Germany 
Axon Labortechnik    Kaiserslautern, Germany 
Beckman Coulter    Pasadena, USA 
BD Biosciences     Franklin Lakes, USA 
Biomers     Ulm, Germany 
Bio-Rad     München, Germany 
Boehringer     Mannheim, Germany 
Carl Zeiss     Oberkochen, Germany 
Dr. Maisch HPLC    Ammerbuch-Entringen, Germany 
Eppendorf     Hamburg, Germany 
Fluka      Taufkirchen, Germany 
GERBU Biotechnik    Heidelberg, Germany 
GE-Healthcare     Freiburg, Germany 
Greiner Bio-One    Frickenhausen, Germany 
Heraeus     Hanau, Germany 
IBA Lifesciences    Göttingen, Germany 
Intavis Bioanalytical Instruments AG  Köln, Germany 
Invitrogen (part of TFS)    Carlsbad, USA 
Jenway      Staffordshire, UK 
LI-CORE     Lincoln, USA 
Life Technologies (part of TFS)   Carlsbad, USA 
Macherey-Nagel    Düren, Germany 
Merck      Darmstadt, Germany 
Materials and Methods 
106 
 
Merck-Millipore/Novagen (part of Merck) Darmstadt, Germany 
Microfluidics Corp.    Westwood, USA 
New England Biolabs (NEB)   Frankfurt, Germany 
Parr Instruments    Moline, USA 
PerkinElmer     Waltham, USA 
PeqLab      Erlangen, Germany 
Roboklon     Berlin, Germany 
Roche      Mannheim, Germany 
Roth      Karlsruhe, Germany 
Santa Cruz Biotechnology   Heidelberg, Germany 
Sarstedt     Nümbrecht, Germany 
Sartorius     Göttingen, Germany 
Serva      Heidelberg, Germany 
Sigma-Aldrich (part of Merck)   Taufkirchen, Germany 
Silantes      München, Germany 
Sorvall (part of TFS)    Waltham, USA 
Source BioScience    Nottingham, UK 
Thermo Fisher Scientific (TFS)   Waltham, USA 
Qiagen      Hilden, Germany 
 
4.2 Molecular Biology Materials 
 
4.2.1 Enzymes for Cloning 
 
PCRs were performed with Pfu Plus! DNA polymerase (Roboklon). Restriction of plasmids and 
PCR-generated inserts was carried out using NEB restriction enzymes. Plasmids were usually 
dephosphorylated using calf intestine alkaline phosphatase (Roche) before ligation with an insert 
achieved by incubation with T4 DNA ligase (Thermo Fisher Scientific). Colony PCRs were performed 
with Taq polymerase (Axon). 
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4.2.2 DNA Ladder 
 
As size standard during agarose gel electrophoresis either 1kb DNA Ladder or 2-Log DNA ladder from 
NEB were used.  
 
4.2.3 Bacterial Selection Reagents 
 
The following reagents were used for selection of bacterial clones after transformation. They were 
prepared as stock-solutions (1000×) and diluted in the growth medium down to the final 
concentration. 
Substance Storage Temp. Solvent  Concentration (final) 
Ampicillin  -20°C H2O 100 µg/ml 
Bluo-Gal -20°C DMF 20 µg/ml 
Chloramphenicol +4°C Ethanol 25 µg/ml 
Gentamicin +4°C H2O 7 µg/ml 
Kanamycin -20°C H2O 50 µg/ml 
Tetracyclin -20°C Ethanol 10 µg/ml 
 
4.2.4 Bacterial Media 
 
Bacteria were usually grown in Luria broth (LB) or on LB agar dishes. After transformation they were 
grown in super optimal broth with catabolite repression medium (SOC). All media were autoclaved 
before use. 
Medium Ingredient Concentration  
LB 
Trypton 
Yeast extract 
Sodium chloride 
10 g/l 
5 g/l 
10 g/l 
LB agar 
Trypton 
Yeast extract 
Sodium chloride 
Agar 
10 g/l 
5 g/l 
10 g/l 
15 g/l 
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SOC 
Trypton 
Yeast extract 
Sodium chloride 
Potassium chloride 
Magnesium chloride 
10 g/l 
5 g/l 
10 g/l 
0.59 g/l 
0.19 g/l 
 
4.2.5 Bacterial Strains 
 
Strain Application Source 
E.coli DH5α  Cloning Invitrogen  
E.coli BL21 (DE3) Protein expression Invitrogen  
E.coli BL21-CodonPlus-RIL (DE3) Protein expression Invitrogen  
E.coli DH10MultiBacCre Cloning/Recombination Imre Berger (EMBL, Grenoble) 
 
4.2.6 Oligonucleotides 
 
Oligonucleotides were purchased from Biomers. They were used as primers in PCR reactions for 
molecular cloning of the indicated inserts and for sequencing. 
Primer name Sequence (5`-3`) Insert 
hArf3 For NcoI AAAAAACCATGGGCAATATCTTTGG hArf3 
hArf3 Rev HindIII TTTTTTAAGCTTTTACTTCTTGTTTTTGAGC hArf3 
hArf4 For NcoI AAAAAACCATGGGCCTCACTATC hArf4 
hArf4 Rev HindIII TTTTTTAAGCTTTTAACGTTTTGAAAGC hArf4 
hArf5 For NcoI_new AAAAAACCATGGGCCTCACCG hArf5 
hArf5 Rev HindIII TTTTTTAAGCTTTTAGCGCTTTGACAGC hArf5 
Sec24D mut2936A-C-fw GGGTATTATCCCACAAAAGAGGCC Sec24D-Q979P 
Sec24D mut2936A-C-rev GGCCTCTTTTGTGGGATAATACCC Sec24D-Q979P 
Sec24D mut3047C-T-fw CGGAGGCTCTTTTTATGTGGATTTCC Sec24D-S1016F 
Sec24D mut3047C-T-rev GGAAATCCACATAAAAAGAGCCTCCG Sec24D-S1016F 
Sec24D fwd NotI AAAAAGCGGCCGCATGAGTCAACAAGGTTACGTG Q979P/S1016F 
seq-pFBDM MCSII rev GCATTCATTTTATGTTTCAGG Q979P/S1016F 
M13-FP TGTAAAACGACGGCCAGT for sequencing 
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M13-RP CAGGAAACAGCTATGACC for sequencing 
pBakPAC-FP TAAAATGATAACCATCTCGC for sequencing 
pEGFP-RP AACAGCTCCTCGCCCTTG for sequencing 
pMON Sequencing 2 AGGAGAGCGCACGAG for sequencing 
recA promoter TGAGCATACAGTATAATTGC for sequencing 
S-Pr. Sec24D rev ACCTTGGGTGCTGGATAT for sequencing 
S-Pr. Sec24D rev-2 GGATCTTATGAATATGTTGCC for sequencing 
S-Pr. Sec24D rev-3 GGCCTCGCTGGGGCTGG for sequencing 
T7 TAATACGACTCACTATAGGG for sequencing 
 
4.2.7 Plasmids 
 
Plasmid name Insert(s) Application Creator 
pHV738 hNMT1; hMetAP1 Expression Simone Röhling 
pMON5840-hArf1 hArf1 Expression Simone Röhling 
pET21d-hArf3 hArf3 Cloning Vincent Popoff 
pET21d-hArf4 hArf4 Cloning Vincent Popoff 
pET21d-hArf5 hArf5 Cloning Vincent Popoff 
pET21d-hArf5 hArf6 Cloning Vincent Popoff 
pMON5840-hArf3 hArf3 Expression This study 
pMON5840-hArf4 hArf4 Expression This study 
pMON5840-hArf5 hArf5 Expression This study 
pMON5840-hArf6 hArf6 Expression This study 
pFBDM-HT-hSec23A hSec23A Expression Frank Adolf 
pFBDM-HT-hSec23A/24D-LIL834AAA hSec23A/HT-hSec24D-
LIL834AAA 
Expression Frank Adolf 
pFBDM-HT-hSec23A/24D-Q979P hSec23A/HT-hSec24D-Q979P Expression This study 
pFBDM-HT-hSec23A/24D-S1016F hSec23A/HT-hSec24D-
S1016F 
Expression This study 
pFBDM-HT-hSec13/31A hSec13/HT-hSec31A Expression Frank Adolf 
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4.3 Materials for Protein Biochemistry and Cell Biology 
 
4.3.1 Antibodies 
 
Primary antibodies 
Epitope Clone/Specification Host  Dilution WB Dilution IFA Source 
Bet1 sc-136390 (17) Mouse 1:200 - Santa Cruz 
Calnexin ab75801 Mouse 1:1000 1:400 Abcam 
ERGIC-1 16108-1-AP Rabbit 1:500  - Acris  
ERGIC-53 sc-365158 (C6) Mouse 1:200  - Santa Cruz 
γR-COP (Pavel et al., 1998) Rabbit 1:5000 - F. Wieland lab 
GM130 610822 Rabbit 1:250 - BD Biosciences 
GS27  sc-135932 (25) Mouse 1:200 - Santa Cruz 
GS28 sc-15270 (N-16) Goat 1:100 - Santa Cruz 
Histone H3 ab1791 Rabbit 1:1000 - Abcam 
p24 (Gommel et al., 1999) Rabbit 1:5000   1:400  F. Wieland lab 
Sec22b sc-101276 (29-F7) Mouse 1:200 - Santa Cruz  
Sec23 sc-12107 (E-19) Goat 1:200 - Santa Cruz  
Syntaxin5 sc-365124 (B8) Mouse - 1:100  Santa Cruz 
Ykt6 sc-30097 (NL-198) Rabbit 1:100 - Santa Cruz 
Primary antibodies were stored at -20°C diluted in PBST with 1 % (w/v) BSA. 
Secondary antibodies 
Epitope Fluorophor Host Dilution WB Dilution IFA Source 
Goat IgG Alexa-680 Donkey 1:10000 - Invitrogen  
Mouse IgG Alexa-546 Goat  1:1000 Invitrogen 
Mouse IgG Alexa-680 Goat 1:10000 - Invitrogen 
Rabbit IgG Alexa-488 Goat  1:1000 Invitrogen  
Rabbit IgG Alexa-680 Goat 1:10000 - Invitrogen  
Secondary antibodies used for Western blot (WB) were diluted in PBST with 1 % (w/v) BSA and stored 
at 4°C. Antibodies for immunofluorescence assay (IFA) were diluted in PBS with 1 or 5 % (w/v) BSA. 
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4.3.2 Cell Culture Media 
 
Medium Supplementation Concentration (final) 
αMEM (Minimum Essential Medium Eagle) Fetal calf serum (FCS) 
Penicillin 
Streptomycin 
L-glutamine 
10 % (v/v) 
100 mg/ml 
100 mg/ml 
2 mM 
DMEM (Dulbecco’s Modified Eagle’s Medium) Fetal calf serum (FCS) 
Penicillin 
Streptomycin 
L-glutamine 
(L-proline) 
10 % (v/v) 
100 mg/ml 
100 mg/ml 
2 mM 
(100 mg/l) 
Sf9 (GIBCO SF-900 II SFM) - - 
DMEM and αMEM were usually purchased from Sigma-Aldrich. For SILAC experiments, DMEM with 
isotope-labeled arginine (Arg-10) and lysine (Lys-8) from Silantes was used. Here, the medium was 
additionally supplemented with L-proline in order to prevent conversion of arginine to proline 
(Bendall et al., 2008). 
 
4.3.3 Cell Lines 
 
Cell Line Species Application Source 
HeLa Homo sapiens COPI/COPII reconstitution, 
WB, SILAC proteomics, 
cytosol preparation 
ACC57 (DMSZ) 
HepG2 Homo sapiens COPI reconstitution, WB, 
SILAC proteomics 
- 
Immortalized 
macrophages (iMΦ) 
Mus musculus COPI reconstitution, WB, 
SILAC proteomics 
Eicke Latz (Uniklinik, Bonn) 
Control fibroblasts  Homo sapiens WB, IFA Jinoh Kim (UC, Davis); 
CRL-2091 (ATCC) 
Patient fibroblasts 
“Lukas” 
Homo sapiens WB, IFA Jinoh Kim (UC, Davis); 
(Garbes et al., 2015) 
Sf9 Spodoptera 
frugiperda 
Protein expression Invitrogen  
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4.3.4 Nucleotides 
 
Nucleotide Stock conc. [mM] Source 
Adenosine-5`-triphosphate (ATP) 40 Roche 
Guanosine-5`-triphosphate (GTP) 25 Affymetrix 
Guanosine-5`-O-[γ-thio]-triphosphate (GTPγS) 25 Sigma-Aldrich 
Guanosine-5`-O-[β, γ-imido]-triphosphate (GMP-PNP) 25 Sigma-Aldrich 
Nucleotides were prepared as stock solutions in 25 mM HEPES pH 7.2 (KOH), 150 mM KOAc, 5 mM 
MgOAc and stored at -20°C. 
 
4.3.5 ATP Regenerating System (ATPr) 
 
During COPI/COPII budding reactions, an ATP regenerating system was added, as it has been shown 
to support vesicle biogenesis through an unknown mechanism (Aridor et al., 1995; Aridor et al., 
1998). 
Component Stock conc. [mM] Source 
Adenosine-5`-triphosphate (ATP) 40 mM Roche 
Creatine phosphate (CP) 200 mM Sigma-Aldrich 
Creatine kinase (CK) 8 mg/ml Roche 
Components of the ATPr system were prepared as separate stocks in 25 mM HEPES pH 7.2 (KOH), 
150 mM KOAc, 5 mM MgOAc. ATP and CP were stored at -20°C. Creatine kinase was stored at -80°C. 
 
4.3.6 Protein Molecular Weight Standard 
 
During SDS-PAGE, Precision Plus Protein™ Prestained Standard from Bio-Rad was used for 
determination of the apparent molecular masses of proteins. It ranges from 10 to 250 kDa. 
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4.3.7 Affinity Chromatography 
 
Proteins tagged with polyhistidine were (partially) purified through affinity chromatography with 
Ni-Sepharose High Performance from GE Healthcare. Coatomer which was tagged with a 
One-STreP-Tag (OST) that consists of two times Strep-Tag® II was purified with Strep®-Tactin 
Sepharose® (IBA Lifesciences). For pulldown experiments, GST-tagged proteins were coupled to 
Glutathione Sepharose 4B (GE Healthcare). 
 
4.3.8 Fast Protein Liquid Chromatography (FPLC) – Gel Filtration 
 
Proteins expressed without an affinity tag or with a polyhistidin tag were purified by gel filtration 
(size exclusion chromatography). To this end, an Ettan LC FPLC system was used in combination with 
a Superose6 or a Superdex75 column (both GE Healthcare). For buffer exchange, disposable PD-10 
desalting columns were used (GE Healthcare). 
 
4.4 Methods in Molecular Biology 
 
4.4.1 Polymerase Chain Reaction (PCR) 
 
PCRs for the production of inserts were performed with Pfu Plus! DNA polymerase (Roboklon), 
primers (Biomers) at a concentration of 10-100 µM, 200 µM dNTPs, and 10-50 ng template DNA. 
They were run in a PCR Spring cycler (Thermo Fisher Scientific). The melting temperature was usually 
set to 95°C and elongation was performed at 72°C. The elongation times were calculated by 
assuming that 1 kb of DNA is replicated per minute. The annealing temperatures were determined 
for each reaction individually. 
 
4.4.2 Overlap Extension PCR 
 
Overlap extension PCRs were performed in order to introduce point mutations into a gene. In a first 
round, two PCRs were performed to generate fragments of the insert which overlap at the site where 
Materials and Methods 
114 
 
the mutation is to be introduced. These two overlapping fragments are used as templates in a 
second round of PCR to generate the final insert which covers the whole length of the desired gene 
and carries the mutation. 
 
4.4.3 Colony PCR 
 
In order to screen for positive clones after a transformation, colony PCRs were performed. To this 
end, Taq polymerase (Axon) was used instead of a high precision polymerase. Moreover, a bacterial 
colony served as template for the PCR reaction instead of purified DNA. 
 
4.4.4 Agarose Gel Electrophoresis 
 
Agarose gels were prepared with 1-2 % (w/v) agarose dissolved in TAE buffer (40 mM Tris-HCl pH 8.0, 
20 mM acetic acid, 1 mM EDTA), supplemented with 10 µl/l DNA Stain Clear G (Serva). DNA samples 
were mixed with 5× GelPilot DNA Loading Dye (Qiagen) prior to electrophoresis. Agarose gels were 
inspected with a Bio-Rad GelDoc system. 
 
4.4.5 Gel Extraction and PCR Purification 
 
Desired PCR fragments and plasmids were routinely purified by gel extraction using a QIAquick Gel 
Extraction Kit or with a QIAquick PCR Purification Kit (both Qiagen). Kits were used according to the 
manufacturer’s manuals. 
 
4.4.6 Ethanol Precipitation 
 
In order to increase their purity or concentration, DNA samples were subjected to ethanol 
precipitation. To this end, they were mixed with cold 100 % ethanol (2 volumes) and 3 M sodium 
acetate (0.1 volume) and incubated at -20°C for 30 min. Precipitated DNA was harvested 
(14.000 rpm, 15 min, 4°C) and washed once with 1 ml of 70 % (v/v) ethanol (14.000 rpm, 15 min, 
4°C). After discarding the ethanol, DNA was dried and resuspended in the desired volume ddH2O. 
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4.4.7 Restriction 
 
For subsequent ligation, 5-10 µg of plasmid DNA and 1-5 µg of insert DNA were digested with 
restriction enzymes purchased from NEB in a recommended buffer for 1-3 h. Fragments were 
purified by either ethanol precipitation, gel extraction, or using a PCR purification kit (Qiagen). Prior 
to DNA sequencing, samples were usually subjected to a preparative restriction using 500-1000 µg of 
plasmid. 
 
4.4.8 Ligation 
 
Prior to ligation, restricted plasmids were treated with calf intestine alkaline phosphatase (CIP) to 
remove 5` phosphates and prevent re-ligation of partially digested plasmids. After CIP treatment, 
50-200 ng of plasmid DNA was mixed with up to 10-fold molar excess of insert in ligation buffer 
together with T4 ligase (Thermo Fisher Scientific). The reaction was incubated for 1-2 h at room 
temperature or over night at 16°C before transformation. 
 
4.4.9 Plasmid and Bacmid Preparation 
 
Plasmids were purified using either the NucleoSpin Plasmid Kit (Machery-Nagel) or the QIAprep Spin 
Miniprep Kit (Qiagen) following the manufacturer’s manual. Bacmids were isolated following the 
instructions of the Bac-to-Bac manual from Invitrogen using the solutions S1-S3 from the NucleoSpin 
Plasmid Kit (Machery-Nagel). 
 
4.4.10 Transformation of E.coli 
 
Chemically competent E.coli strains DH5α, BL21 (DE3), and BL21-CodonPlus-RIL (DE3) (all Invitrogen) 
were transformed via heat shock. The competent cells were carefully mixed with purified plasmid 
DNA (5-10 ng) or whole ligation reactions, incubated on ice for 30 minutes and subjected to a brief 
heat shock at 42°C for 45 seconds. The cells were allowed to recover on ice for 2 minutes before 
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adding 1 ml of SOC medium and incubation at 37°C for 1 h, shaking. Finally, the cells were streaked 
onto LB agar plates containing the required selection reagents. 
DH10MultiBacCre cells (Imre Berger, EMBL Grenoble) were transformed through electroporation. 
They were carefully mixed with 10 ng plasmid DNA and incubated on ice for 10-20 minutes. The 
electroporation was performed in 2mm cuvettes using a GenePulser Xcell™ (Bio-Rad) at 2.5 kV, 200 Ω 
electrical resistance, and an electrical capacity of 25 μF. Cells were recovered in 1 ml SOC medium 
shaking at 37°C for 3 h. Recovered cells were streaked into LB agar plates supplemented with the 
required selection reagents. 
 
4.4.11 Bacterial Expression of ADP-ribosylation Factors 
 
Small GTPases of the Arf family were expressed in E.coli. To this end, pMON5480 plasmids encoding 
one of the five human Arf family members were co-transformed with the pHV738 plasmid, which 
encodes human glycylpeptide N-tetradecanoyltransferase 1 (hNMT1) and methionine 
aminopeptidase (hMetAP1), in BL21 (DE3) or BL21-CodonPlus-RIL (DE3) cells (both Invitrogen). Cells 
containing both plasmids were used to inoculate 100-300 ml of pre-culture which was grown at 27°C 
or 37°C over night shaking at 180 rpm. Of the pre-culture, 100 ml were used to inoculate a final 
2 liter expression culture. The final expression culture was usually incubated at 27°C, for Arf4 and 
Arf5 occasionally at 37°C, shaking with 180 rpm. The optical density measured at 600nm (OD600) 
during the expression was monitored using a Jenway 6300 Spectrophotometer (Jenway). Shortly 
after inoculation of the final expression culture, the BSA/myristate solution was prepared. To this 
end, 42 mg of sodium myristate (Sigma-Aldrich), dissolved in 3 ml PBS by heating in a microwave was 
mixed with 20 ml of PBS containing 4.5 % (w/v) fatty acid free BSA (Sigma-Aldrich), pre-heated to 
50°C. Once an OD600 of approximately 0.6 was reached, the BSA/myristate solution was added. Ten 
minutes after the addition, IPTG (Gerbu) to a final concentration of 1 mM was added to the culture 
to induce the expression of hNMT1 and hMetAP1. After 1 h, the expression of the respective Arf 
protein was induced upon addition of nalidixic acid (dissolved in 300 mM NaOH) to a final 
concentration of 30 µg/ml. The expression culture was further incubated for 3-4 h before harvest of 
the cells by centrifugation (4000 ×g, 20 min, 4°C). The harvested cells were usually snap-frozen in 
liquid nitrogen and stored for later usage at -80°C. 
 
Materials and Methods 
117 
 
4.4.12 Preparation of Bacterial Glycerol Stocks 
 
Glycerol stocks of transformed bacterial strains were usually used to inoculate over night 
pre-cultures for protein expression. They were prepared by taking a small aliquot of overnight 
culture and mixing it with glycerol to a final concentration of 20 % (v/v). The stocks were immediately 
stored at -80°C. 
 
4.5 Biochemical Methods 
 
4.5.1 SDS Polyacrylamide Gelelectrophoresis (SDS-PAGE) 
 
Standard, discontinuous SDS-PAGE for adjacent Western blotting or to monitor protein purification 
procedures was performed with a PROTEAN II system (Bio-Rad). For self-casting of gels, 4× stock 
solutions of the stacking gel buffer (0.5 M Tris-HCl pH 6.8) and the separating gel buffer (1.5 M 
Tris-HCl pH 8.8) were prepared and stored at 4°C. Gels were casted using Rotiphorese®Gel 30 
acrylamide (Roth). The stacking gels were prepared with a final acrylamide concentration of 4 %. For 
separating gels the concentration was chosen according to the proteins that were to be analyzed 
ranging from 10 % to 15 % final acrylamide concentration. Samples designated for later MS analysis 
were separated on pre-cast Novex™ 10% Tris-Glycine Gels using an XCell SureLock™ electrophoresis 
system (both Invitrogen). 
Samples for SDS-PAGE were denatured in 1× SDS sample buffer which was prepared as a 4× stock 
solution (200 mM Tris-HCl pH 6.8, 40 % (v/v) glycerol, 12 % (v/v) β-mercaptoethanol, 8 % (w/v) SDS, 
0.2 % (w/v) bromophenol blue) via heating to 95°C for 5-10 min. Self-casted gels were run in SDS 
running buffer (25 mM Tris, 192 mM glycine, 0.1 % (w/v) SDS) at a constant electric voltage of 200 V. 
Pre-casted gels were run in NuPAGE™ MES SDS running buffer (Invitrogen) at 140 V. 
 
4.5.2 Coomassie Staining 
 
Coomassie staining of SDS gels was performed to monitor the purification of proteins, to ensure 
equal conditions during pulldown experiments, and to stain proteins destined for MS analysis prior to 
excision from the gel. For purification monitoring and pulldown experiments, SDS gels were stained 
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with Coomassie Brilliant Blue R250 (Bio-Rad). To this end, the gels were briefly heated in staining 
solution (0.25 % (w/v) Coomassie Brilliant Blue R250, 40 % (v/v) ethanol, 10 % (v/v) acetic acid) in a 
microwave and then incubated for approx. 15 minutes. The de-staining was performed by repeatedly 
incubating the gel in de-staining solution (20 % (v/v) ethanol, 5 % (v/v) acetic acid) with occasional 
heating in a microwave. 
Pre-cast gels loaded with samples for MS analysis were stained with Roti-Blue colloidal Coomassie 
(Roth) prepared according to the manufacturer`s manual for a minimum of 2 h. Gels were de-stained 
in de-ionized water. 
 
4.5.3 Western Blot Analysis 
 
Semi-dry Western blotting was performed using a semi-dry Trans-Blot® SD Semi-Dry Transfer Cell 
from Bio-Rad. Proteins were transferred onto Immobilon®-FL PVDF membranes (Merck-Millipore) at 
a constant electric voltage of 20 V for 1.5 h after soaking all blot components with transfer buffer 
(48 mM Tris, 39 mM glycine, 1.3 mM SDS, 20 % (v/v) methanol). 
After blotting, membranes were blocked with 5 % (w/v) milk powder dissolved in PBST 
(35.7 mM Na2HPO4, 14.3 mM KH2PO4, 136 mM NaCl, 3 mM KCl, 0.05 % (v/v) Tween 20) for 30 
minutes at room temperature. Subsequently, the membranes were briefly washed with PBST 
(3× 5-10 min) and then incubated with first antibodies either for at least 2 h at room temperature or 
preferably over night in the cold room at 8°C. Membranes were thoroughly washed with PBST 
(3x 10 min) after incubation with the first antibodies, before detection with fluorophore-coupled 
secondary antibodies for 30-60 minutes at room temperature. After the final antibody incubation, 
membranes were again washed with PBST (3× 10 min), and ultimately 2-3x 10 minutes in PBS 
(35.7 mM Na2HPO4, 14.3 mM KH2PO4, 136 mM NaCl, 3 mM KCl) before scanning at the LI-COR 
Odyssey System (LI-COR) run with Image Studio software (Version 2.1.10).  
 
4.5.4 Protein Concentration Determination (Bradford Assay) 
 
Protein concentration was determined using Bio-Rad Protein Assay Dye Reagent (Bradford). After 
incubation with the dye, absorbance of the samples at 405 nm and 620 nm was measured using an 
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Anthos Reader 2001 (Anthos). In parallel to the samples which were prepared in triplicates standard 
samples prepared from BSA-solution of known concentration were measured. 
 
4.5.5 Purification of Untagged ADP-ribosylation Factors 
 
For a regular purification of myristoylated Arf proteins, bacterial pellets originating from four liters of 
expression culture were first resuspended in 30-50 ml of cold Arf lysis buffer (50 mM Tris-HCl pH 8.0, 
1 mM MgCl2, 1 mM DTT, 1 mM GDP, 1 tablet cOmplete™ EDTA-free Protease Inhibitor Cocktail from 
Roche). Cells were broken during 5-7 runs through a Microfluidizer® (Microfluidics) at an applied 
pressure of 15.000 psi. Cell debris was removed by ultracentrifugation using a Beckman Coulter 
Optima™ LE-80L/L-90K ultracentrifuge equipped with a TLA50.2/TFT55.38 rotor (100.000 ×g, 1 h, 
4°C). The supernatant was filled up to 200 ml using Arf lysis buffer without GDP. Afterwards, an 
ammonium sulfate precipitation (ASP) was performed. To this end, the lysate was stirred in an 
ice-cooled water bath and finely grounded ammonium sulfate was slowly added over a period of 
45 minutes until a final concentration of 35-40 % was reached. The supernatant was continued to stir 
for 45 more minutes before the precipitate was harvested in a Sorvall RC-6 centrifuge equipped with 
an SLC-1500 rotor (8.000 rpm, 30 min, 4°C). The precipitate was resuspended in Arf lysis buffer with 
GDP, subjected to ultracentrifugation within a Optima™ TLX ultracentrifuge equipped with TLA45/55 
rotor from Beckman Coulter (100.000 ×g, 15 min, 4°C) to remove aggregates and run over a 
Superdex75 (16/60) column using an Ettan LC FPLC system (both GE Healthcare) with storage buffer 
(25 mM HEPES pH 7.4 (KOH), 200 mM KCl, 5 mM MgCl2, 1 mM DTT, 1 mM, 10 % (w/v) glycerol) while 
collecting 0.5 ml fractions. Small samples of the fractions expected to contain the purified proteins 
were checked via SDS-PAGE with Coomassie staining. Those fractions with little contaminations and 
decent amounts of purified Arfs were pooled, concentrated using an Amicon® Ultra (10 kDa cut-off) 
concentrator device (Merck-Millipore), aliquoted, and snap-frozen in liquid nitrogen before long-
term storage at -80°C. 
 
4.5.6 Purification of OST-Coatomer 
 
A standard purification of OST-coatomer (One-STreP-Tag C-terminal of α-COP) was performed with 
two Sf9 cell pellets each originating from 500 ml of expression culture. Cells were resuspended in 
approx. 30 ml of cold OST buffer (25 mM HEPES pH 7.4 (KOH), 200 mM KCl, 1 mM DTT, 1 mM, 
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10 % (w/v) glycerol) supplemented with 1 tablet cOmplete™ EDTA-free Protease Inhibitor Cocktail 
(Roche) and cracked within 5 runs through a Microfluidizer® (Microfluidics) at 15.000 psi. Cell debris 
was removed via centrifugation with a Beckman Coulter Optima™ LE-80L/L-90K ultracentrifuge 
equipped with a TLA50.2/TFT55.38 rotor at 100.000 ×g for 1 h at 4°C. The cleared lysate was 
incubated rotating at 8°C with 2-3 ml of pure Strep®-Tactin Sepharose® beads (IBA) for 2-3 hours. 
After incubation with the lysate, beads were washed twice with 50 ml of OST buffer by centrifugation 
in a Megafuge 40R (Heraeus) (2.000 rpm, 5 min, 4°C), transferred to an empty Econo-Pac 
®chromatography column and washed once more with 50 ml of the buffer. The protein complex was 
eluted stepwise (1 ml steps) from the beads with 2.5 mM desthiobiotin (IBA) dissolved in OST buffer. 
The eluted fractions were analyzed for the presence of protein via the Bradford assay. Those 
fractions which contained significant amounts of protein were pooled and the proteins concentrated 
with a 100 kDa cut-off Amicon® Ultra (Merck-Millipore) if necessary. Desthiobiotin was removed 
from the eluted protein pool via gel filtration using OST buffer without desthiobiotin and a PD-10 
desalting column (GE Healthcare). Finally, the protein was aliquoted and stored at -80°C. 
 
4.5.7 Purification of HT-Sec23/Sec24 and HT-Sec13/Sec31 Complexes 
 
Purification of COPII coat components HT-Sec23/Sec24 and HT-Sec13/Sec31 was usually performed 
with two Sf9 cell pellets originating from 500 ml expression culture, each. The cells were thawed on 
ice and resuspended in approx. 30 ml cold lysis buffer (25 mM HEPES pH 7.2 (KOH), 500 mM KCl, 
5 mM MgCl2, 30 mM imidazole, 0.02 % (v/v) MTG, 1 tablet cOmplete™ EDTA-free Protease Inhibitor 
Cocktail from Roche). Cells were lysed within 5 runs through a Microfluidizer® (Microfluidics) at 
15.000 psi. The lysate was cleared by ultracentrifugation within a TLA50.2/TFT55.38 rotor using a 
Optima™ LE-80L/L-90K ultracentrifuge from Beckman Coulter (100.000 ×g, 1 h, 4°C) and immediately 
incubated rotating with 2-3 ml of pure Ni-Sepharose High Performance beads (GE Healthcare) for 
2-3 h in the cold room. Following incubation with the lysate, sepharose beads were washed three 
times with 50 ml of wash buffer (25 mM HEPES pH 7.2 (KOH), 500 mM KCl, 5 mM MgCl2, 
50 mM imidazole, 0.02 % (v/v) MTG) in batch via centrifugation (3.000 rpm, 5 min, 4°C). For the 
elution, beads were transferred to an empty Econo-Pac ®chromatography column. The complexes 
were eluted in 1 ml steps using elution buffer (25 mM HEPES pH 7.2 (KOH), 500 mM KCl, 5 mM 
MgCl2, 200 mM Imidazole, 0.02 % (v/v) MTG). After determining the protein concentration with the 
Bradford assay, those fraction which contained most protein were pooled and the proteins 
concentrated using a 100 kDa cut-off Amicon® Ultra (Merck-Millipore). From the concentrated 
Ni-bead eluate, aggregates were removed via ultracentrifugation within an Optima™ TLX 
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ultracentrifuge equipped with TLA45/55 rotor from Beckman Coulter (100.000 ×g, 15 min, 4°C). 
Subsequently, the eluate was run over a pre-equilibrated Superose6 column coupled to an Ettan FC 
FPLC system (both GE Healthcare) with storage buffer (25 mM HEPES pH 7.2 (KOH), 200 mM KCl, 
5 mM MgCl2, 10 % (w/v) glycerol, 0.02 % (v/v) MTG) while collecting 0.5 ml fractions. Fractions 
expected to contain the purified protein complexes were inspected by SDS-PAGE with Coomassie 
staining. Finally, those fractions which contained stoichiometric amounts of the complexes were 
pooled, concentrated if necessary, aliquoted, snap-frozen in liquid nitrogen, and stored at -80°C. 
 
4.5.8 COPII Pulldown Assay with Syntaxin5205-328-GST 
 
For the pulldown assay, control GST or Stx5205-328-GST were centrifuged in a TLA45/55 rotor using an 
Optima™ TLX ultracentrifuge from Beckman Coulter (100.000 ×g, 1 h, 4°C) to remove protein 
aggregated. Subsequently, 100 µg of the control GST or 150 µg or the Stx5-GST fragment were 
incubated with 10 µl of pure Glutathione Sepharose 4B (GE Healthcare) in 0.5 ml of assay buffer 
(25 mM HEPES pH 7.2 (KOH), 200 mM KCl, 5 mM MgCl2) for 1 h at 8°C, rotating. Following the 
incubation, the beads were washed twice with 1 ml of assay buffer (3.000 rpm, 2 min, 4°C) using an 
Eppendorf tabletop centrifuge 5417 R. Afterwards, the beads were in a second round incubated with 
30 µg of purified HT-Sec23A/Sec24D variants in a total volume of 0.5 ml for 1 h in the cold room. 
Subsequently, the beads were again washed twice by centrifugation (3.000 rpm, 2 min, 4°C). Bound 
material was eluted by boiling the beads in SDS sample buffer. The resulting samples (40 %) were 
separated by SDS-PAGE and analyzed for the presence of Sec23 by Western blotting. To control for 
equal loading, the lower part of the SDS gel containing the GST constructs was subjected to 
Coomassie staining. 
 
4.6 Cell Biology Methods 
 
4.6.1 Tissue Culture of Mammalian Cells 
 
All mammalian cells used in this study were grown adherent in flasks or on dishes. They were 
cultivated at 37°C in incubators with 5 % CO2. HeLa cells were grown in αMEM medium 
(Sigma-Aldrich) but transferred to DMEM for SILAC experiments. All other cells were generally grown 
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in DMEM (Sigma-Aldrich). Cells were usually grown up to 70-90 % confluency before splitting/dilution 
using Trypsin-EDTA solution (Sigma-Aldrich).  
 
4.6.2 Freezing of Mammalian Cells 
 
For freezing, cells from one 15 cm dish were trypsinized, harvested by centrifugation (300 ×g, 5 min, 
4°C) and gently resuspended in a tiny amount of residual medium. Afterwards, the cells were mixed 
with 1.5 ml of FCS and incubated on ice for 20 minutes. Finally, the resuspended cells were mixed 
with 1.5 ml of ice-cold freezing medium (DMEM supplemented with 20 % DMSO) and transferred 
into Cryo.S™ vials (Greiner Bio-One). The vials were stored at -80°C for 24-48 hours before being 
transferred to a liquid nitrogen tank. 
 
4.6.3 Mycoplasma Treatment 
 
In order to remove mycoplasma contaminations from the fibroblast cells, they were treated with 
BM-cyclin (Roche). The treatment was performed following the instructions provided by the 
manufacturer. Success of the treatment was assessed based on an inspection of the cells using 
fluorescence microscopy and DAPI staining. 
 
4.6.4 Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) 
 
For proteomics experiments, HeLa and HepG2 cells, as well as iMΦ were labeled with heavy lysine 
and arginine. To this end, an SILAC-Lys8-Arg10-Kit (Silantes) was used. To prevent arginine to proline 
conversion by the cells, the DMEM medium was further supplemented with 200 mg/l of L-proline 
(Bendall et al., 2008). Cells were cultivated in heavy amino acid containing medium for five passages 
(approx. 2 weeks) before a small sample was taken. The sample was boiled in SDS-sample buffer, 
subjected to SDS-PAGE, and analyzed by MS for the incorporation of heavy amino acids. Only when 
an incorporation >95 % was reached the cells were used for experiments. 
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4.6.5 Culture of Sf9 Insect Cells 
 
Sf9 insect cells were grown non-adherent in GIBCO SF-900 II SFM medium (Life Technologies) in 
CELLMASTER Roller Bottles from Greiner Bio-One. The cells were cultured at a temperature of 27°C 
shaking at 180 rpm. Density of Sf9 cells was monitored every 2-3 days using a Neubauer improved 
counting chamber (Assistent). In order to provide optimal growth conditions, cells were grown at a 
density of 0.8×106–8×106 cell/ml. 
 
4.6.6 Transfection of Sf9 Insect Cells and Baculovirus Production 
 
Transfection of Sf9 cells was performed with isolated Bacmid DNA. To this end, the isolated DNA was 
dissolved in 20 µl of ddH2O and subsequently mixed with 200 µl GIBCO SF-900 II SFM medium 
(Life Technologies). Meanwhile, 15 µl of X-tremeGENE™ HP Transfection Reagent (Roche) were 
diluted in 100 µl of the Sf9 cell medium. Afterwards, the DNA containing medium and the diluted 
transfection reagent were mixed. Transfections were always performed in duplicate. Hence, 160 µl of 
the transfection mixture was added to two wells of a 6-well plate each containing 3 ml of Sf9 cells 
with a density of 0.25×106 cells/ml. The transfected cells were incubated at 27°C for 72h before 
harvest of the supernatant which contains the first virus generation (P1). To the cells, 3ml of fresh Sf9 
cell medium was added and the cells were incubated for 48 more hours. After two days, the cells 
were resuspended in the medium and harvested in a tabletop centrifuge (13.000 rpm, 1 min). The 
harvested cells were resuspended in SDS sample buffer, boiled, and a small sample loaded onto an 
SDS gel followed by Coomassie staining to assess the success of transfection. 
From the P1 virus, a second generation of virus (P2) was produced by infecting 50 ml of Sf9 cells with 
a density of 0.8×106 cells/ml with 1 and 2 ml of P1 virus. The virus was expanded for 72h by 
incubating the infected cells at 27° and shaking with 70 rpm. Following virus expansion, the 
supernatant containing the P2 virus generation was separated from the Sf9 cells (4.000 rpm, 5 min, 
4°C). The different P2 viruses were next tested in small scale expressions before being used on a 
large scale. To this end, 50 ml of Sf9 cells (2×106 cells/ml) were infected with different amounts of P2 
virus (between 200-800 µl). Three days after the infection, a small sample of the cells was prepared 
for analysis via SDS-PAGE and Coomassie staining. The virus concentration which produced the best 
expression was upscaled and used for final 500 ml expressions. 
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4.6.7 Preparation of Baculovirus-Infected Cell (BIC) Stocks 
 
For later expressions, stocks of baculovirus-infected Sf9 cells (BIC stocks) were prepared. For this, 
200 ml of cells (1×106 cells/ml) were infected with the amount of P2 virus used to infect 500 ml 
expression cultures. The cells were infected with the virus for 24 h. After the infection, the BIC were 
harvested gently (1.200 rpm, 5 min, 4°C), resuspended in 20 ml of freezing medium (60 % GIBCO 
SF-900 II SFM medium, 30 % FCS, 10 % DMSO) and aliquoted (usually 1 ml aliquots). The BIC stocks 
were immediately put to -80°C for 48 h before being transferred to liquid nitrogen for long term 
storage. Potency of the stocks was tested in small scale test expressions. 
 
4.6.8 Large Scale Expression of Protein Complexes in Sf9 Cells 
 
Large scale expressions of protein complexes, i.e. coatomer, Sec23/Sec24, and Sec13/Sec31 were 
performed in 500 ml Sf9 cells at a starting density of 2×106 cells/ml. The cells were infected with 
either P2 virus or with BIC stocks using optimal virus titers which have been determined in small 
scale expressions beforehand. The infected cells were allowed to express the proteins for 72-96 h. 
After the expression, cells were harvested (2.000 rpm, 5 min, 4°C), snap-frozen in liquid nitrogen and 
immediately stored at -80°C. 
 
4.6.9 Preparation of Semi-intact Mammalian Cells (SIC) 
 
Semi-intact cells for subsequent vesicle reconstitution assays were prepared basically as described by 
Mancias and Goldberg (2007). Briefly, mammalian cells grown adherent to 70-90% confluency were 
detached with Trypsin-EDTA solution (Sigma-Aldrich). The protease was inactivate by adding 300 µl 
of 1 mg/ml trypsin inhibitor (Sigma-Aldrich) followed by resuspension of the cells in 20 ml of PBS 
(35.7 mM Na2HPO4, 14.3 mM KH2PO4, 136 mM NaCl, 3 mM KCl) for one 15 cm dish. The cells were 
subsequently harvested via centrifugation (300 ×g, 5 min, 4°C) and resuspended again in 10 ml PBS. 
At this step, cells originating from two 15 cm dishes were combined in one 50 ml falcon tube. Next, 
20 µl of 40 mg/ml digitonin (Sigma-Aldrich) was added to each falcon tube, the cells were mixed with 
the detergent by inversion (3-4 times) and incubated on ice for 5 min. The permeabilization was 
quenched by adding 30 ml of cold PBS. The now semi-intact cells were harvested (300 ×g, 5 min, 4°C), 
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resuspended in 50 ml of assay buffer (25 mM HEPES pH 7.2 (KOH), 200 mM KCl, 5 mM MgCl2) and 
incubated on ice for 10 min for further removal of the cytosol. Afterwards, the SIC were harvested 
again (300 ×g, 5 min, 4°C) and resuspended in a small volume of assay buffer (0.3-0.5 ml). The protein 
concentration of the SIC was subsequently determined via the Bradford assay and the cells were 
used for a reconstitution assay within 1 h after preparation. 
 
4.6.10 Preparation of HeLa Cell Cytosol 
 
For preparation of cytosol, cells from 6 confluent 15 cm dishes were trypsinized and resuspended in 
20 ml of PBS (35.7 mM Na2HPO4, 14.3 mM KH2PO4, 136 mM NaCl, 3 mM KCl) per dish, supplemented 
with 300 µl of 1 mg/ml trypsin inhibitor (Sigma-Aldrich). The cells were subsequently harvested via 
centrifugation (300 ×g, 5 min, 4°C), combined, and washed with 50 ml of assay buffer (25 mM HEPES 
pH 7.2 (KOH), 200 mM KCl, 5 mM MgCl2). After the second harvest, cells were resuspended in a small 
volume (~1 ml) of assay buffer. Cell lysis was achieved through nitrogen cavitation (800 psi, 30 min, 
on ice) using a 4639 cell disruption vessel (Parr Instruments). The soluble cytosolic fraction was 
cleared from debris via centrifugation at 100.000 ×g within an Optima™ TLX ultracentrifuge and a 
TLA45/55 rotor (Beckman Coulter) at 4°C for 1 h. 
 
4.6.11 In vitro reconstitution of COPI and COPII Vesicles from SIC 
 
In vitro reconstitution of COPI and COPII vesicles was essentially performed as described previously 
by Adolf et al. (2013). Briefly, first recombinant proteins used for reconstitution reactions were 
centrifuged using a Beckman Coulter Optima™ TLX ultracentrifuge equipped with a TLA45/55 rotor 
(100.000 ×g, 15 min, 4°C) to remove aggregates. Afterwards, semi-intact cells were prepared as 
described above. For a regular COPII reconstitution reaction, 200 µg of SIC were incubated with 4 µg 
of Sar1, 8 µg of HT-Sec23/Sec24, and 10 µg of HT-Sec13/Sec31. COPI reconstitution from 200 µg SIC 
was performed with 4 µg of Arf and 10 µg of OST-coatomer. For both, COPI and COPII budding 
reactions, SIC and proteins were incubated with ATP-regenerating system (40 mM creatine 
phosphate (Sigma-Aldrich), 0.2 mg/mL creatine kinase (Roche), 1 mM ATP (Roche)) and guanine-
nucleotide (1 mM GTP (Affymetrix) or 0.2 mM GMP-PNP/GTPγS (Sigma-Aldrich)) for 30 minutes at 
30°C in a final volume of 200 or 400 µl of assay buffer (25 mM HEPES pH 7.2 (KOH), 200 mM KCl, 
5 mM MgCl2). For some experiments, 150 µg of cytosol per 200 µg of SIC was added to the 
Materials and Methods 
126 
 
incubation. In negative controls either nucleotides or crucial coat proteins were omitted. After 
30 min, generated vesicles were separated from SIC via medium-speed centrifugation (14.000 ×g, 
10 min, 4°C) in a table top centrifuge. The vesicle containing supernatant was immediately 
transferred to a fresh tube and the vesicles were either harvested directly by high-speed 
centrifugation (100.000 ×g, 30 min, 4°C) using a TLA45/55 rotor or subjected to further purification 
via floatation. 
 
4.6.12 Floatation of Vesicles using an Iodixanol Density Gradient 
 
In order to separate reconstituted vesicles form the excess of recombinant coat proteins, they were 
subjected to density gradient floatation. To this end, vesicle containing supernatant, obtained after 
medium-speed centrifugation, was brought to 40% iodixanol concentration and the whole sample 
was adjusted to 1x assay buffer (25 mM HEPES pH 7.2 (KOH), 200 mM KCl, 5 mM MgCl2). The final 
volume of the load sample was 700 µl. It was subsequently put into a 4 ml UltraClear™ Thinwall 
SW-60 Tube (Beckman Coulter), overlaid with 1200 µl of 30% iodixanol and finally 400 µl of 20% 
iodixanol density gradient matrix both prepared in 1x assay buffer. The gradient was ultracentrifuged 
over night (14-16 h) at 250.000 ×g and 4°C in a Optima™ LE-80L/L-90K ultracentrifuge equipped with 
a SW-60 rotor (Beckman Coulter). To initially assess the movement of vesicles, 10 fractions (230 µl) 
were taken from top to bottom, diluted with 770 µl assay buffer and centrifuged in a TLA45/55 rotor 
from Beckman Coulter (100.000 ×g, 2 h, 4°C). The harvested material was boiled in SDS sample buffer 
and subjected to Western blot analysis. 
 
4.6.13 Vesicle Reconstitution for SILAC Proteomics 
 
For a single SILAC mass spectrometry sample, two vesicle reconstitution or a vesicles reconstitution 
plus a mock reaction were performed in parallel. One of the reactions was performed with light SIC, 
the other reaction from SILAC-labeled heavy cells. In total, 1200 µg of SIC were used for each 
condition, split into 6 separate budding reactions. Following the budding reaction, the samples were 
subjected to floatation within iodixanol density gradients. From each gradient, the top 200 µl were 
discarded and one major vesicle containing 500 µl fraction taken. This fraction was diluted with 1 ml 
of assay buffer and subjected to ultracentrifugation using a Beckman Coulter Optima™ TLX 
ultracentrifuge equipped with a TLA45/55 rotor (100.000 ×g, 2 h, 4°C). The supernatant was again 
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discarded and the harvested material from each gradient was solubilized within 5 µl of SDS sample 
buffer and boiling at 95°C for 10 min. All sub-samples were combined into one large sample 
containing the floated/harvested material from one reaction performed with light and one reaction 
performed with heavy SIC. The final sample was briefly run into a pre-cast Novex™ 10% Tris-Glycine 
Gel (Invitrogen), just so that the sample had entered the gel. The gel was subsequently stained with 
Roti-Blue colloidal Coomassie (Roth), de-stained in de-ionized water and handed over to the MS 
facility for downstream analyses. 
All SILAC experiments were performed at least in duplicate with switched labels to make sure that 
the labeling procedure had no influence on the cells. 
 
4.7 Imaging, Mass Spectrometry and Data Analysis 
 
4.7.1 Immunofluorescence Assay (IFA) and Confocal Microscopy 
 
For immunofluorescence assays, 0.5-1.0×105 cells were seeded onto sterile cover slips (Roth) in a 
24-well plate in the evening and cultivated over night for 12-16 h prior to the assay. On the next day, 
the cells were washed twice with 2-3 ml of PBS (35.7 mM Na2HPO4, 14.3 mM KH2PO4, 136 mM NaCl, 
3 mM KCl) before permeabilization/fixation by incubating the cells with ice-cold, pure methanol for 
20 min at -20°C. After incubation with methanol, cells were washed again twice with PBS before 
incubation with PBS containing 1 % (w/v) BSA (Sigma-Aldrich) for 30-60 minutes at room 
temperature to prevent later unspecific binding of antibodies. After this blocking step, the cells were 
incubated with first antibodies, diluted in 1 % BSA-PBS by putting the cover slips onto small drops of 
the antibody solutions in a humidified Petri dish. Incubation with the primary antibodies was 
performed over night (12-16 h) at 8°C. On the following day, unbound antibodies were removed by 
washing the cover slips twice by putting them on drops of PBS and letting them sit for 5-10 minutes. 
Afterwards, the samples were incubated with secondary antibodies diluted in 1 % (w/v) BSA-PBS for 
60 minutes in the dark at room temperature. The cover slips were washed two more times with PBS 
and once with ddH2O before mounting onto microscopy glass slides using 5-10 µl of DAPI containing 
ProLong™ Gold Antifade (Life Technologies). Samples were kept at 8°C in the dark until imaging. 
Imaging of the samples was performed at the Nikon Imaging Center at the Heidelberg University 
using a PerkinElmer ERS-6 spinning disk confocal microscope. Z-stacks were acquired in 150 nm steps 
with a 100× oil immersion objective using the PerkinElmer Volocity 6.3 software to operate the 
Materials and Methods 
128 
 
microscope. They were further subjected to deconvolution using the Huygens Remote Manager 
v3.4.1. Downstream processing of the images was done with Fiji/ImageJ 2.0.0-rc-54 software. 
 
4.7.2 Electron Microscopy 
 
Electron microscopy was performed at the Interdisciplinary Center for Neurosciences of the 
Heidelberg University (IZN). For resin-embedding, in vitro reconstituted COPI vesicles were purified 
via floatation within an iodixanol gradient. Vesicles from three gradients were sequentially harvested 
by centrifugation (100.000 ×g, 1 h, 4°C) as described above in the presence of 2 % glutaraldehyde 
(v/v) dissolved in assay buffer (25 mM HEPES pH 7.2 (KOH), 200 mM KCl, 5 mM MgCl2). The vesicles 
were then resuspended in 10 µl assay buffer and the samples further prepared as described 
previously by Adolf et al. (2013). Briefly, tannic acid in assay buffer was added to a final 
concentration of 0.5 % (w/v) and the samples incubated for 1 h. Subsequently, the samples were 
washed, treated with 2 % (v/v) osmium tetroxide/ 1.5 % (w/v) ferrocyanide and washed again. 
Finally, samples were stained with uranyl acetate and embedded using glycid ether 100. Ultrathin 
sections of the embedded samples were further contrasted with uranyl acetate/ lead citrate. Image 
acquisition was performed at an EM 10 transmission electron microscope from Carl Zeiss operated at 
60 kV. 
Negative stain EM was performed on vesicles reconstituted as described previously (Beck et al., 
2008). Samples were adsorbed onto a carbon grid for 30 min. The sample was subsequently fixed for 
10 min by putting it on a drop of 1 % (v/v) glutaraldehyde in assay buffer and then washed in the 
same way with just buffer three times for 1 min. The samples were then treated with 0.05 % (w/v) 
tannic acid for 5 minutes and washed again four times with water. Contrasting was achieved by 
incubating the grids on a drop of water containing 0.4 % (w/v) uranyl acetate/ 1.8 % methyl cellulose 
on an ice block. Finally, excess of contrasting solution was removed from the grids and they were 
dried at room temperature. 
 
4.7.1 Size Determination of COPI Vesicles 
 
Bioinformatics to determine the size of vesicles was performed at the Biomedical Computer Vision 
Group of the Heidelberg University and the DKFZ. Briefly, size determination was achieved by 
employing the segmentation routine introduced by Dimopoulos et al. which exploits the membrane 
pattern for the detection of an object boundary (Dimopoulos et al., 2014). We performed a semi-
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automated segmentation. First all intact vesicles were localized manually and subsequently used as 
seeds for the following segmentation. Second, the method described by Dimopoulos et al. (2014) 
was performed to obtain the membrane profiles of a few examples. Segmented vesicles displaying a 
low-score were excluded from the further analyses. Finally, the vesicle area enclosed by its 
membrane was computed from the pixel size information.  
 
4.7.2 Mass Spectrometry of Reconstituted Vesicles 
 
Mass spectrometric analysis was performed at the Core Facility for Mass Spectrometry and 
Proteomics of the Center for Molecular Biology of the Heidelberg University (ZMBH). In summary, gel 
pieces were excised, reduced with DTT, alkylated with iodoacetamide and trypsin-digested using a 
DigestPro MSi platform (Intavis) as described previously (Shevchenko et al., 2006). Following in-gel 
digest, peptides were analyzed by liquid chromatography with subsequent mass spectrometry 
(LC-MS). LC was performed with an UltiMate 3000 directly coupled either to an Orbitrap Elite™ or a Q 
Exactive™ for MS analysis (all instruments from Thermo Fisher Scientific). For analysis with the 
Orbitrap Elite™, peptides were loaded onto an Acclaim™ PepMap™ 100 C-18 Trap-column (Thermo 
Fisher Scientific) at a flow rate of 30 µl/min using 0.1 % trifluoroacetic acid. The peptides were eluted 
from the trap-column and further separated using a 75 µm x 250 mm Acclaim™ PepMap™ 100 C-18 
RSLC analytical column (Thermo Fisher Scientific). Elution was performed with a gradient starting 
with 3 % buffer A (0.1% formic acid, 1 % acetonitrile) and ending with 40 % buffer B (0.1% formic 
acid, 90 % acetonitrile) over the course of 2 h with a flow rate of 300 nl/min. MS data acquisition was 
performed through automatic switches between a full scan and up to 30 data-dependent MS/MS 
scans. For samples analyzed with the Q Exactive™, peptides were directly loaded onto a 
75 µm x 300 mm column packed with ReproSil Pur™ C18 AQ (Dr. Maisch HPLC) and eluted with the 
same 2 h gradient just described. Here, MS data was acquired with automatic switches between a full 
scan and up to 15 data-dependent MS/MS. 
The initial data analysis was performed with MaxQuant v1.5.3.8 (Cox and Mann, 2008). Standard 
setting for each instrument type were used and a search performed against human or mouse protein 
databases extracted from UniProt (The UniProt, 2017). Carbamidomethylation of cysteine residues 
was set as fixed modification. Methionine oxidation, asparagine and glutamine deamination, and 
N-terminal acetylation were set as variable modifications. The options “match between runs” and 
“requantify” were both enabled. All results were filtered for a false discovery rate of 1% on a peptide 
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spectrum match and on protein level. The MaxQuant output files were downstream processed and 
analyzed using R-Script and Microsoft Excel. 
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6 Appendix 
 
6.1 Abbreviations 
 
AP  Adaptor protein complex 
Arf  ADP-ribosylation factor 
ATP  Adenosine 5′-triphosphate 
Bet1  Blocked in early transport 1 homologue; ER-Golgi Q-SNARE 
BFA  Brefeldin A 
BSA  Bovine serum albumin 
CBB  Coomassie brilliant blue 
CCV  clathrin-coated vesicle 
CM  Coatomer 
COPI  Coat protein complex I 
COPII  Coat protein complex II 
DMEM  Dulbecco’s modified eagle’s medium 
DMSO  Dimethyl sulfoxide 
DNA  Desoxyribonucleic acid 
DTT  Dithiothreitol 
EDTA  Ethylenediaminetetraacetic acid 
ER  Endoplasmic reticulum 
ERGIC  ER-Golgi intermediate compartment 
GAP  GTPase-activating protein 
GBF1  Golgi-specific brefeldin A-resistant factor 1 
GDP  Guanosine 5′-diphosphate 
GEF  Guanine nucleotide exchange factor 
GGA  Golgi-localized, gamma ear-containing, Arf-binding proteins 
GM130  Cis-Golgi matrix protein of 130 kDa 
GMP-PNP Guanosine-5′-O-[β,γ-imido]-triphosphate 
GP  Glycosylphosphatidylinositol 
GS15  Golgi SNARE of 15 kDa; intra-Golgi Q-SNARE 
GS27  Golgi SNARE of 27 kDa; ER-Golgi Q-SNARE 
GS28  Golgi SNARE of 28 kDa; intra-Golgi Q-SNARE 
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GST  Glutathione-S-transferase 
GTP  Guanosine-5′-triphosphate 
GTPγS  Guanosine-5′-O-[γ-thio]-triphosphate 
HeLa  Human epithelial cell line derived from cervical cancer 
HEPES  4-(2-hydroxyethyl)-1-piperazin-ethansulfonic acid 
HepG2  Human cell line derived from hepatic cancer 
IFA  Immunofluorescence assay 
iMΦ  Immortalized murine macrophages 
IP  Immunoprecipitation 
IPTG  Isopropyl-1-thio-β-D-galactopyranoside 
KDEL  ER-retrieval sequence composed of Lysine (K)-Aspartate (D)-Glutamate (E)-Leucine 
(L) 
kDa  Kilo Dalton 
LB  Luria broth 
OD  Optical density 
p24  Transmembrane emp24 domain-containing protein 
PBS  Phosphate buffer saline 
PBST  Phosphate buffer saline + Tween 20 
PCR  Polymerase chain reaction 
psi  Pounds per square inch 
PVDF  Polyvinyldifluoride 
rpm  Revolutions per minute 
Sar1  Secretion-associated and Ras-related protein 1 
SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
Sec  Secretion mutant 
Sec22b  Vesicle-trafficking protein Sec22b; ER-Golgi R-SNARE 
SEM  Standard error of the mean 
Sf9 cells Insect cell line derived from Sf21 (spodoptera frugiperda) ovarie cells  
SNARE  N- ethylmaleimide sensitive-factor attachment receptors  
SRP  Signal recognition particle 
Stx5  Syntaxin5; ER-Golgi Q-SNARE 
TGN  Trans-Golgi network 
×g  Times gravity 
Ykt6  Synaptobrevin homologueYkt6; intra-Golgi R-SNARE 
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6.2 Publications 
 
Major parts of this thesis are presented in the following manuscripts: 
Rhiel, M., Hessling, B., Gao, Q., Hellwig, A., Adolf, F., and Wieland, F.T. (2017). Quantitative 
proteomics of isotypic mammalian COPI vesicles. In preparation. 
Adolf, F., Rhiel, M., Hessling, B., Hellwig, A., and Wieland, F.T. (2017). SILAC-based proteomic profiling 
of mammalian COPII vesicles. In preparation. 
 
Further publications: 
Adolf, F., Rhiel, M., Reckmann, I., and Wieland, F.T. (2016). Sec24C/D-isoform-specific sorting of the 
preassembled ER-Golgi Q-SNARE complex. Mol. Biol. Cell 27, 2697-2707. 
Rhiel, M., Bittl, V., Tribensky, A., Charnaud, S.C., Strecker, M., Muller, S., Lanzer, M., Sanchez, C., 
Schaeffer-Reiss, C., Westermann, B., Crabb, B.S., Gilson, P.R., Külzer, S., and Przyborski, J.M. (2016). 
Trafficking of the exported P. falciparum chaperone PfHsp70x. Sci Rep 6, 36174.  
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